[
  {
    "question_number": "Q44",
    "question_text": "What is the typical serum potassium level in Hypokalemic Periodic Paralysis?",
    "options": "{\"A\": \"Low\", \"B\": \"Normal\", \"C\": \"High\", \"D\": \"Variable\"}",
    "correct_answer": "A",
    "source_file": "Part 1 2021_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2021,
    "explanation": "Classification Reason: Tests knowledge of the specific electrolyte abnormality (low potassium) during attacks in a channelopathy affecting muscle function (Hypokalemic Periodic Paralysis).",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q56",
    "question_text": "A patient presents with progressive proximal weakness and an autosomal recessive pattern in siblings. Creatine kinase is elevated, and EMG shows motor unit action potentials (MUAP). What is the likely diagnosis?",
    "options": "{\"A\": \"Spinal Muscular Atrophy (SMA)\", \"B\": \"Duchenne Muscular Dystrophy\", \"C\": \"Limb-Girdle Muscular Dystrophy\", \"D\": \"Congenital Myopathy\"}",
    "correct_answer": "A",
    "source_file": "Part 1 2021_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2021,
    "explanation": "Classification Reason: Describes features (weakness pattern, inheritance, CK, EMG findings) pointing towards a neuromuscular disorder, specifically SMA (a motor neuron disease affecting muscle function).",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q56",
    "question_text": "A patient presents with progressive proximal weakness and an autosomal recessive pattern in siblings. Creatine kinase is elevated, and EMG shows motor unit action potentials (MUAP). What is the likely diagnosis?",
    "options": "{\"A\": \"Spinal Muscular Atrophy (SMA)\", \"B\": \"Duchenne Muscular Dystrophy\", \"C\": \"Limb-Girdle Muscular Dystrophy\", \"D\": \"Myasthenia Gravis\"}",
    "correct_answer": "A",
    "source_file": "Part 1 2021_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2021,
    "explanation": "Classification Reason: Describes features (weakness pattern, inheritance, CK, EMG findings) pointing towards a neuromuscular disorder, specifically SMA (a motor neuron disease affecting muscle function).",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q324",
    "question_text": "A female patient with myasthenia gravis (MG) and thymus hyperplasia (grade 4) shows no improvement in her symptoms. What is the recommended management?",
    "options": "{\"A\": \"Thymus removal\", \"B\": \"Steroid therapy\", \"C\": \"Plasma exchange\", \"D\": \"Immunosuppressive therapy\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2021_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2021,
    "explanation": "Classification Reason: Focuses on the management (specifically thymectomy indication) of Myasthenia Gravis, a neuromuscular junction disorder.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q200",
    "question_text": "A 48-year-old male presents with toe walking and weakness. His family history reveals normal parents (cousin) and one affected sister. Which of the following conditions is least likely to be the cause of his symptoms?",
    "options": "{\"A\": \"Calpainopathy\", \"B\": \"Dysferlinopathy\", \"C\": \"Lamininopathy\", \"D\": \"Sarcoglycanopathy\"}",
    "correct_answer": "B",
    "source_file": "Part II 2019_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2019,
    "explanation": "Classification Reason: Presents a likely inherited muscle disease scenario (suggestive of limb-girdle muscular dystrophy) and requires knowledge of different genetic myopathies to determine the least likely diagnosis.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q110",
    "question_text": "A 40-year-old male presented to the outpatient clinic with a history of progressive bilateral upper and lower limb proximal weakness. There are no cranial nerve or bulbar symptoms, and no other systemic symptoms. On examination, there is muscle tenderness but no skin manifestation. Lab investigations showed CK of 40,000. Muscle biopsy showed perifascicular atrophy. Which antibody is associated with the patient's diagnosis?",
    "options": "{\"A\": \"Anti-HMGCR\", \"B\": \"Anti-Jo-1\", \"C\": \"Anti-Mi-2\", \"D\": \"Anti-SRP\"}",
    "correct_answer": "C",
    "source_file": "Part I 2023_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2023,
    "explanation": "Classification Reason: Focuses on clinical features (proximal weakness, high CK), biopsy findings (perifascicular atrophy suggesting dermatomyositis despite lack of rash), and associated autoantibodies characteristic of inflammatory myopathies. As per instructions, inflammatory/autoimmune muscle diseases are classified under Neuromuscular.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q110",
    "question_text": "A 40-year-old male presented to the outpatient clinic with a history of progressive bilateral upper and lower limb proximal weakness. There are no cranial nerve or bulbar symptoms, and no other systemic symptoms. On examination, there is muscle tenderness but no skin manifestation. Lab investigations showed CK of 40,000. Muscle biopsy showed perifascicular atrophy. Which antibody is associated with the patient's diagnosis?",
    "options": "{\"A\": \"Anti-HMGCR\", \"B\": \"Anti-Jo-1\", \"C\": \"Anti-Mi-2\", \"D\": \"Anti-SRP\"}",
    "correct_answer": "C",
    "source_file": "Part I 2023_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2023,
    "explanation": "Classification Reason: Describes clinical features (proximal weakness, high CK), specific muscle biopsy findings (perifascicular atrophy strongly suggesting Dermatomyositis), and asks for an associated autoantibody (Anti-Mi-2 is associated with classic Dermatomyositis). This falls under inflammatory muscle disease, classified as Neuromuscular per instructions.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q4",
    "question_text": "Which of the following genetic mutations is associated with myotonic dystrophy type 1 (DM1)?",
    "options": "{\"A\": \"CTG\", \"B\": \"CCTG\", \"C\": \"GAA\", \"D\": \"CGG\"}",
    "correct_answer": "A",
    "source_file": "Part 1 2020_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2020,
    "explanation": "Classification Reason: Asks for the specific genetic repeat expansion (CTG) responsible for Myotonic Dystrophy type 1, a primary neuromuscular disorder.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q11",
    "question_text": "What is the inheritance pattern of paramyotonia congenita?",
    "options": "{\"A\": \"Autosomal dominant\", \"B\": \"Autosomal recessive\", \"C\": \"X-linked\", \"D\": \"Sporadic\"}",
    "correct_answer": "A",
    "source_file": "Part 1 2020_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2020,
    "explanation": "Classification Reason: Asks for the mode of inheritance for paramyotonia congenita, a genetic neuromuscular channelopathy causing myotonia.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q14",
    "question_text": "In a scenario of a patient with cardiomegaly, bilateral carpal tunnel syndrome, peripheral sensory polyneuropathy, and autonomic symptoms with a family history of similar symptoms, what would you order?",
    "options": "{\"A\": \"Transthyretin\", \"B\": \"Genetic testing\", \"C\": \"Echocardiogram\", \"D\": \"Nerve conduction studies\"}",
    "correct_answer": "B",
    "source_file": "Part 1 2020_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2020,
    "explanation": "Classification Reason: Describes classic features of Familial Amyloid Polyneuropathy (FAP), particularly the TTR type, and asks for the key diagnostic test (Transthyretin gene testing or protein analysis).",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q26",
    "question_text": "In a case scenario of a patient with an androgen receptor gene defect suggestive of Kennedy syndrome, what associated findings should be expected?",
    "options": "{\"A\": \"Diabetes Mellitus (DM)\", \"B\": \"Hepatomegaly\", \"C\": \"Testicular atrophy\", \"D\": \"Gynecomastia\"}",
    "correct_answer": "C",
    "source_file": "Part 1 2021_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2021,
    "explanation": "Classification Reason: Focuses on the associated systemic (endocrine) features, like gynecomastia and testicular atrophy, characteristic of Kennedy Syndrome (Spinal and Bulbar Muscular Atrophy), a neuromuscular disease.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q36",
    "question_text": "In a scenario of Hereditary Sensory and Autonomic Neuropathy type 1 (HSAN 1) characterized by painful ulcers and mutilation, which gene is implicated?",
    "options": "{\"A\": \"SPTLC1\", \"B\": \"IKABh\", \"C\": \"TRKA\", \"D\": \"RAB7\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2020 copy_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2020,
    "explanation": "Classification Reason: Links a specific type of hereditary neuropathy (HSAN 1) with its characteristic phenotype (sensory loss, ulcers) to the causative gene (SPTLC1).",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q59",
    "question_text": "In a case of Kennedy disease (imbalance, muscle cramps and perioral fasciculation, proximal weakness, bulbar weakness, shin twitching, no mention of gynecomastia), what will be found on genetic test?",
    "options": "{\"A\": \"CTG\", \"B\": \"GAA\", \"C\": \"CGG\", \"D\": \"CAG\"}",
    "correct_answer": "D",
    "source_file": "Part 2 Adult Neurology residency 2024 V9_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Describes clinical features of Kennedy disease (SBMA) and asks for the specific type of genetic mutation (CAG repeat expansion in the androgen receptor gene).",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q121",
    "question_text": "A young female presents with recurrent neuropathy after minor trauma. Which of the following is the most likely diagnosis?",
    "options": "{\"A\": \"PMP22 deletion\", \"B\": \"PMZ0\", \"C\": \"PMP22 duplication\", \"D\": \"MPZ mutation\"}",
    "correct_answer": "A",
    "source_file": "Part II 2019_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2019,
    "explanation": "Classification Reason: Describes the classic presentation of Hereditary Neuropathy with liability to Pressure Palsies (HNPP) and asks for the underlying genetic mechanism (PMP22 deletion).",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q122",
    "question_text": "A 30-year-old male has severe demyelinating neuropathy with palpable nerves and a biopsy showing onion bulbs and elevated CSF protein. What is the most likely diagnosis?",
    "options": "{\"A\": \"Charcot-Marie-Tooth disease type 1 (CMT1)\", \"B\": \"Charcot-Marie-Tooth disease type 2 (CMT2)\", \"C\": \"Charcot-Marie-Tooth disease type 3 (CMT3)\", \"D\": \"Charcot-Marie-Tooth disease type X (CMTx)\"}",
    "correct_answer": "C",
    "source_file": "Part II 2019_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2019,
    "explanation": "Classification Reason: Describes features highly suggestive of a severe, early-onset demyelinating neuropathy (Dejerine-Sottas syndrome or CMT3), requiring knowledge of CMT subtypes.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q155",
    "question_text": "What is the most common familial gene associated with amyotrophic lateral sclerosis (ALS)?",
    "options": "{\"A\": \"C9ORF72\", \"B\": \"TDP-43\", \"C\": \"SOD1\", \"D\": \"FUS\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2019_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2019,
    "explanation": "Classification Reason: Asks for the most frequent gene mutation (C9ORF72) linked to familial ALS, a primary motor neuron disease.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q157",
    "question_text": "A case of Duchenne muscular dystrophy presents with Gower's sign and calf hypertrophy. What is the most appropriate method to diagnose this condition?",
    "options": "{\"A\": \"Muscle biopsy\", \"B\": \"CK level\", \"C\": \"Genetic testing\", \"D\": \"Electromyography\"}",
    "correct_answer": "C",
    "source_file": "Promotion 2021_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2021,
    "explanation": "Classification Reason: Presents classic signs of Duchenne muscular dystrophy and asks for the gold standard diagnostic method (genetic testing), although CK and biopsy are also part of the workup.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q145",
    "question_text": "A male patient presents with sensory motor axonal neuropathy, decreased pain, temperature, and vibration sensation, along with a family history. What is the likely genetic mutation?",
    "options": "{\"A\": \"RET\", \"B\": \"SPTLC\", \"C\": \"TRKA\", \"D\": \"IKAP\"}",
    "correct_answer": "B",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Focuses on identifying a potential gene responsible for an inherited sensory/autonomic neuropathy (HSAN) based on clinical presentation.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q63",
    "question_text": "A patient was diagnosed with Metachromatic Leukodystrophy. What will you find on nerve conduction studies (NCS)?",
    "options": "{\"A\": \"Demyelinating neuropathy\", \"B\": \"Axonal neuropathy\", \"C\": \"Normal nerve conduction studies\", \"D\": \"Mixed demyelinating and axonal neuropathy\"}",
    "correct_answer": "A",
    "source_file": "Part 2 Adult Neurology residency 2024 V9_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Although Metachromatic Leukodystrophy is a genetic disorder, the question specifically asks about the nerve conduction study (NCS) findings (demyelinating neuropathy), which is a core diagnostic aspect within Neuromuscular neurology.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q151",
    "question_text": "A patient presented with lower limb distal weakness. The family pedigree showed autosomal dominant inheritance, and the scenario is suggestive of hereditary motor and sensory neuropathy (HMSN). The patient underwent genetic testing which showed no PMP22 duplication. What should be done next?",
    "options": "{\"A\": \"Repeat PMP22 test\", \"B\": \"Test for DGP1\", \"C\": \"Test for MPZ\", \"D\": \"Test for PMP22 deletion\"}",
    "correct_answer": "C",
    "source_file": "Promotion 2019_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2019,
    "explanation": "Classification Reason: Concerns the genetic diagnostic pathway and next steps for a patient with a hereditary neuropathy (Charcot-Marie-Tooth disease/HMSN), a primary Neuromuscular condition.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q39",
    "question_text": "A young man who went to sleep at 10 PM woke up at midnight with weakness in his whole body and shortness of breath. The attack resolved after a few hours. What is the mechanism of action of the treatment for this condition?",
    "options": "{\"A\": \"Cholinesterase\", \"B\": \"Carbonic anhydrase\", \"C\": \"Hypokalemic\", \"D\": \"Rest\"}",
    "correct_answer": "B",
    "source_file": "Part 2 2020 copy_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2020,
    "explanation": "Classification Reason: Describes symptoms suggestive of Hypokalemic Periodic Paralysis, a genetic channelopathy affecting muscle function. The question asks about treatment mechanism (related to carbonic anhydrase inhibitors), falling under Neuromuscular disorders.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q70",
    "question_text": "Which of the following statements is true regarding Paramyotonia congenita?",
    "options": "{\"A\": \"It is an autosomal dominant condition with equal incidence in males and females.\", \"B\": \"It is caused by mutations in the SCN4A gene.\", \"C\": \"The myotonia intensifies with exercise.\", \"D\": \"It typically presents with paradoxical myotonia worsening with cold exposure.\"}",
    "correct_answer": "C",
    "source_file": "Part I 2018_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2018,
    "explanation": "Classification Reason: Asks about the characteristics (inheritance, gene, clinical features like paradoxical myotonia) of Paramyotonia Congenita, a genetic sodium channelopathy causing myotonia, classified under Neuromuscular disorders.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q110",
    "question_text": "What is the diagnosis for a patient with symptoms consistent with Monomelic Amyotrophy (Hirayama disease)?",
    "options": "{\"A\": \"CIDP\", \"B\": \"AIDP\", \"C\": \"Monomelic Amyotrophy\", \"D\": \"ALS\"}",
    "correct_answer": "C",
    "source_file": "Part II 2018_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2018,
    "explanation": "Classification Reason: Asks for the diagnosis of Monomelic Amyotrophy (Hirayama disease), a focal lower motor neuron disorder affecting the distal upper limb, considered within the spectrum of Neuromuscular diseases.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q44",
    "question_text": "A 13-year-old boy presents for evaluation of muscle pain and stiffness over the past year. His muscle stiffness worsens in cold weather and was especially severe after ice-skating. He demonstrates percussion myotonia at the thenar eminence. Which channel mutation is most likely responsible for his presentation?",
    "options": "{\"A\": \"Sodium channel (SCN4A)\", \"B\": \"Chloride channel\", \"C\": \"Calcium channel\", \"D\": \"Potassium channel\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2020 copy_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2020,
    "explanation": "Classification Reason: Describes classic symptoms of Paramyotonia Congenita (cold-induced myotonia) and asks for the underlying genetic cause (SCN4A sodium channel mutation), a Neuromuscular channelopathy.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q76",
    "question_text": "A case about a male with external ophthalmoplegia and ptosis, with onset before he was 10 years old. What is the mutation associated with this condition?",
    "options": "{\"A\": \"Large deletion of mitochondrial DNA\", \"B\": \"Sporadic mutation in mitochondrial DNA\", \"C\": \"Mutation in ribosomal-related mitochondrial DNA\", \"D\": \"Point mutation in nuclear DNA affecting mitochondrial function\"}",
    "correct_answer": "A",
    "source_file": "Part I 2018_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2018,
    "explanation": "Classification Reason: Describes symptoms of Chronic Progressive External Ophthalmoplegia (CPEO), a mitochondrial myopathy. Although genetic, the primary manifestation is muscle weakness (ophthalmoplegia), placing it under Neuromuscular. The question links the phenotype to the common mutation type.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q176",
    "question_text": "In a patient with Type 2 Charcot-Marie-Tooth disease, what is the typical feature?",
    "options": "{\"A\": \"SNAP drop\", \"B\": \"Affects upper limbs more than lower limbs\", \"C\": \"Demyelination of peripheral nerves\", \"D\": \"Early onset muscle hypertrophy\"}",
    "correct_answer": "A",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Asks about specific clinical or electrophysiological features (like sensory nerve action potential - SNAP - changes) of Charcot-Marie-Tooth disease type 2, a hereditary axonal neuropathy classified under Neuromuscular disorders.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q140",
    "question_text": "In Charcot-Marie-Tooth disease type 2A (CMT2A), what would you expect?",
    "options": "{\"A\": \"Upper limb involvement greater than lower limb\", \"B\": \"Loss of SNAPs\", \"C\": \"Normal motor nerve conduction velocities\", \"D\": \"Predominant demyelination\"}",
    "correct_answer": "B",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Asks about expected features (like sensory nerve action potential - SNAP - loss) of Charcot-Marie-Tooth disease type 2A, a subtype of hereditary axonal neuropathy falling under Neuromuscular disorders.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q42",
    "question_text": "In a scenario of paramyotonia congenita, which channel is involved, particularly worsened by cold and exercise?",
    "options": "{\"A\": \"SCN4A\", \"B\": \"CACNA1S\", \"C\": \"KCNJ2\", \"D\": \"CLCN1\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2020 copy_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2020,
    "explanation": "Classification Reason: Identifies the specific ion channel (SCN4A - sodium channel) involved in Paramyotonia Congenita, a Neuromuscular channelopathy characterized by cold/exercise-induced myotonia.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q60",
    "question_text": "A patient with hereditary peripheral neuropathy and transient CNS symptoms presents. What is the likely diagnosis?",
    "options": "{\"A\": \"CMTX\", \"B\": \"CMT2\", \"C\": \"CMT1A\", \"D\": \"CMT4\"}",
    "correct_answer": "A",
    "source_file": "Part 2 - 2023_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2023,
    "explanation": "Classification Reason: Focuses on diagnosing a specific subtype of Charcot-Marie-Tooth (CMT) disease, a hereditary neuropathy known for both peripheral and sometimes central nervous system manifestations (CMTX caused by GJB1 mutations). CMT is a core Neuromuscular topic.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q108",
    "question_text": "In hereditary neuropathy with liability to pressure palsies (HNPP), what is the gene involved?",
    "options": "{\"A\": \"PMP22 duplication\", \"B\": \"PMP22 deletion\", \"C\": \"MPZ mutation\", \"D\": \"GJB1 mutation\"}",
    "correct_answer": "B",
    "source_file": "Part 2 - 2023_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2023,
    "explanation": "Classification Reason: Directly asks for the specific genetic defect (PMP22 deletion) underlying Hereditary Neuropathy with Liability to Pressure Palsies (HNPP), a primary Neuromuscular disorder affecting peripheral nerves.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q229",
    "question_text": "In a case of Duchenne muscular dystrophy where the patient\u2019s brother has the same disease, which of the following statements is true?",
    "options": "{\"A\": \"The disease is autosomal dominant.\", \"B\": \"The heart is rarely involved in this disease.\", \"C\": \"The mother is a carrier.\", \"D\": \"The disease is curable.\"}",
    "correct_answer": "C",
    "source_file": "Promotion 2019_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2019,
    "explanation": "Classification Reason: Addresses the inheritance pattern (X-linked, implying maternal carrier status) and clinical features within the context of Duchenne Muscular Dystrophy, a primary neuromuscular disorder.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q42",
    "question_text": "A patient presents with findings suggestive of Myotonic dystrophy. Which gene is associated with this condition?",
    "options": "{\"A\": \"CAG (CAG repeat)\", \"B\": \"CTG (CTG repeat)\", \"C\": \"DMPK\", \"D\": \"AR (androgen receptor)\"}",
    "correct_answer": "C",
    "source_file": "Part 1 2021_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2021,
    "explanation": "Classification Reason: Asks for the specific gene (DMPK) and type of mutation (CTG repeat expansion) directly causing Myotonic Dystrophy type 1, a core neuromuscular disease.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q302",
    "question_text": "A female patient with a history of neuropathic ulcer underwent testing for PMP22 deletion and duplication, which was negative. What is the gene associated with her condition?",
    "options": "{\"A\": \"IK\", \"B\": \"T\", \"C\": \"HSANI\", \"D\": \"SPLECT\"}",
    "correct_answer": "C",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Asks to identify a gene potentially associated with a hereditary sensory and autonomic neuropathy (HSAN), a type of inherited peripheral neuropathy, placing it within the neuromuscular domain.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q168",
    "question_text": "A typical scenario of hereditary motor and sensory neuropathy (HMSN) shows a biopsy revealing onion bulb formations. What gene is associated with this condition?",
    "options": "{\"A\": \"PMP-22\", \"B\": \"MPZ\", \"C\": \"GJB1\", \"D\": \"MFN2\"}",
    "correct_answer": "A",
    "source_file": "Part I 2022_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2022,
    "explanation": "Classification Reason: Links characteristic pathological findings (onion bulbs suggesting demyelination) in HMSN (specifically CMT type 1) to the most commonly associated gene (PMP22 duplication for CMT1A), focusing on a primary peripheral neuropathy.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q5",
    "question_text": "A 2-month-old infant had apnea, macroglossia, and cardiac disease. What is the likely diagnosis?",
    "options": "{\"A\": \"Pompe Disease\", \"B\": \"Congenital Hypothyroidism\", \"C\": \"Beckwith-Wiedemann Syndrome\", \"D\": \"Congenital Myotonic Dystrophy\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2021_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Describes the classic triad of infantile-onset Pompe disease (Acid Maltase Deficiency), a glycogen storage disease affecting muscle (including cardiac and respiratory muscles).",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q128",
    "question_text": "A one-month-old baby presented with a history of one week of lethargy, weak cry, and weak sucking. Examination showed hypotonia, ptosis, and non-reactive pupils. What is the diagnosis?",
    "options": "{\"A\": \"Botulism\", \"B\": \"Spinal muscular atrophy\", \"C\": \"Congenital myasthenic syndrome\", \"D\": \"Infantile botulism mimicking Guillain-Barr\\u00e9 syndrome\"}",
    "correct_answer": "A",
    "source_file": "Part 2 Adult Neurology residency 2024 V9_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Focuses on recognizing the clinical features of infant botulism, a neuromuscular junction disorder caused by toxin affecting acetylcholine release.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q243",
    "question_text": "A newborn presents with macroglossia, hypotonia, and myotonia. Which enzyme deficiency is most likely responsible for this condition?",
    "options": "{\"A\": \"Alpha-galactosidase\", \"B\": \"Glycogen phosphorylase\", \"C\": \"Acid alpha-glucosidase\", \"D\": \"Acid maltase\"}",
    "correct_answer": "B",
    "source_file": "Part II 2019_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2019,
    "explanation": "Classification Reason: Describes features (hypotonia, macroglossia, though myotonia is less typical for Pompe but seen in congenital myotonic dystrophy) suggestive of a neonatal neuromuscular disorder, potentially Pompe disease or similar, linking phenotype to underlying enzyme defect.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q344",
    "question_text": "An infant presents with hypotonia, cardiomegaly, and macroglossia. Creatine Kinase (CK) levels are elevated. What is the most likely diagnosis?",
    "options": "{\"A\": \"Acid Maltase deficiency (Pompe disease)\", \"B\": \"Phosphofructokinase deficiency\", \"C\": \"Duchenne muscular dystrophy\", \"D\": \"Congenital hypothyroidism\"}",
    "correct_answer": "A",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Tests recognition of classic infantile Pompe disease based on hypotonia, cardiomegaly, macroglossia, and elevated CK, focusing on this neuromuscular/metabolic disorder.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q66",
    "question_text": "A man with a long history of malnutrition presented with peripheral neuropathy, ataxia, deafness, and retinal degeneration. He was diagnosed with Strachan syndrome, which is a deficiency in:",
    "options": "{\"A\": \"Vitamin A\", \"B\": \"Vitamin E\", \"C\": \"Vitamin B12\", \"D\": \"Vitamin B2\"}",
    "correct_answer": "B",
    "source_file": "Part 2 2020 copy_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2020,
    "explanation": "Classification Reason: Describes a neurological syndrome caused by nutritional deficiencies, leading to peripheral neuropathy and ataxia, fitting better under neuromuscular disorders related to metabolic/nutritional causes.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q397",
    "question_text": "A patient who underwent bariatric surgery 6 months ago presents with weakness and imbalance. Symptoms started 3 months ago, and examination reveals loss of proprioception and spasticity. B12 and methylmalonic acid levels are normal. What deficiency is most likely?",
    "options": "{\"A\": \"Zinc deficiency\", \"B\": \"B12 deficiency\", \"C\": \"Copper deficiency\", \"D\": \"Folate deficiency\"}",
    "correct_answer": "C",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Deals with neurological deficits (myeloneuropathy) arising from a post-surgical nutritional deficiency (copper), a common topic within neuromuscular medicine.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q40",
    "question_text": "After gastric bypass surgery, a patient presents with symptoms of Vitamin B1 deficiency. What is the most appropriate management?",
    "options": "{\"A\": \"Vitamin B1 (Thiamine)\", \"B\": \"Vitamin B12\", \"C\": \"Vitamin B6\", \"D\": \"Folate\"}",
    "correct_answer": "A",
    "source_file": "Part 2 - 2023_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2023,
    "explanation": "Classification Reason: Focuses on identifying and managing a specific nutritional deficiency (Thiamine) presenting with neurological symptoms after bariatric surgery, often covered under neuromuscular/metabolic aspects rather than acute critical care unless specified as Wernicke's encephalopathy.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q26",
    "question_text": "A patient with Crohn\u2019s disease who underwent resection presents with fat in the stool, ataxia, and decreased reflexes, along with myelopathy. What is the diagnosis?",
    "options": "{\"A\": \"Vitamin E deficiency\", \"B\": \"Vitamin B12 deficiency\", \"C\": \"Copper deficiency\", \"D\": \"Thiamine deficiency\"}",
    "correct_answer": "A",
    "source_file": "Part 1 2020_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2020,
    "explanation": "Classification Reason: Links malabsorption to a specific neurological syndrome (spinocerebellar ataxia, myelopathy, areflexia) caused by Vitamin E deficiency, fitting under nutritional/metabolic neuromuscular disorders.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q75",
    "question_text": "A lady post-bariatric surgery is noted to have posterior column symptoms and numbness with weakness. She has an unsteady gait in the dark, a positive Romberg test, and decreased vibration sense. What vitamin deficiency is most likely?",
    "options": "{\"A\": \"Vitamin B12\", \"B\": \"Vitamin B1\", \"C\": \"Vitamin E\", \"D\": \"Vitamin D\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2018_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2018,
    "explanation": "Classification Reason: Describes neurological symptoms (posterior column dysfunction) secondary to post-bariatric surgery nutritional deficiency, placing it within neuromuscular/metabolic categories.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q229",
    "question_text": "A patient who had bariatric surgery developed weakness and large fiber neuropathy, with normal B12 and MMA levels. What is the most likely deficiency?",
    "options": "{\"A\": \"Thiamine\", \"B\": \"Copper\", \"C\": \"Magnesium\", \"D\": \"Zinc\"}",
    "correct_answer": "B",
    "source_file": "Part II 2018_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2018,
    "explanation": "Classification Reason: Focuses on identifying a specific post-bariatric nutritional deficiency (Copper) causing neuropathy/myelopathy when common causes are excluded, relevant to neuromuscular medicine.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q44",
    "question_text": "Scenario of a patient who had a mastectomy and presents with arm pain and dysesthesia over the fourth and fifth fingers. What should be done next?",
    "options": "{\"A\": \"MRI of plexus\", \"B\": \"Nerve conduction studies\", \"C\": \"Ultrasound of the axilla\", \"D\": \"Electromyography\"}",
    "correct_answer": "A",
    "source_file": "Part II 2018_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2018,
    "explanation": "Classification Reason: The symptoms (pain, dysesthesia in C8/T1 distribution) following surgery near the axilla strongly suggest brachial plexopathy, a neuromuscular condition. The question asks for the appropriate diagnostic imaging.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q58",
    "question_text": "A patient presents with spasticity and upper motor neuron signs. A video shows tongue fasciculations and atrophy. What is the likely diagnosis?",
    "options": "{\"A\": \"Amyotrophic lateral sclerosis (ALS)\", \"B\": \"Multiple sclerosis\", \"C\": \"Spinal muscular atrophy\", \"D\": \"Primary lateral sclerosis\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2021_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2021,
    "explanation": "Classification Reason: The combination of upper motor neuron signs (spasticity) and lower motor neuron signs (fasciculations, atrophy), particularly involving bulbar muscles (tongue), is characteristic of ALS, a primary neuromuscular disease.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q3",
    "question_text": "A case scenario of a patient with Vitamin B12 deficiency (with symptoms involving vibration and proprioception) but with Vitamin B12 levels at the upper normal limit. What should you order?",
    "options": "{\"A\": \"Homocysteine (if their methylmalonic acid is elevated, it will be the answer)\", \"B\": \"Serum folate\", \"C\": \"Complete blood count\", \"D\": \"MRI of the spinal cord\"}",
    "correct_answer": "A",
    "source_file": "Part 1 2021_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2021,
    "explanation": "Classification Reason: Focuses on the diagnostic workup for suspected B12 deficiency presenting with neurological symptoms (sensory neuropathy affecting proprioception/vibration - posterior columns/peripheral nerves). While related to nutrition/metabolism, the clinical presentation is primarily neuromuscular.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q31",
    "question_text": "A patient came with right upper limb weakness and intrinsic hand atrophy and diminished reflexes. What is the likely diagnosis?",
    "options": "{\"A\": \"Multifocal motor neuropathy (MMN)\", \"B\": \"Amyotrophic lateral sclerosis (ALS)\", \"C\": \"Peripheral neuropathy\", \"D\": \"Carpal tunnel syndrome\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2021_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Tests the ability to localize a neurological deficit and differentiate between neuromuscular conditions (ALS, MMN, peripheral neuropathy) based on clinical signs.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q2",
    "question_text": "A patient with a radial fracture one month ago presents with pain and erythema. The exam was difficult due to pain. What is the diagnosis?",
    "options": "{\"A\": \"Complex regional pain syndrome\", \"B\": \"Arterial insufficiency\", \"C\": \"Dejerine-Roussy syndrome\", \"D\": \"Cellulitis\"}",
    "correct_answer": "A",
    "source_file": "Part 1 2020_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2020,
    "explanation": "Classification Reason: Describes features highly suggestive of Complex Regional Pain Syndrome (CRPS Type 1), a neuropathic pain disorder affecting the peripheral nervous system, often falling under neuromuscular or pain management.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q35",
    "question_text": "A young male patient presents with eyelid myotonia that increases after eating ice cream or exposure to cold. What is the diagnosis?",
    "options": "{\"A\": \"Paramyotonia congenita\", \"B\": \"Myotonic dystrophy\", \"C\": \"Congenital myopathy\", \"D\": \"Periodic paralysis\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2021_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Describes classic features of paramyotonia congenita, a neuromuscular channelopathy.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q37",
    "question_text": "A young female presents with dilated pupils, dysphagia, and descending weakness. What is the diagnosis?",
    "options": "{\"A\": \"Presynaptic NMJ disorder\", \"B\": \"Postsynaptic NMJ disorder\", \"C\": \"Upper motor neuron lesion\", \"D\": \"Peripheral neuropathy\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2021_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: The symptom cluster (mydriasis, dysphagia, descending weakness) strongly suggests Botulism, a disorder affecting the presynaptic neuromuscular junction (NMJ).",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q7",
    "question_text": "A patient presents after a hysterectomy with weakness in hip flexion and knee extension. Which nerve is likely affected?",
    "options": "{\"A\": \"Femoral\", \"B\": \"Obturator\", \"C\": \"Sciatic\", \"D\": \"Lateral femoral cutaneous\"}",
    "correct_answer": "A",
    "source_file": "PART I - 2024 - KSMC Revision_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2024,
    "explanation": "Classification Reason: Tests knowledge of peripheral nerve anatomy (femoral nerve) and localization based on motor deficits, often related to surgical injury.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q9",
    "question_text": "In a known case of Duchenne muscular dystrophy, what are the first symptoms?",
    "options": "{\"A\": \"Walk on toe\", \"B\": \"Loss of fine movement\", \"C\": \"Difficulty rising from the floor\", \"D\": \"Frequent falls\"}",
    "correct_answer": "A",
    "source_file": "PART I - 2024 - KSMC Revision_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2024,
    "explanation": "Classification Reason: Asks about the typical early motor symptoms of Duchenne muscular dystrophy, a primary muscle disease.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q5",
    "question_text": "A patient with a known case of diabetes mellitus presents with peripheral neuropathy and has impaired sensation for pinprick up to mid-shin. Which treatment has level A evidence in the management of peripheral neuropathy?",
    "options": "{\"A\": \"Pregabalin\", \"B\": \"Gabapentin\", \"C\": \"Amitriptyline\", \"D\": \"Duloxetine\"}",
    "correct_answer": "A",
    "source_file": "PART I - 2024 - KSMC Revision_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2024,
    "explanation": "Classification Reason: Focuses on the evidence-based pharmacological management of symptomatic diabetic peripheral neuropathy, a common neuromuscular condition.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q15",
    "question_text": "A male patient presents with stiffness that worsens with repeated exercise. Which of the following conditions is most likely?",
    "options": "{\"A\": \"Myotonia congenita\", \"B\": \"Paramyotonia congenita\", \"C\": \"Hypokalemic periodic paralysis\", \"D\": \"Duchenne muscular dystrophy\"}",
    "correct_answer": "B",
    "source_file": "PART I - 2024 - KSMC Revision_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2024,
    "explanation": "Classification Reason: Describes symptoms characteristic of myotonia (muscle stiffness), specifically paradoxical myotonia (worsening with exercise) seen in paramyotonia congenita, a neuromuscular channelopathy.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q5",
    "question_text": "A patient presents with peripheral neuropathy, and his symptoms were provoked after minor surgery. Which vitamin deficiency should be considered?",
    "options": "{\"A\": \"Vitamin E\", \"B\": \"Cobalamin\", \"C\": \"Thiamine\", \"D\": \"Pyridoxine\"}",
    "correct_answer": "B",
    "source_file": "PART I - 2024 - KSMC Revision_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2024,
    "explanation": "Classification Reason: Core concept is the etiology of peripheral neuropathy, specifically vitamin deficiencies that can be unmasked or worsened by stressors like surgery.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q215",
    "question_text": "Regarding the age of onset of myasthenia gravis (MG), which of the following statements is correct?",
    "options": "{\"A\": \"Female in the 3rd decade, male in the 6th and 7th decades\", \"B\": \"Female in the 5th decade, male in the 3rd decade\", \"C\": \"Female in the 2nd decade, male in the 6th and 7th decades\", \"D\": \"Female and male both commonly present in the 4th decade\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2018_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2018,
    "explanation": "Classification Reason: Tests knowledge of the epidemiology (age and sex distribution) of Myasthenia Gravis, a neuromuscular junction disorder.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q190",
    "question_text": "Which of the following is most common in the pathophysiology of Myasthenia Gravis (MG)?",
    "options": "{\"A\": \"Acetylcholine binding\", \"B\": \"Acetylcholine blocking\", \"C\": \"Acetylcholine modulating\", \"D\": \"Acetylcholine degradation\"}",
    "correct_answer": "B",
    "source_file": "Promotion 2018_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2018,
    "explanation": "Classification Reason: Focuses on the underlying pathophysiology (antibody action at the neuromuscular junction) of Myasthenia Gravis.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q7",
    "question_text": "A patient presents with hip flexion weakness, thigh adduction weakness, and knee extension weakness after abdominal surgery. She is on warfarin. Where is the lesion likely located?",
    "options": "{\"A\": \"Femoral at iliacus\", \"B\": \"Femoral at psoas\", \"C\": \"Obturator nerve lesion\", \"D\": \"Lumbosacral plexus injury\"}",
    "correct_answer": "A",
    "source_file": "PART I - 2024 - KSMC Revision_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2024,
    "explanation": "Classification Reason: Focuses on localizing a peripheral nerve injury (femoral neuropathy, possibly complicated by iliopsoas hematoma due to warfarin) based on the pattern of muscle weakness.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q199",
    "question_text": "A smoker male presents with bilateral ptosis and proximal weakness. Where is the lesion located?",
    "options": "{\"A\": \"Nerves\", \"B\": \"Spinal cord\", \"C\": \"Neuromuscular junction (NMJ)\", \"D\": \"Muscle\"}",
    "correct_answer": "C",
    "source_file": "Promotion 2018_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2018,
    "explanation": "Classification Reason: Assesses the ability to localize the neurological deficit based on classic symptoms (ptosis, proximal weakness, smoking history) suggesting a neuromuscular junction disorder like Myasthenia Gravis or Lambert-Eaton syndrome.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q15",
    "question_text": "A male patient presents with perioral fasciculation, areflexia, and systemic manifestations. Which of the following conditions could be associated with these symptoms?",
    "options": "{\"A\": \"Diabetes Mellitus (DM)\", \"B\": \"Hypertension (HTN)\", \"C\": \"Amyotrophic Lateral Sclerosis (ALS)\", \"D\": \"Hypocalcemia\"}",
    "correct_answer": "A",
    "source_file": "PART I - 2024 - KSMC Revision_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2024,
    "explanation": "Classification Reason: Describes features suggestive of a motor neuron disease or specific neuropathy (e.g., Kennedy's disease, although options are limited/unclear) primarily affecting the neuromuscular system.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q16",
    "question_text": "In a patient with myasthenia gravis, which medication should be avoided in the case of decreased thiopurine S-methyltransferase (TPMT) enzyme activity?",
    "options": "{\"A\": \"Azathioprine\", \"B\": \"Mycophenolate\", \"C\": \"Cyclophosphamide\", \"D\": \"Methotrexate\"}",
    "correct_answer": "A",
    "source_file": "PART I - 2024 - KSMC Revision_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2024,
    "explanation": "Classification Reason: Relates directly to the pharmacogenetics and safe use of immunosuppressive therapy (Azathioprine) specifically in the context of treating Myasthenia Gravis, a neuromuscular junction disorder.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q237",
    "question_text": "In a patient with Bell's palsy, which muscle is involved?",
    "options": "{\"A\": \"Stylohyoid\", \"B\": \"Temporalis\", \"C\": \"Masseter\", \"D\": \"Levator palpebrae\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2019_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2019,
    "explanation": "Classification Reason: Tests knowledge of muscles innervated by the facial nerve (CN VII), specifically Stylohyoid in this option list, which is affected in Bell's Palsy. This relates to cranial nerve function/anatomy.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q1",
    "question_text": "What is the cause of prolonged duration and drop amplitude in CMAP?",
    "options": "{\"A\": \"Low temperature\", \"B\": \"Conduction block in some fibres\", \"C\": \"Demyelination\", \"D\": \"Axonal loss\"}",
    "correct_answer": "B",
    "source_file": "Part 2 - 2023_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2023,
    "explanation": "Classification Reason: Tests interpretation of specific findings (prolonged duration, amplitude drop) on nerve conduction studies (CMAP), specifically identifying the effect of low temperature on physiological parameters.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q4",
    "question_text": "A scenario about a patient with shoulder and arm pain, with MRI spine showing disc prolapse at the level of C5. What is the muscle to be examined by EMG?",
    "options": "{\"A\": \"Infraspinatus\", \"B\": \"Supraspinatus\", \"C\": \"Teres minor\", \"D\": \"Subscapularis\"}",
    "correct_answer": "A",
    "source_file": "Part 2 - 2023_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2023,
    "explanation": "Classification Reason: Assesses knowledge of clinical neurophysiology (EMG) and neuroanatomy, specifically which muscle(s) are innervated by the C5 nerve root and are appropriate to test for radiculopathy.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q3",
    "question_text": "In a case of Mononeuritis Multiplex with weight loss and fever, which histologic finding is most characteristic?",
    "options": "{\"A\": \"Onion rings\", \"B\": \"Lymphocyte infiltration\", \"C\": \"IgG deposit\", \"D\": \"Necrotizing vasculitis\"}",
    "correct_answer": "B",
    "source_file": "Part 2 - 2023_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2023,
    "explanation": "Classification Reason: Focuses on the characteristic histopathology (suggesting vasculitis given the context - lymphocytic infiltration) found in nerve biopsies for Mononeuritis Multiplex, a peripheral nerve disorder.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q16",
    "question_text": "A case of Crohn\u2019s disease underwent resection and presented with ataxia and decreased reflexes. What is the diagnosis?",
    "options": "{\"A\": \"Vitamin E deficiency\", \"B\": \"Vitamin B12 deficiency\", \"C\": \"Copper deficiency\", \"D\": \"Thiamine deficiency\"}",
    "correct_answer": "B",
    "source_file": "Part I 2019_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2019,
    "explanation": "Classification Reason: Concerns neurological complications (ataxia, areflexia suggesting peripheral nerve/spinal cord involvement) secondary to nutritional deficiency following bowel resection, impacting nerve function.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q111",
    "question_text": "A patient with a radial fracture one month ago complains of pain and erythema. Examination was difficult because of pain. What is the likely diagnosis?",
    "options": "{\"A\": \"Complex regional pain syndrome\", \"B\": \"Arterial insufficiency\", \"C\": \"Dejerine Roussy syndrome\", \"D\": \"Cellulitis\"}",
    "correct_answer": "A",
    "source_file": "Part I 2023_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2023,
    "explanation": "Classification Reason: Asks for the diagnosis of Complex Regional Pain Syndrome (CRPS), a neurological disorder involving peripheral sensory/autonomic nerve dysfunction and pain pathways, often post-injury.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q19",
    "question_text": "In a case of dermatomyositis, what are the histology findings?",
    "options": "{\"A\": \"Perifascicular atrophy\", \"B\": \"Endomysial inflammation with invasion of non-necrotic fibers\", \"C\": \"Rimmed vacuoles in muscle fibers\", \"D\": \"Neurogenic atrophy\"}",
    "correct_answer": "A",
    "source_file": "Part 1 2020_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2020,
    "explanation": "Classification Reason: Tests knowledge of characteristic muscle biopsy findings in dermatomyositis, an inflammatory myopathy.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q19",
    "question_text": "In a case of dermatomyositis, what are the histology findings?",
    "options": "{\"A\": \"Perifascicular atrophy\", \"B\": \"Endomysial inflammation with CD8+ T cells\", \"C\": \"Rimmed vacuoles in muscle fibers\", \"D\": \"Granulomatous inflammation\"}",
    "correct_answer": "A",
    "source_file": "Part 1 2020_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2020,
    "explanation": "Classification Reason: Tests knowledge of characteristic muscle biopsy findings in dermatomyositis, an inflammatory myopathy.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q74",
    "question_text": "A female patient fell from a height of 3 meters while cleaning her house and presents with severe headache and nausea. What is the most appropriate next step in her management?",
    "options": "{\"A\": \"Reassure and discharge\", \"B\": \"Observation in hospital\", \"C\": \"CT brain\", \"D\": \"Administer analgesics and monitor\"}",
    "correct_answer": "C",
    "source_file": "Part I 2018_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2018,
    "explanation": "Classification Reason: Deals with the acute management and diagnostic workup of potential traumatic brain injury (TBI) in an emergency setting.",
    "subspecialty": "Critical Care Neurology"
  },
  {
    "question_number": "Q64",
    "question_text": "An elderly patient presented with fluctuating levels of consciousness. Which of the following should be done?",
    "options": "{\"A\": \"Metabolic panel screen\", \"B\": \"Brain MRI\", \"C\": \"Lumbar puncture\", \"D\": \"Electroencephalogram (EEG)\"}",
    "correct_answer": "A",
    "source_file": "Part 2 Adult Neurology residency 2024 V9_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Addresses the initial workup for acute fluctuating encephalopathy (delirium), a common presentation requiring urgent assessment often in acute or critical care settings.",
    "subspecialty": "Critical Care Neurology"
  },
  {
    "question_number": "Q165",
    "question_text": "Which of the following is a therapeutic effect of mannitol?",
    "options": "{\"A\": \"Decreased mean arterial pressure\", \"B\": \"Increased intravascular volume\", \"C\": \"Increased intracranial pressure\", \"D\": \"Decreased blood viscosity\"}",
    "correct_answer": "B",
    "source_file": "Promotion 2023_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2023,
    "explanation": "Classification Reason: Focuses on the physiological effects and mechanism of action of mannitol, a key osmotic agent used for managing increased intracranial pressure (ICP) in neurocritical care.",
    "subspecialty": "Critical Care Neurology"
  },
  {
    "question_number": "Q77",
    "question_text": "A patient with intracerebral hemorrhage (ICH) followed by midline shift had an EVD inserted and then developed signs of infection. Blood and CSF cultures were sent. You want to start empirical treatment. What should you do?",
    "options": "{\"A\": \"Remove EVD\", \"B\": \"Remove EVD and give intraventricular vancomycin\", \"C\": \"Replace EVD and give IV vancomycin\", \"D\": \"Remove EVD and give cefepime\"}",
    "correct_answer": "C",
    "source_file": "Promotion 2018_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2018,
    "explanation": "Classification Reason: Concerns the management of a common and serious complication (infection) associated with an invasive neuromonitoring device (EVD) used in critically ill neurological patients.",
    "subspecialty": "Critical Care Neurology"
  },
  {
    "question_number": "Q65",
    "question_text": "A patient on warfarin develops intracranial hemorrhage. What is the next step? (No PCC in answers)",
    "options": "{\"A\": \"IV vitamin K\", \"B\": \"Fresh frozen plasma\", \"C\": \"Protamine sulfate\", \"D\": \"Supportive care and blood pressure control\"}",
    "correct_answer": "A",
    "source_file": "Part 2 Adult Neurology residency 2024 V9_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Deals with the urgent management of anticoagulant-associated intracerebral hemorrhage, specifically the choice of reversal agents in an acute/critical setting.",
    "subspecialty": "Critical Care Neurology"
  },
  {
    "question_number": "Q73",
    "question_text": "A patient with head trauma arrives at the emergency department conscious and oriented. After one hour, he loses consciousness and has a dilated right pupil. What abnormality would you expect to see on a brain CT?",
    "options": "{\"A\": \"Epidural hemorrhage\", \"B\": \"Subdural hemorrhage\", \"C\": \"Subarachnoid hemorrhage\", \"D\": \"Lobar hemorrhage\"}",
    "correct_answer": "A",
    "source_file": "Part I 2018_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2018,
    "explanation": "Classification Reason: Describes a classic clinical progression (\"lucid interval\") highly suggestive of epidural hematoma following TBI, testing knowledge of acute TBI complications.",
    "subspecialty": "Critical Care Neurology"
  },
  {
    "question_number": "Q164",
    "question_text": "What is a potential complication of using hypertonic saline in the treatment of increased ICP?",
    "options": "{\"A\": \"Cerebral edema\", \"B\": \"Pulmonary edema\", \"C\": \"Increased intracranial pressure\", \"D\": \"Decreased mean arterial pressure\"}",
    "correct_answer": "B",
    "source_file": "Promotion 2023_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2023,
    "explanation": "Classification Reason: Focuses on the potential adverse effects and complications associated with hypertonic saline, a therapy used primarily for managing raised ICP in critical care.",
    "subspecialty": "Critical Care Neurology"
  },
  {
    "question_number": "Q63",
    "question_text": "An elderly patient is brought to the emergency department by his family after they found him unresponsive in bed. The last time he was seen well was 1 day ago. A CT scan of the brain shows a large infarction in the right middle cerebral artery (MCA) with midline shift. What is the most important thing to do?",
    "options": "{\"A\": \"Decompressive craniectomy\", \"B\": \"Admission to stroke unit\", \"C\": \"Initiate intravenous thrombolysis\", \"D\": \"Start antiplatelet therapy\"}",
    "correct_answer": "A",
    "source_file": "Part 2 Adult Neurology residency 2024 V9_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Addresses the life-saving management (decompressive craniectomy) of malignant MCA infarction, a critical complication of large ischemic stroke requiring urgent neurosurgical intervention.",
    "subspecialty": "Critical Care Neurology"
  },
  {
    "question_number": "Q163",
    "question_text": "An elderly patient was admitted after a cardiac arrest and is now in the ICU. He is intubated, sedated, and given muscle relaxants. His pupils are non-reactive, and there is no motor response. What should be done next?",
    "options": "{\"A\": \"Perform an EEG\", \"B\": \"Obtain an MRI\", \"C\": \"Start hypothermia measures\", \"D\": \"Administer intravenous fluids\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2023_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2023,
    "explanation": "Classification Reason: Concerns the initial steps in neurological assessment and prognostication (e.g., EEG) for a comatose patient following cardiac arrest in the ICU setting.",
    "subspecialty": "Critical Care Neurology"
  },
  {
    "question_number": "Q20",
    "question_text": "A female patient post subarachnoid hemorrhage (SVD) presented with headache, visual field deficit, and suspected SIADH. With blood pressure low below 90, what is the diagnosis?",
    "options": "{\"A\": \"Pituitary Apoplexy\", \"B\": \"Cerebral Vasospasm\", \"C\": \"Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH)\", \"D\": \"Hydrocephalus\"}",
    "correct_answer": "A",
    "source_file": "Part 2 - 2023_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2023,
    "explanation": "Classification Reason: Deals with recognizing and diagnosing a potential acute complication (pituitary apoplexy) in the context of a recent critical neurological event (subarachnoid hemorrhage).",
    "subspecialty": "Critical Care Neurology"
  },
  {
    "question_number": "Q155",
    "question_text": "A female patient diagnosed with cerebral venous thrombosis (CVT) was admitted to the ICU and then deteriorated. A CT scan showed brain edema. What is in favor of hypertonic saline over mannitol?",
    "options": "{\"A\": \"Increased intravascular volume\", \"B\": \"More rapid diuresis\", \"C\": \"Lower risk of rebound intracranial hypertension\", \"D\": \"Less risk of electrolyte imbalance\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2019_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2019,
    "explanation": "Classification Reason: Compares the properties and indications of two osmotic therapies (hypertonic saline vs. mannitol) used to manage cerebral edema, a common critical care challenge, specifically in the context of CVT.",
    "subspecialty": "Critical Care Neurology"
  },
  {
    "question_number": "Q149",
    "question_text": "When should a patient with Guillain-Barr\u00e9 syndrome be admitted to the ICU?",
    "options": "{\"A\": \"Rapid progression of weakness\", \"B\": \"Severe autonomic or swallowing dysfunction\", \"C\": \"Evolving respiratory distress\", \"D\": \"Persistent severe pain\"}",
    "correct_answer": "C",
    "source_file": "Part II 2019_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2019,
    "explanation": "Classification Reason: Focuses on identifying clinical criteria that necessitate ICU admission for monitoring and potential intervention (like mechanical ventilation) in a patient with GBS, a critical care decision.",
    "subspecialty": "Critical Care Neurology"
  },
  {
    "question_number": "Q4",
    "question_text": "A brain CT shows coup contrecoup injury (left frontal and right temporal bleed). What is the mechanism of injury?",
    "options": "{\"A\": \"Trauma\", \"B\": \"Ischemic stroke\", \"C\": \"Infectious encephalitis\", \"D\": \"Metabolic encephalopathy\"}",
    "correct_answer": "A",
    "source_file": "Part 1 2020_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2020,
    "explanation": "Classification Reason: Relates specific imaging findings (coup-contrecoup pattern) on brain CT directly to the underlying mechanism of traumatic brain injury.",
    "subspecialty": "Critical Care Neurology"
  },
  {
    "question_number": "Q156",
    "question_text": "What is the difference between mannitol and hypertonic saline?",
    "options": "{\"A\": \"Decrease intracranial pressure (ICP)\", \"B\": \"More nephrotoxicity\", \"C\": \"Increase cerebral blood flow\", \"D\": \"Different effects on serum sodium levels\"}",
    "correct_answer": "B",
    "source_file": "Promotion 2019_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2019,
    "explanation": "Classification Reason: Compares the pharmacological properties, mechanisms, or side effects of two primary osmotic agents used for managing raised ICP in neurocritical care.",
    "subspecialty": "Critical Care Neurology"
  },
  {
    "question_number": "Q167",
    "question_text": "What is the most important predictor of outcome in cardiac arrest?",
    "options": "{\"A\": \"Duration of CPR\", \"B\": \"Bilateral somatosensory evoked potentials (SSEP)\", \"C\": \"Absent pupillary response in 24 hours\", \"D\": \"Initial rhythm at time of arrest\"}",
    "correct_answer": "A",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Asks about key factors, particularly neurological examination findings and neurophysiological tests (SSEP), used for prognostication after cardiac arrest in the ICU.",
    "subspecialty": "Critical Care Neurology"
  },
  {
    "question_number": "Q152",
    "question_text": "EVD associated with infection:",
    "options": "{\"A\": \"Less than 3% risk of infection.\", \"B\": \"Infection improved if the catheter changed every 5 days.\", \"C\": \"Increasing after 7 days.\", \"D\": \"Prophylactic antibiotics reduce infection rates.\"}",
    "correct_answer": "C",
    "source_file": "Promotion 2019_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2019,
    "explanation": "Classification Reason: Addresses the epidemiology, risk factors, and prevention strategies related to infections associated with external ventricular drains (EVDs), a common neurocritical care intervention.",
    "subspecialty": "Critical Care Neurology"
  },
  {
    "question_number": "Q70",
    "question_text": "Which of the following statements is true regarding the duration of effect between hypertonic saline and mannitol?",
    "options": "{\"A\": \"The effects of hypertonic saline typically last longer than those of mannitol.\", \"B\": \"The effects of mannitol typically last longer than those of hypertonic saline.\", \"C\": \"Both have the same duration of effect.\", \"D\": \"Neither has a significant duration of effect.\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2023_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2023,
    "explanation": "Classification Reason: Compares the pharmacodynamic properties (duration of action) of two osmotic agents frequently used in the management of increased ICP.",
    "subspecialty": "Critical Care Neurology"
  },
  {
    "question_number": "Q10",
    "question_text": "A patient came with high blood pressure and a picture of PRESS syndrome. What is the management?",
    "options": "{\"A\": \"Monitoring\", \"B\": \"Control BP\", \"C\": \"Administer corticosteroids\", \"D\": \"Immediate neurosurgical intervention\"}",
    "correct_answer": "B",
    "source_file": "PART I - 2024 - KSMC Revision_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2024,
    "explanation": "Classification Reason: Focuses on the acute management (blood pressure control) of Posterior Reversible Encephalopathy Syndrome (PRES), a condition often associated with hypertensive emergencies or critical illness.",
    "subspecialty": "Critical Care Neurology"
  },
  {
    "question_number": "Q344",
    "question_text": "Which of the following statements is true regarding mannitol and hypertonic saline in the management of increased intracranial pressure (ICP)?",
    "options": "{\"A\": \"Both agents improve red blood cell rheology.\", \"B\": \"Both agents can cause metabolic acidosis.\", \"C\": \"A rebound exacerbation of increased ICP may occur after stopping a continuous infusion of either agent.\", \"D\": \"Both agents reduce cerebral edema by decreasing blood-brain barrier permeability.\"}",
    "correct_answer": "C",
    "source_file": "Promotion 2023_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2023,
    "explanation": "Classification Reason: Tests knowledge of the shared physiological effects, potential complications, and clinical considerations when using mannitol and hypertonic saline for ICP management.",
    "subspecialty": "Critical Care Neurology"
  },
  {
    "question_number": "Q33",
    "question_text": "A vague scenario describes a patient with no history available, brought to the ER with decreased level of consciousness and fever. A CT scan of the brain and CSF analysis are normal. What should be done next?",
    "options": "{\"A\": \"Dantrolene\", \"B\": \"Acyclovir\", \"C\": \"Antibiotics\", \"D\": \"Toxicity screening\"}",
    "correct_answer": "B",
    "source_file": "Part 2 2020 copy_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2020,
    "explanation": "Classification Reason: Addresses the diagnostic and therapeutic approach to undifferentiated acute encephalopathy/coma in an emergency/critical care setting when initial standard tests are unrevealing, requiring consideration of broad differentials.",
    "subspecialty": "Critical Care Neurology"
  },
  {
    "question_number": "Q145",
    "question_text": "In a case of subarachnoid hemorrhage (SAH), the patient is found to have hyponatremia, high urine sodium, and high osmolarity. What is the appropriate treatment?",
    "options": "{\"A\": \"Fluid restriction\", \"B\": \"Intravenous fluids (IVF)\", \"C\": \"Diuretics\", \"D\": \"Hypertonic saline\"}",
    "correct_answer": "B",
    "source_file": "Part II 2019_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2019,
    "explanation": "Classification Reason: Focuses on the diagnosis and management of Cerebral Salt Wasting (CSW), a specific electrolyte disturbance commonly encountered as a complication following SAH in the critical care setting.",
    "subspecialty": "Critical Care Neurology"
  },
  {
    "question_number": "Q47",
    "question_text": "What is the most important predictor of outcome in cardiac arrest?",
    "options": "{\"A\": \"Duration of CPR\", \"B\": \"Bilateral SSEP\", \"C\": \"Absent pupillary response in 24 hours\", \"D\": \"Initial rhythm on ECG\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2021_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Asks about key factors, particularly neurological examination findings and neurophysiological tests (SSEP), used for prognostication after cardiac arrest in the ICU. (Duplicate of Q167)",
    "subspecialty": "Critical Care Neurology"
  },
  {
    "question_number": "Q32",
    "question_text": "What is the best predictor for a patient in a coma (not considering brain death or time)?",
    "options": "{\"A\": \"Etiology\", \"B\": \"Somatosensory Evoked Potential (SSPE)\", \"C\": \"Pupillary light reflex\", \"D\": \"Glasgow Coma Scale score\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2020 copy_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2020,
    "explanation": "Classification Reason: Addresses general principles of prognostication in comatose patients, highlighting the importance of etiology and neurophysiological testing commonly used in critical care.",
    "subspecialty": "Critical Care Neurology"
  },
  {
    "question_number": "Q56",
    "question_text": "A 19-year-old female patient came with encephalopathy; MRI showed high signal intensity in the basal ganglia and thalamus; what is the next step?",
    "options": "{\"A\": \"Lumbar puncture (LP)\", \"B\": \"Anti-MOG antibody testing\", \"C\": \"Aquaporin-4 antibody testing\", \"D\": \"Start empirical antiviral therapy\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2021_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Addresses the diagnostic workup (specifically the need for LP) in a patient presenting with acute encephalopathy and non-specific but concerning MRI findings, a common scenario requiring urgent evaluation.",
    "subspecialty": "Critical Care Neurology"
  },
  {
    "question_number": "Q157",
    "question_text": "A patient with a long ICU stay developed neuropathy/myopathy. What is the recommended management?",
    "options": "{\"A\": \"Physiotherapy and supportive care\", \"B\": \"Steroid\", \"C\": \"IVIG or PLEX\", \"D\": \"Nutritional optimization\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2021_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2021,
    "explanation": "Classification Reason: Focuses on the recognition and management of Critical Illness Polyneuropathy/Myopathy (CIP/CIM), a neurological complication specifically related to prolonged stays in the intensive care unit.",
    "subspecialty": "Critical Care Neurology"
  },
  {
    "question_number": "Q408",
    "question_text": "What is a poor prognostic indicator after cardiac arrest at 24 hours?",
    "options": "{\"A\": \"Bilateral absent N20 response\", \"B\": \"Pupillary light reflex present\", \"C\": \"Early myoclonus status epilepticus\", \"D\": \"Normal EEG background activity\"}",
    "correct_answer": "A",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Tests knowledge of specific neurophysiological findings (absent SSEP N20 response) used for neurological prognostication following cardiac arrest in the ICU.",
    "subspecialty": "Critical Care Neurology"
  },
  {
    "question_number": "Q143",
    "question_text": "A patient with a 3 mm hemorrhage in the putamen is stable but has increased edema and decreased level of consciousness. What is the appropriate treatment?",
    "options": "{\"A\": \"Triple H\", \"B\": \"Osmotic treatment\", \"C\": \"Dexamethasone\", \"D\": \"Surgical evacuation\"}",
    "correct_answer": "B",
    "source_file": "Part II 2019_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2019,
    "explanation": "Classification Reason: Deals with the management of secondary brain injury (worsening edema and neurological decline) following an intracerebral hemorrhage, specifically the use of osmotic therapy.",
    "subspecialty": "Critical Care Neurology"
  },
  {
    "question_number": "Q62",
    "question_text": "In a Guillain-Barr\u00e9 syndrome scenario, what is the predicting factor for intubation?",
    "options": "{\"A\": \"Presence of dysautonomia\", \"B\": \"Age over 60\", \"C\": \"Rapid progression of symptoms\", \"D\": \"Presence of respiratory failure\"}",
    "correct_answer": "D",
    "source_file": "Part 2 2021_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Identifies clinical factors used to predict the need for mechanical ventilation (intubation) in GBS patients, a critical decision point in their ICU management.",
    "subspecialty": "Critical Care Neurology"
  },
  {
    "question_number": "Q5",
    "question_text": "An elderly male presents with decreased oral intake for one week and is inattentive during examination. What would you expect to find on EEG?",
    "options": "{\"A\": \"Generalized slowing\", \"B\": \"Normal\", \"C\": \"PLEDs\", \"D\": \"Focal spikes\"}",
    "correct_answer": "A",
    "source_file": "Part 1 2020_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2020,
    "explanation": "Classification Reason: Relates a common clinical presentation of delirium/metabolic encephalopathy in the elderly to its expected electroencephalographic (EEG) correlate, often evaluated in acute settings.",
    "subspecialty": "Critical Care Neurology"
  },
  {
    "question_number": "Q29",
    "question_text": "What is the threshold of intracranial pressure (ICP) that is considered abnormal?",
    "options": "{\"A\": \"20 mmHg\", \"B\": \"22 mmHg\", \"C\": \"25 mmHg\", \"D\": \"30 mmHg\"}",
    "correct_answer": "B",
    "source_file": "Part II 2018_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2018,
    "explanation": "Classification Reason: Asks for the standard definition of elevated intracranial pressure, a fundamental concept in neurocritical care monitoring and management.",
    "subspecialty": "Critical Care Neurology"
  },
  {
    "question_number": "Q121",
    "question_text": "Assessment of blood-brain barrier (BBB) in traumatic brain injury (TBI) is best indicated by which of the following markers?",
    "options": "{\"A\": \"S100B\", \"B\": \"Myelin basic protein\", \"C\": \"Serum specific enolase\", \"D\": \"Glial fibrillary acidic protein\"}",
    "correct_answer": "A",
    "source_file": "Part II 2018_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2018,
    "explanation": "Classification Reason: Concerns the use of biochemical markers (like S100B) to assess aspects of brain injury pathophysiology (BBB disruption) specifically in the context of TBI.",
    "subspecialty": "Critical Care Neurology"
  },
  {
    "question_number": "Q162",
    "question_text": "A patient with ventricular hemorrhage is being evaluated for ventriculostomy. Which one of the following statements is true?",
    "options": "{\"A\": \"The risk of infection is 3%.\", \"B\": \"The risk of infection increases after day 7.\", \"C\": \"Changing the ventricular tube every 5 days decreases the rate of infection.\", \"D\": \"Prophylactic antibiotics have no role in preventing ventriculostomy infections.\"}",
    "correct_answer": "B",
    "source_file": "Promotion 2022_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2022,
    "explanation": "Classification Reason: Addresses the epidemiology and risk factors associated with infections related to external ventricular drains (EVDs/ventriculostomy), a common critical care procedure. (Similar to Q152)",
    "subspecialty": "Critical Care Neurology"
  },
  {
    "question_number": "Q168",
    "question_text": "What is assessed to evaluate the blood-brain barrier (BBB) in traumatic brain injury (TBI)?",
    "options": "{\"A\": \"S100\", \"B\": \"Myelin basic protein\", \"C\": \"Serum specific enolase\", \"D\": \"Glial fibrillary acidic protein\"}",
    "correct_answer": "A",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Concerns the use of biochemical markers (like S100B) to assess aspects of brain injury pathophysiology (BBB disruption) specifically in the context of TBI. (Duplicate of Q121)",
    "subspecialty": "Critical Care Neurology"
  },
  {
    "question_number": "Q160",
    "question_text": "What is the most appropriate test to order next for an elderly patient admitted with cardiac arrest who is intubated and sedated?",
    "options": "{\"A\": \"Beta 2 glycoprotein antibody\", \"B\": \"Cholesterol, triglycerides, LDL\", \"C\": \"NOTCH 3\", \"D\": \"Brain death assessment\"}",
    "correct_answer": "D",
    "source_file": "Promotion 2022_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2022,
    "explanation": "Classification Reason: Focuses on the critical next step in evaluating an unresponsive, intubated patient post-cardiac arrest, which often involves prognostication or formal brain death assessment.",
    "subspecialty": "Critical Care Neurology"
  },
  {
    "question_number": "Q80",
    "question_text": "What is the most important diagnostic factor in hypoxic post-cardiac arrest in comatose patients?",
    "options": "{\"A\": \"Serum lactate levels\", \"B\": \"Neurological examination findings\", \"C\": \"Electroencephalogram (EEG)\", \"D\": \"Imaging studies\"}",
    "correct_answer": "B",
    "source_file": "Part I 2022_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2022,
    "explanation": "Classification Reason: Highlights the central role of the neurological examination and supportive tests like EEG in assessing and prognosticating hypoxic-ischemic brain injury after cardiac arrest.",
    "subspecialty": "Critical Care Neurology"
  },
  {
    "question_number": "Q67",
    "question_text": "A patient is brought unconscious to the emergency department. A CT of the brain shows multiple hemorrhages at the anterior and posterior aspects. What is the likely mechanism of these intracranial hemorrhages?",
    "options": "{\"A\": \"Traumatic\", \"B\": \"Brain tumor\", \"C\": \"Hypertensive hemorrhage\", \"D\": \"Cerebral amyloid angiopathy\"}",
    "correct_answer": "A",
    "source_file": "Part 2 Adult Neurology residency 2024 V9_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Infers the most probable cause (trauma) based on the characteristic pattern (e.g., coup-contrecoup) of intracranial hemorrhages seen on imaging in an acutely unconscious patient.",
    "subspecialty": "Critical Care Neurology"
  },
  {
    "question_number": "Q3",
    "question_text": "A patient presented with visual symptoms, confusion, and is taking immunosuppressants for renal transplantation. Brain MRI showed PRESS. What is the management?",
    "options": "{\"A\": \"Control blood pressure\", \"B\": \"Change medication\", \"C\": \"Increase immunosuppressant dosage\", \"D\": \"Refer to a specialist\"}",
    "correct_answer": "A",
    "source_file": "Part 1 2020_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2020,
    "explanation": "Classification Reason: Deals with management of an acute neurological complication (PRESS) often seen in critically ill or immunosuppressed patients, focusing on immediate management priorities like BP control and addressing the precipitating factor.",
    "subspecialty": "Critical Care Neurology"
  },
  {
    "question_number": "Q153",
    "question_text": "A patient had an accident and presents with a Glasgow Coma Scale (GCS) score of 5. What is the role of corticosteroids in this case?",
    "options": "{\"A\": \"Improve functional disability but not change morbidity\", \"B\": \"No evidence in traumatic brain injury\", \"C\": \"Increase risk of infection and worsen outcomes\", \"D\": \"Recommended only in cases with spinal cord injury\"}",
    "correct_answer": "B",
    "source_file": "Promotion 2019_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2019,
    "explanation": "Classification Reason: Addresses a specific management question (corticosteroid use) in the context of severe traumatic brain injury, a core critical care neurology topic.",
    "subspecialty": "Critical Care Neurology"
  },
  {
    "question_number": "Q9",
    "question_text": "A patient with SAH presents with low sodium levels and high urine osmolarity. The patient is hypotensive and tachycardic. What is the appropriate treatment?",
    "options": "{\"A\": \"Fluid restriction\", \"B\": \"IV fluid\", \"C\": \"Hypertonic saline administration\", \"D\": \"Vasopressor support\"}",
    "correct_answer": "B",
    "source_file": "Part 1 2021_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2021,
    "explanation": "Classification Reason: Focuses on managing a common and critical electrolyte imbalance (hyponatremia) specifically in the context of SAH, differentiating CSW from SIADH based on volume status, requiring critical care intervention.",
    "subspecialty": "Critical Care Neurology"
  },
  {
    "question_number": "Q10",
    "question_text": "An elderly patient with a history of inability to care for himself presents with decreased level of consciousness. What would you expect to find on EEG?",
    "options": "{\"A\": \"Diffuse slowing\", \"B\": \"Periodic lateralized epileptiform discharges (PLED)\", \"C\": \"Sharp and wave complexes\", \"D\": \"Normal alpha rhythm\"}",
    "correct_answer": "A",
    "source_file": "Part 1 2021_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2021,
    "explanation": "Classification Reason: Addresses the expected EEG finding in an elderly patient with acute altered mental status, likely reflecting encephalopathy common in critical illness or acute decline.",
    "subspecialty": "Critical Care Neurology"
  },
  {
    "question_number": "Q77",
    "question_text": "An elderly female is brought to the ER with a level of consciousness that is altered. Her labs show INR of 3. A Brain CT is attached. What is the best next step?",
    "options": "{\"A\": \"Vitamin K\", \"B\": \"TPA\", \"C\": \"Daratumumab\", \"D\": \"FFP\"}",
    "correct_answer": "A",
    "source_file": "Part I 2022_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2022,
    "explanation": "Classification Reason: Focuses on the immediate management (reversal of anticoagulation) of an acute intracranial hemorrhage in a patient with elevated INR, a critical neurological emergency often managed initially in an ER/ICU setting.",
    "subspecialty": "Critical Care Neurology"
  },
  {
    "question_number": "Q159",
    "question_text": "In the same scenario, what is the diagnosis based on the EEG findings?",
    "options": "{\"A\": \"Nonconvulsive status\", \"B\": \"Brain death\", \"C\": \"Vegetative state\", \"D\": \"Encephalopathy\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2021_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2021,
    "explanation": "Classification Reason: Involves interpreting EEG findings for diagnosis/prognostication in a post-cardiac arrest patient managed in the ICU (referring to context from Q158).",
    "subspecialty": "Critical Care Neurology"
  },
  {
    "question_number": "Q78",
    "question_text": "A 63-year-old male admitted with left hemiparesis underwent CABG. He was successfully extubated off sedatives. In the ICU, it was noticed that the patient is awake but not communicating and not following commands. His neurological examination showed no focal deficits. What is the best sensitive test to order?",
    "options": "{\"A\": \"Brain CT\", \"B\": \"Blood MEL\", \"C\": \"EEG\", \"D\": \"Lumbar Puncture\"}",
    "correct_answer": "C",
    "source_file": "Part I 2022_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2022,
    "explanation": "Classification Reason: Deals with diagnosing the cause of altered mental status (specifically considering NCSE) in a post-operative ICU patient, where EEG is the crucial diagnostic tool.",
    "subspecialty": "Critical Care Neurology"
  },
  {
    "question_number": "Q158",
    "question_text": "In a case scenario of an elderly patient post-cardiac arrest who was put on hypothermic measures and experienced shivering, sedation, and muscle blockers were administered. After 24 to 48 hours, brainstem reflexes were absent. What is the next step?",
    "options": "{\"A\": \"EEG\", \"B\": \"SEPs\", \"C\": \"Stop sedation\", \"D\": \"Stop muscle blockers\"}",
    "correct_answer": "D",
    "source_file": "Promotion 2021_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2021,
    "explanation": "Classification Reason: Addresses the critical steps in evaluating a post-cardiac arrest patient with absent brainstem reflexes, including managing confounders (sedation/paralysis) and planning further neuroprognostic tests.",
    "subspecialty": "Critical Care Neurology"
  },
  {
    "question_number": "Q22",
    "question_text": "Following a road traffic accident (RTA), the patient developed post-concussion syndrome. What is the reason for this condition?",
    "options": "{\"A\": \"Shear injury\", \"B\": \"Cerebral contusion\", \"C\": \"Epidural hematoma\", \"D\": \"Subarachnoid hemorrhage\"}",
    "correct_answer": "A",
    "source_file": "Part 2 - 2023_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2023,
    "explanation": "Classification Reason: Asks about the pathophysiology (shear injury/diffuse axonal injury) underlying post-concussion syndrome following traumatic brain injury.",
    "subspecialty": "Critical Care Neurology"
  },
  {
    "question_number": "Q76",
    "question_text": "In a patient with liver failure, what will you see on EEG?",
    "options": "{\"A\": \"Triphasic wave\", \"B\": \"Periodic lateralized epileptiform discharges\", \"C\": \"Generalized slowing\", \"D\": \"Alpha coma pattern\"}",
    "correct_answer": "A",
    "source_file": "Part I 2018_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2018,
    "explanation": "Classification Reason: Identifies a specific EEG pattern (triphasic waves) associated with a metabolic encephalopathy (hepatic) often managed in critical care settings.",
    "subspecialty": "Critical Care Neurology"
  },
  {
    "question_number": "Q141",
    "question_text": "Which of the following is the most important predictor of outcome in cardiac arrest?",
    "options": "{\"A\": \"Time to defibrillation\", \"B\": \"Age of the patient\", \"C\": \"Initial rhythm\", \"D\": \"Bystander CPR\"}",
    "correct_answer": "A",
    "source_file": "Part II 2018_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2018,
    "explanation": "Classification Reason: Deals with factors predicting neurological outcome after cardiac arrest, a core concept in critical care neurology prognostication.",
    "subspecialty": "Critical Care Neurology"
  },
  {
    "question_number": "Q492",
    "question_text": "What is a potential risk associated with the use of mannitol in patients?",
    "options": "{\"A\": \"Hyperkalemia\", \"B\": \"Renal failure\", \"C\": \"Pulmonary edema\", \"D\": \"Volume overload\"}",
    "correct_answer": "D",
    "source_file": "Promotion 2023_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2023,
    "explanation": "Classification Reason: Focuses on the side effects and risks of a specific medication (mannitol) commonly used in the neurocritical care setting for managing intracranial pressure.",
    "subspecialty": "Critical Care Neurology"
  },
  {
    "question_number": "Q1",
    "question_text": "A patient presented with confusion and recurrent seizures two days after hemodialysis, with normal imaging. What is the likely reason?",
    "options": "{\"A\": \"Water influx inside cells causing edema\", \"B\": \"Uremic toxicity\", \"C\": \"Electrolyte imbalance causing neuronal hyperexcitability\", \"D\": \"Hypotension-induced cerebral ischemia\"}",
    "correct_answer": "A",
    "source_file": "PART I - 2024 - KSMC Revision_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2024,
    "explanation": "Classification Reason: Addresses the pathophysiology of a neurological complication (Dialysis Disequilibrium Syndrome) directly related to a critical care procedure (hemodialysis).",
    "subspecialty": "Critical Care Neurology"
  },
  {
    "question_number": "Q144",
    "question_text": "A 29-year-old male is found unconscious on the street. What do you expect as the mechanism of injury based on the attached CT scan?",
    "options": "{\"A\": \"Aneurysmal\", \"B\": \"Trauma\", \"C\": \"Hypertension\", \"D\": \"Ischemic stroke\"}",
    "correct_answer": "B",
    "source_file": "Part II 2019_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2019,
    "explanation": "Classification Reason: Involves interpreting acute neuroimaging (implied CT showing trauma, SAH, or ICH) to determine the cause of unconsciousness requiring emergency management.",
    "subspecialty": "Critical Care Neurology"
  },
  {
    "question_number": "Q150",
    "question_text": "What is considered a poor prognosis in burst suppression?",
    "options": "{\"A\": \"Burst suppression with identical bursts\", \"B\": \"Burst suppression with variable bursts\", \"C\": \"Burst suppression induced by sedative medications\", \"D\": \"Burst suppression with preserved reactivity\"}",
    "correct_answer": "A",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Concerns the prognostic significance of a specific EEG pattern (burst suppression) in critically ill patients.",
    "subspecialty": "Critical Care Neurology"
  },
  {
    "question_number": "Q79",
    "question_text": "A 67-year-old female experiences recurrent episodes of headache, nausea, and vomiting shortly after dialysis. What is the most likely diagnosis?",
    "options": "{\"A\": \"Dialysis disequilibrium syndrome\", \"B\": \"Uremic encephalopathy\", \"C\": \"Hypertensive crisis\", \"D\": \"Intracranial hemorrhage\"}",
    "correct_answer": "A",
    "source_file": "Part I 2022_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2022,
    "explanation": "Classification Reason: Focuses on diagnosing a specific neurological syndrome (Dialysis Disequilibrium Syndrome) occurring as a direct complication of hemodialysis.",
    "subspecialty": "Critical Care Neurology"
  },
  {
    "question_number": "Q148",
    "question_text": "A patient with renal failure missed one dialysis session. What would you expect to see on EEG?",
    "options": "{\"A\": \"Generalized slowing\", \"B\": \"Triphasic waves\", \"C\": \"Epileptiform discharges\", \"D\": \"Normal EEG\"}",
    "correct_answer": "B",
    "source_file": "Part II 2019_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2019,
    "explanation": "Classification Reason: Asks for the expected EEG finding related to metabolic encephalopathy (uremic) due to missed dialysis, a common scenario encountered in acutely ill patients.",
    "subspecialty": "Critical Care Neurology"
  },
  {
    "question_number": "Q511",
    "question_text": "What is a common side effect of hypertonic saline administration?",
    "options": "{\"A\": \"Hypokalemia\", \"B\": \"Hypernatremia\", \"C\": \"Hypotension\", \"D\": \"Bradycardia\"}",
    "correct_answer": "B",
    "source_file": "Promotion 2023_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2023,
    "explanation": "Classification Reason: Addresses a common side effect (hypernatremia) of a medication (hypertonic saline) frequently used in neurocritical care to manage cerebral edema/ICP.",
    "subspecialty": "Critical Care Neurology"
  },
  {
    "question_number": "Q12",
    "question_text": "Cardiac arrest in a smoker patient complicated with hypotension and intubation. After 1 month, the patient returned to the clinic with chronic headaches and dizziness. What is the pathogenesis?",
    "options": "{\"A\": \"Hypercapnia\", \"B\": \"Vasospasm\", \"C\": \"Hypoxic-ischemic encephalopathy\", \"D\": \"Post-intubation airway trauma\"}",
    "correct_answer": "B",
    "source_file": "Part 2 - 2023_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2023,
    "explanation": "Classification Reason: Discusses potential pathogenesis contributing to neurological symptoms following cardiac arrest and critical care management, relating back to the initial critical event.",
    "subspecialty": "Critical Care Neurology"
  },
  {
    "question_number": "Q62",
    "question_text": "In a case scenario of post-subarachnoid hemorrhage (SAH) and hyponatremia, what is the recommended treatment?",
    "options": "{\"A\": \"3% hypertonic saline\", \"B\": \"Fluid restriction\", \"C\": \"Vasopressin\", \"D\": \"Normal saline infusion\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2018_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2018,
    "explanation": "Classification Reason: Addresses the management of hyponatremia, a common complication following subarachnoid hemorrhage, often requiring ICU-level intervention like hypertonic saline.",
    "subspecialty": "Critical Care Neurology"
  },
  {
    "question_number": "Q169",
    "question_text": "What is the most important predictor of outcome in cardiac arrest?",
    "options": "{\"A\": \"Bilateral SSEP\", \"B\": \"Duration of CPR\", \"C\": \"Absent pupillary response at 24 hours\", \"D\": \"Age of the patient\"}",
    "correct_answer": "A",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Deals with factors, particularly neurological examination findings (pupillary response) and neurophysiological tests (SSEP), used for prognostication after cardiac arrest in the critical care setting.",
    "subspecialty": "Critical Care Neurology"
  },
  {
    "question_number": "Q50",
    "question_text": "An approximately 70-year-old male patient post-CABG 2 days ago is extubated, awake but not following commands, and all labs are normal. What is the best diagnostic test?",
    "options": "{\"A\": \"Lumbar puncture (LP)\", \"B\": \"MRI of the brain\", \"C\": \"CT of the brain\", \"D\": \"EEG\"}",
    "correct_answer": "D",
    "source_file": "Part 1 2021_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2021,
    "explanation": "Classification Reason: Deals with diagnosing the cause of altered mental status (specifically considering NCSE) in a post-operative ICU patient, where EEG is the crucial diagnostic tool.* (Duplicate concept of Q78)",
    "subspecialty": "Critical Care Neurology"
  },
  {
    "question_number": "Q97",
    "question_text": "A brain CT picture shows coup and contrecoup injury. What is the most likely cause?",
    "options": "{\"A\": \"Traumatic aneurysm\", \"B\": \"Coup-contrecoup injury\", \"C\": \"Infection\", \"D\": \"Malignancy\"}",
    "correct_answer": "B",
    "source_file": "Part II 2018_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2018,
    "explanation": "Classification Reason: Involves interpreting a specific pattern of injury (coup-contrecoup) on a brain CT scan to determine the etiology as trauma, relevant to neurotrauma critical care.",
    "subspecialty": "Critical Care Neurology"
  },
  {
    "question_number": "Q151",
    "question_text": "An elderly patient with a history of sick sinus syndrome had a pacemaker implanted and subsequently developed a right subdural hematoma. On day 3, she has decreased level of consciousness and left-sided weakness. A repeat CT shows expected postoperative changes. What is the next appropriate test?",
    "options": "{\"A\": \"EEG\", \"B\": \"CTA\", \"C\": \"Echocardiogram\", \"D\": \"Holter monitor\"}",
    "correct_answer": "A",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Focuses on diagnosing the cause of acute neurological decline (likely non-convulsive seizures) in a post-operative patient with known intracranial pathology, requiring urgent assessment (EEG) often in a critical care setting.",
    "subspecialty": "Critical Care Neurology"
  },
  {
    "question_number": "Q6",
    "question_text": "A female patient with high blood pressure (180/??) presents with seizures and confusion. MRI shows bilateral occipital cortical hyperintensity. What is the likely diagnosis?",
    "options": "{\"A\": \"Posterior reversible encephalopathy syndrome (PRES)\", \"B\": \"Ischemic stroke\", \"C\": \"Viral encephalitis\", \"D\": \"Hypertensive intracerebral hemorrhage\"}",
    "correct_answer": "A",
    "source_file": "Part 1 2020_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2020,
    "explanation": "Classification Reason: Concerns the diagnosis of PRES, an acute neurological condition often associated with hypertensive emergency, seizures, and requiring urgent management and monitoring typical of critical care.",
    "subspecialty": "Critical Care Neurology"
  },
  {
    "question_number": "Q93",
    "question_text": "A case of intracerebral hemorrhage (ICH) with a 6 mm midline shift is presented. What is an appropriate treatment option?",
    "options": "{\"A\": \"Osmotic therapy\", \"B\": \"Surgical intervention\", \"C\": \"Observation\", \"D\": \"Anticoagulation\"}",
    "correct_answer": "B",
    "source_file": "Part II 2018_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2018,
    "explanation": "Classification Reason: Deals with management decisions (osmotic therapy vs. surgery) for significant mass effect from ICH, a neurocritical care emergency requiring ICP management.",
    "subspecialty": "Critical Care Neurology"
  },
  {
    "question_number": "Q161",
    "question_text": "In a sedated patient, which diagnostic test is least likely to provide useful information?",
    "options": "{\"A\": \"EEG\", \"B\": \"MRI\", \"C\": \"SSEP\", \"D\": \"Brain death assessment\"}",
    "correct_answer": "D",
    "source_file": "Promotion 2022_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2022,
    "explanation": "Classification Reason: Evaluates understanding of the utility of diagnostic tools (EEG, MRI, SSEP) in assessing sedated or comatose patients, a common critical care scenario. Brain death assessment is a clinical determination process, not a typical diagnostic test for underlying pathology in this context.",
    "subspecialty": "Critical Care Neurology"
  },
  {
    "question_number": "Q171",
    "question_text": "A patient was in the ICU for 33 days. On the 3rd day, he has a persistent sleep-wake cycle. What is the most likely term for this condition?",
    "options": "{\"A\": \"Stupor\", \"B\": \"Vegetative\", \"C\": \"Minimally conscious state\", \"D\": \"Coma\"}",
    "correct_answer": "B",
    "source_file": "part 2 2024_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Tests the definition and terminology of states of consciousness (vegetative state) following prolonged critical illness or brain injury.",
    "subspecialty": "Critical Care Neurology"
  },
  {
    "question_number": "Q17",
    "question_text": "A patient has an MRI showing tonsillar herniation. What is the next best step in management?",
    "options": "{\"A\": \"Send to neurosurgery\", \"B\": \"Administer mannitol\", \"C\": \"Intubate and hyperventilate\", \"D\": \"Dexamethasone\"}",
    "correct_answer": "A",
    "source_file": "Part 2 - 2023_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2023,
    "explanation": "Classification Reason: Concerns the immediate management step for a critical finding (tonsillar herniation) indicative of imminent brainstem compression and requiring urgent intervention.",
    "subspecialty": "Critical Care Neurology"
  },
  {
    "question_number": "Q30",
    "question_text": "A 30-year-old male was found unconscious on the street. What do you expect as the mechanism of injury for the attached CT scan, which appeared to show a coup-contrecoup bleed?",
    "options": "{\"A\": \"Aneurysmal\", \"B\": \"Trauma\", \"C\": \"Hypertension\", \"D\": \"Ischemic stroke\"}",
    "correct_answer": "B",
    "source_file": "Part 2 2020 copy_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2020,
    "explanation": "Classification Reason: Involves interpreting CT findings (coup-contrecoup pattern) to determine the mechanism (trauma) of brain injury in an acutely unconscious patient.",
    "subspecialty": "Critical Care Neurology"
  },
  {
    "question_number": "Q170",
    "question_text": "Which test is used to assess the blood-brain barrier (BBB) in traumatic brain injury (TBI)?",
    "options": "{\"A\": \"S100\", \"B\": \"Myelin basic protein\", \"C\": \"Serum specific enolase\", \"D\": \"Glial fibrillary acidic protein\"}",
    "correct_answer": "A",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Concerns the use of specific biomarkers to assess blood-brain barrier integrity and brain injury severity after TBI, relevant to neurotrauma critical care.",
    "subspecialty": "Critical Care Neurology"
  },
  {
    "question_number": "Q8",
    "question_text": "In a patient with dialysis, what is the pathophysiology behind the disequilibrium syndrome?",
    "options": "{\"A\": \"Influx of water to the cells\", \"B\": \"Excessive removal of potassium causing hyperkalemia\", \"C\": \"Accumulation of uremic toxins in the bloodstream\", \"D\": \"Decreased cerebral blood flow due to hypotension during dialysis\"}",
    "correct_answer": "A",
    "source_file": "Part 1 2020_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2020,
    "explanation": "Classification Reason: Asks about the pathophysiology of dialysis disequilibrium syndrome, an acute neurological complication related to hemodialysis, often managed in an inpatient or critical care setting.",
    "subspecialty": "Critical Care Neurology"
  },
  {
    "question_number": "Q75",
    "question_text": "In a case of intracerebral hemorrhage (ICH) in the basal ganglia, what is the target blood pressure?",
    "options": "{\"A\": \"160/100\", \"B\": \"140/90\", \"C\": \"180/110\", \"D\": \"120/80\"}",
    "correct_answer": "B",
    "source_file": "Part I 2018_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2018,
    "explanation": "Classification Reason: Asks for the guideline target blood pressure in the acute management of intracerebral hemorrhage, a core principle of neurocritical care.",
    "subspecialty": "Critical Care Neurology"
  },
  {
    "question_number": "Q61",
    "question_text": "What is assessed to evaluate the blood-brain barrier (BBB) in traumatic brain injury (TBI)?",
    "options": "{\"A\": \"S100\", \"B\": \"Myelin basic protein\", \"C\": \"Serum specific enolase\", \"D\": \"Glial fibrillary acidic protein\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2021_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Concerns the use of biomarkers (like S100) to assess blood-brain barrier integrity in the context of acute TBI, relevant to neurocritical care. (Similar/duplicate concept to Q170).",
    "subspecialty": "Critical Care Neurology"
  },
  {
    "question_number": "Q345",
    "question_text": "A patient had cerebellar intracerebral hemorrhage (ICH) near the 4th ventricle with dilated lateral ventricles and 3rd ventricle. Which of the following is the next step in management?",
    "options": "{\"A\": \"Insert EVD and release high ICP\", \"B\": \"Do CT angiography to look for posterior circulation aneurysm\", \"C\": \"Start intravenous antihypertensive therapy to control blood pressure\", \"D\": \"Perform urgent surgical decompression of the cerebellar hemorrhage\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2023_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2023,
    "explanation": "Classification Reason: Focuses on the management of acute obstructive hydrocephalus secondary to cerebellar hemorrhage, a neurocritical care emergency requiring urgent intervention like EVD placement.",
    "subspecialty": "Critical Care Neurology"
  },
  {
    "question_number": "Q85",
    "question_text": "Which type of brain herniation is commonly associated with a fixed dilated pupil?",
    "options": "{\"A\": \"Uncal herniation\", \"B\": \"Central herniation\", \"C\": \"Tonsillar herniation\", \"D\": \"Subfalcine herniation\"}",
    "correct_answer": "A",
    "source_file": "Part I 2022_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2022,
    "explanation": "Classification Reason: Tests knowledge of the clinical signs (fixed dilated pupil) associated with specific types of brain herniation (uncal), a critical neurological emergency.",
    "subspecialty": "Critical Care Neurology"
  },
  {
    "question_number": "Q66",
    "question_text": "A patient had a road traffic accident (RTA) and was intubated in the ICU for 33 days. The patient has an intact wake and sleep cycle but no interaction with the environment. How would you label the patient?",
    "options": "{\"A\": \"Vegetative state\", \"B\": \"Persistent vegetative state\", \"C\": \"Coma\", \"D\": \"Locked-in syndrome\"}",
    "correct_answer": "A",
    "source_file": "Part 2 Adult Neurology residency 2024 V9_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Tests the definition and diagnosis of states of consciousness (vegetative state) following severe traumatic brain injury and prolonged ICU stay. (Similar concept to Q171).",
    "subspecialty": "Critical Care Neurology"
  },
  {
    "question_number": "Q2",
    "question_text": "A patient presented with visual symptoms, confusion, and is taking immunosuppressants for renal transplantation. Brain MRI showed PRES. What is the mechanism involved?",
    "options": "{\"A\": \"Failure of autoregulation\", \"B\": \"Demyelination of white matter\", \"C\": \"Direct infectious encephalitis\", \"D\": \"Autoimmune vasculitis\"}",
    "correct_answer": "A",
    "source_file": "Part 1 2020_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2020,
    "explanation": "Classification Reason: Asks about the underlying mechanism (failure of autoregulation) of Posterior Reversible Encephalopathy Syndrome (PRES), an acute neurological condition often requiring critical care management. (Similar concept to Q6).",
    "subspecialty": "Critical Care Neurology"
  },
  {
    "question_number": "Q499",
    "question_text": "An elderly patient who suffered a cardiac arrest is not waking up. What is the next best step in management?",
    "options": "{\"A\": \"EEG\", \"B\": \"MRI\", \"C\": \"Somatosensory evoked potentials (SSEP)\", \"D\": \"Administer intravenous fluids\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2023_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2023,
    "explanation": "Classification Reason: Concerns the appropriate next step in prognostication (using tools like EEG or SSEP) for a patient who remains comatose after cardiac arrest, a common neurocritical care scenario.",
    "subspecialty": "Critical Care Neurology"
  },
  {
    "question_number": "Q69",
    "question_text": "In a case scenario about cerebellar hemorrhage, what is the next step in management?",
    "options": "{\"A\": \"Neurosurgery consultation for evacuation\", \"B\": \"Initiate high-dose corticosteroids\", \"C\": \"Start anticoagulation therapy\", \"D\": \"Observe with serial neurological exams\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2018_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2018,
    "explanation": "Classification Reason: Asks for the critical next management step (neurosurgical consultation for potential evacuation) in acute cerebellar hemorrhage, which carries a high risk of rapid deterioration.",
    "subspecialty": "Critical Care Neurology"
  },
  {
    "question_number": "Q41",
    "question_text": "An elderly man has a 1-month history of right-sided weakness and confusion. A brain CT shows a crescentic-shaped hypodensity. What is the mechanism of the lesion?",
    "options": "{\"A\": \"Bridging veins rupture\", \"B\": \"Middle meningeal artery rupture\", \"C\": \"Cerebral artery thrombosis\", \"D\": \"Venous sinus thrombosis\"}",
    "correct_answer": "A",
    "source_file": "Part I 2019_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2019,
    "explanation": "Classification Reason: Describes a typical chronic subdural hematoma presentation and asks for its underlying mechanism (rupture of bridging veins), a common condition evaluated and managed in acute/critical care neurology and neurosurgery.",
    "subspecialty": "Critical Care Neurology"
  },
  {
    "question_number": "Q76",
    "question_text": "A patient who was arrested by police presents with encephalopathy and has a halitosis odor. What treatment should be administered?",
    "options": "{\"A\": \"Thiamine\", \"B\": \"Flumazine\", \"C\": \"Naloxone\", \"D\": \"Glucose\"}",
    "correct_answer": "A",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Concerns the immediate empirical treatment (Thiamine) for suspected Wernicke's encephalopathy in a patient presenting with acute altered mental status in a context suggestive of malnutrition or alcohol abuse, an acute neurological emergency.",
    "subspecialty": "Critical Care Neurology"
  },
  {
    "question_number": "Q126",
    "question_text": "A patient presents with subarachnoid hemorrhage and hyponatremia (serum sodium 129), with a blood pressure of 100 mmHg and high serum and urine osmolarity. What is the significance of these findings? (Note: Incomplete options)",
    "options": "{\"A\": \"Syndrome of inappropriate antidiuretic hormone secretion (SIADH) causing euvolemic hyponatremia\", \"B\": \"Cerebral salt wasting (CSW) causing hypovolemic hyponatremia with hypotension\", \"C\": \"Hypervolemic hyponatremia due to heart failure\", \"D\": \"Pseudohyponatremia due to hyperlipidemia or hyperproteinemia\"}",
    "correct_answer": "B",
    "source_file": "Part 2 - 2023_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2023,
    "explanation": "Classification Reason: Focuses on recognizing and managing complications (hyponatremia, distinguishing CSW vs SIADH) following subarachnoid hemorrhage, a core critical care neurology scenario.",
    "subspecialty": "Critical Care Neurology"
  },
  {
    "question_number": "Q42",
    "question_text": "A patient with intracerebral hemorrhage (ICH) two days later has a blood pressure of 170/90 and a marginally low platelet count of 145. What is the next best step in management?",
    "options": "{\"A\": \"Labetalol\", \"B\": \"Amlodipine\", \"C\": \"Platelet transfusion\", \"D\": \"Observation with supportive care\"}",
    "correct_answer": "A",
    "source_file": "Part 2 - 2023_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2023,
    "explanation": "Classification Reason: Addresses acute management decisions (blood pressure control, consideration of platelet transfusion adequacy) in a patient during the early phase following intracerebral hemorrhage, typical of neurocritical care.",
    "subspecialty": "Critical Care Neurology"
  },
  {
    "question_number": "Q62",
    "question_text": "A patient with acute stroke received tPA and subsequently developed difficulty with speaking or swallowing. What should be done next?",
    "options": "{\"A\": \"Antihistamine, Steroid\", \"B\": \"Intubate\", \"C\": \"Administer fresh frozen plasma\", \"D\": \"Observe and monitor closely\"}",
    "correct_answer": "A",
    "source_file": "Part 2 - 2023_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2023,
    "explanation": "Classification Reason: Deals with managing an acute, potentially life-threatening complication (likely orolingual angioedema) of tPA administration in stroke, requiring urgent intervention often in an ICU/ER setting.",
    "subspecialty": "Critical Care Neurology"
  },
  {
    "question_number": "Q254",
    "question_text": "What EEG finding is associated with poor prognosis?",
    "options": "{\"A\": \"Non-reactive continuous alpha.\", \"B\": \"FIRDA.\", \"C\": \"Hypsarrhythmia.\", \"D\": \"Continuous spindles.\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2019_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2019,
    "explanation": "Classification Reason: Asks about the prognostic significance of specific EEG patterns (e.g., non-reactive alpha coma) frequently encountered in critically ill or comatose patients, a key aspect of neuroprognostication in critical care.",
    "subspecialty": "Critical Care Neurology"
  },
  {
    "question_number": "Q392",
    "question_text": "A 56-year-old male patient is found in his house with decreased level of consciousness. He was last seen normal 1 day ago. A brain CT scan is performed. What will you do?",
    "options": "{\"A\": \"Admit to ward for observation\", \"B\": \"Start empirical antibiotics immediately\", \"C\": \"Perform lumbar puncture immediately\", \"D\": \"Admit to ICU for close monitoring and supportive care\"}",
    "correct_answer": "D",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Describes an acute neurological emergency (altered consciousness of unknown duration/etiology) requiring urgent evaluation and management decisions, fitting critical care neurology principles.",
    "subspecialty": "Critical Care Neurology"
  },
  {
    "question_number": "Q327",
    "question_text": "In a case of trauma, which biomarker is most reliable for detecting disrupted blood-brain barrier (BBB)?",
    "options": "{\"A\": \"S100\\u03b2\", \"B\": \"Neuron-specific enolase (NSE)\", \"C\": \"GFAP\", \"D\": \"MBP\"}",
    "correct_answer": "A",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Asks about the use of specific biomarkers (like S100\u03b2) in the context of acute TBI to assess injury severity, including BBB disruption, relevant to neurocritical care/neurotrauma. (Similar concept to Q170/Q61).",
    "subspecialty": "Critical Care Neurology"
  },
  {
    "question_number": "Q195",
    "question_text": "A patient presents with acute confusion and is found to have elevated blood levels of urea. What is the most likely cause of their symptoms?",
    "options": "{\"A\": \"Dialysis disequilibrium syndrome\", \"B\": \"Hypernatremia\", \"C\": \"Uremic encephalopathy\", \"D\": \"Hepatic encephalopathy\"}",
    "correct_answer": "C",
    "source_file": "Part I 2022_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2022,
    "explanation": "Classification Reason: Focuses on identifying the cause of metabolic encephalopathy (Uremic encephalopathy) presenting as acute confusion, a common scenario requiring diagnosis and management in acute/critical care settings.",
    "subspecialty": "Critical Care Neurology"
  },
  {
    "question_number": "Q95",
    "question_text": "A patient with subarachnoid hemorrhage (SAH) presents with hyponatremia. What should you do?",
    "options": "{\"A\": \"IV fluid (Hypertonic saline or fluid restriction depending on cause - SIADH vs CSW)\", \"B\": \"Immediate administration of isotonic saline\", \"C\": \"Restrict all fluids regardless of volume status\", \"D\": \"Start vasopressin receptor antagonists\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2021_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Focuses on the management strategy for hyponatremia, a common and important complication in the critical care management of SAH patients. (Similar concept to Q126).",
    "subspecialty": "Critical Care Neurology"
  },
  {
    "question_number": "Q460",
    "question_text": "A patient presents with a headache for months, has papilledema, and an MRI shows hydrocephalus with transependymal edema. What should be done next, considering the presenting symptoms were seizure and confusion?",
    "options": "{\"A\": \"HIV antibody test\", \"B\": \"EEG\", \"C\": \"Lumbar puncture\", \"D\": \"Neurosurgical consultation\"}",
    "correct_answer": "A",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Describes a patient with signs/symptoms of increased intracranial pressure (papilledema, hydrocephalus) presenting acutely with seizure and confusion. The management involves urgent diagnostic workup (potentially for an infectious/inflammatory cause like cryptococcal meningitis suggested by HIV test option), fitting within the scope of acute/critical care neurology.",
    "subspecialty": "Critical Care Neurology"
  },
  {
    "question_number": "Q491",
    "question_text": "An elderly male with left-sided weakness and dysarthria, who is on dabigatran, underwent thrombectomy without receiving tPA. He later has a CT scan showing bleeding. What should be administered to reverse the bleeding?",
    "options": "{\"A\": \"Osmotic therapy\", \"B\": \"Idarucizumab\", \"C\": \"Vitamin K\", \"D\": \"Prothrombin complex concentrate\"}",
    "correct_answer": "B",
    "source_file": "Promotion 2023_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2023,
    "explanation": "Classification Reason: Concerns the acute management (reversal agent for DOAC) of hemorrhagic transformation after stroke intervention, a critical complication managed in neurocritical care.",
    "subspecialty": "Critical Care Neurology"
  },
  {
    "question_number": "Q115",
    "question_text": "A patient progressed rapidly to quadriplegia and was intubated. He is awake and following commands with ocular movement, and the MRI is normal. What should be done next?",
    "options": "{\"A\": \"NCS/RNS\", \"B\": \"Cerebral angiography\", \"C\": \"Toxicology\", \"D\": \"Lumbar puncture\"}",
    "correct_answer": "A",
    "source_file": "Part 2 Adult Neurology residency 2024 V9_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Describes a patient with acute severe weakness requiring mechanical ventilation (neuromuscular respiratory failure or locked-in state). The urgency and need for ICU support place the diagnostic approach (NCS/RNS for GBS/MG crisis vs other causes) within the realm of critical care neurology.",
    "subspecialty": "Critical Care Neurology"
  },
  {
    "question_number": "Q174",
    "question_text": "An EEG shows a burst suppression pattern. What is the most likely status of the patient?",
    "options": "{\"A\": \"Brain dead\", \"B\": \"Deep coma\", \"C\": \"Under general anesthesia\", \"D\": \"Hypothermia\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2023_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2023,
    "explanation": "Classification Reason: Requires interpretation of a critical EEG pattern (burst suppression) typically associated with severe diffuse cerebral dysfunction, coma, or deep anesthesia, relevant in critical care settings.",
    "subspecialty": "Critical Care Neurology"
  },
  {
    "question_number": "Q19",
    "question_text": "A patient who is status post cardiac arrest and has been discharged from the hospital returns to the clinic complaining of sudden jerky movements sometimes upon touching. What is your diagnosis?",
    "options": "{\"A\": \"Lance Adams Syndrome\", \"B\": \"Myoclonus\", \"C\": \"Epileptic seizure\", \"D\": \"Parkinson's disease\"}",
    "correct_answer": "A",
    "source_file": "Part 1 2021_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2021,
    "explanation": "Classification Reason: Asks for the diagnosis of a specific neurological sequela (post-hypoxic myoclonus / Lance Adams Syndrome) following a critical care event (cardiac arrest).",
    "subspecialty": "Critical Care Neurology"
  },
  {
    "question_number": "Q179",
    "question_text": "Hypertonic saline is contraindicated in which of the following patient populations?",
    "options": "{\"A\": \"Patients with end-stage kidney disease\", \"B\": \"Patients with diabetes mellitus\", \"C\": \"Patients with hypertension\", \"D\": \"Patients with traumatic brain injury\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2023_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2023,
    "explanation": "Classification Reason: Assesses knowledge regarding the contraindications for using hyperosmolar therapy (hypertonic saline) in critically ill neurological patients, considering systemic effects like fluid/sodium load in renal failure.",
    "subspecialty": "Critical Care Neurology"
  },
  {
    "question_number": "Q178",
    "question_text": "What is the benefit of using mannitol over hypertonic saline in the management of increased intracranial pressure?",
    "options": "{\"A\": \"Less nephrotoxic\", \"B\": \"Increased intravascular volume\", \"C\": \"Better hypotension management\", \"D\": \"Faster onset of action\"}",
    "correct_answer": "D",
    "source_file": "Promotion 2023_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2023,
    "explanation": "Classification Reason: Compares two common agents (mannitol vs. hypertonic saline) used for managing elevated intracranial pressure in neurocritical care, focusing on their different properties and side effect profiles.",
    "subspecialty": "Critical Care Neurology"
  },
  {
    "question_number": "Q42",
    "question_text": "For the same patient, what is the recommended treatment?",
    "options": "{\"A\": \"Osmotic therapy\", \"B\": \"Surgery\", \"C\": \"Corticosteroids\", \"D\": \"Antiepileptic drugs\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2021_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Without the preceding scenario, the options (osmotic therapy, surgery) suggest management of elevated intracranial pressure or a structural lesion requiring intervention, typically managed in a critical care setting.* (Assumes context relates to acute brain injury/swelling).",
    "subspecialty": "Critical Care Neurology"
  },
  {
    "question_number": "Q43",
    "question_text": "A delirious patient presents. What is your next step?",
    "options": "{\"A\": \"Metabolic panel\", \"B\": \"Review medication\", \"C\": \"Perform neurological examination\", \"D\": \"Order brain imaging\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2021_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Focuses on the initial workup of delirium, a common problem in acutely ill or hospitalized patients, often managed within neurocritical care or hospital neurology.",
    "subspecialty": "Critical Care Neurology"
  },
  {
    "question_number": "Q2",
    "question_text": "A brain CT shows a coup contrecoup injury with left frontal and right temporal bleed. What is the most likely mechanism of injury?",
    "options": "{\"A\": \"Trauma\", \"B\": \"Cardioembolic\", \"C\": \"Artery to artery\", \"D\": \"Obstruction of venous flow\"}",
    "correct_answer": "A",
    "source_file": "PART I - 2024 - KSMC Revision_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2024,
    "explanation": "Classification Reason: Identifies mechanism based on imaging characteristic of Traumatic Brain Injury (TBI). Management of acute TBI often falls under neurocritical care.",
    "subspecialty": "Critical Care Neurology"
  },
  {
    "question_number": "Q41",
    "question_text": "Alcoholic patient came with post-traumatic seizure and delirium; he was on Keppra and Depakin, then seizure improved. After 2 days, the patient had worsening of his delirium; what will you do?",
    "options": "{\"A\": \"Alcohol level\", \"B\": \"Toxicology screening\", \"C\": \"Ammonia\", \"D\": \"Electrolyte panel\"}",
    "correct_answer": "C",
    "source_file": "Part 2 2021_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Deals with the differential diagnosis and management of worsening delirium in a complex patient (alcoholism, post-traumatic seizure), likely in an inpatient or critical care setting, considering metabolic causes like hepatic encephalopathy.",
    "subspecialty": "Critical Care Neurology"
  },
  {
    "question_number": "Q196",
    "question_text": "A patient who has recently delivered vaginally and is experiencing eclampsia presents with progressive flaccid paralysis. What is the next best step in management?",
    "options": "{\"A\": \"Magnesium level\", \"B\": \"Nerve conduction study (NCS)\", \"C\": \"Calcium level\", \"D\": \"MRI\"}",
    "correct_answer": "A",
    "source_file": "Part II 2019_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2019,
    "explanation": "Classification Reason: Concerns the urgent investigation of acute flaccid paralysis in a postpartum patient treated for eclampsia, where magnesium toxicity is a critical differential.",
    "subspecialty": "Critical Care Neurology"
  },
  {
    "question_number": "Q356",
    "question_text": "A young lady with SLE nephritis on dialysis presents with seizures and confusion. MRI shows high blood pressure with findings consistent with PRES. What is your diagnosis?",
    "options": "{\"A\": \"Lupus cerebritis\", \"B\": \"Posterior Reversible Encephalopathy Syndrome (PRES)\", \"C\": \"Cerebral Venous Thrombosis (CVT)\", \"D\": \"Herpes Simplex Virus (HSV) encephalitis\"}",
    "correct_answer": "B",
    "source_file": "Promotion 2023_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2023,
    "explanation": "Classification Reason: Focuses on identifying Posterior Reversible Encephalopathy Syndrome (PRES), a clinico-radiological syndrome often associated with hypertension, renal failure, or autoimmune conditions, frequently requiring acute management of blood pressure and neurological status.",
    "subspecialty": "Critical Care Neurology"
  },
  {
    "question_number": "Q146",
    "question_text": "A mother receiving antiepileptic drugs has an infant who developed intraventricular hemorrhage (IVH). Which medication is most likely responsible?",
    "options": "{\"A\": \"Keppra\", \"B\": \"Lacosamide\", \"C\": \"Phenytoin\", \"D\": \"Valproate (VA)\"}",
    "correct_answer": "C",
    "source_file": "Part II 2019_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2019,
    "explanation": "Classification Reason: Concerns a critical neurological event (IVH) in a neonate potentially related to in utero drug exposure, placing it within the context of neonatal critical care neurology.",
    "subspecialty": "Critical Care Neurology"
  },
  {
    "question_number": "Q337",
    "question_text": "A pregnant patient presents with recurrent vomiting. What should be administered?",
    "options": "{\"A\": \"Thiamine\", \"B\": \"Ondansetron\", \"C\": \"Intravenous fluids\", \"D\": \"Vitamin B6\"}",
    "correct_answer": "A",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Addresses the acute management/prevention (Thiamine administration) of potential Wernicke's encephalopathy in a high-risk setting (hyperemesis gravidarum), fitting best under Critical Care Neurology.",
    "subspecialty": "Critical Care Neurology"
  },
  {
    "question_number": "Q120",
    "question_text": "A patient developed cognitive impairment and ataxia. MRI showed high signals in the mammillary bodies. What is the most likely deficiency?",
    "options": "{\"A\": \"Thiamine\", \"B\": \"Vitamin B12\", \"C\": \"Folate\", \"D\": \"Copper\"}",
    "correct_answer": "A",
    "source_file": "Part II 2018_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2018,
    "explanation": "Classification Reason: Describes the classic clinical and radiological features of Wernicke's encephalopathy, an acute neurological condition often managed in critical care settings due to thiamine deficiency.",
    "subspecialty": "Critical Care Neurology"
  },
  {
    "question_number": "Q71",
    "question_text": "Pregnant lady came with confusion and had a history of increased vomiting; she has no ophthalmology findings; what will you give?",
    "options": "{\"A\": \"Thiamine\", \"B\": \"Intravenous glucose\", \"C\": \"Antiemetics\", \"D\": \"Corticosteroids\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2021_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Describes a scenario highly suggestive of impending or early Wernicke's encephalopathy requiring urgent treatment (Thiamine), fitting within Critical Care Neurology.",
    "subspecialty": "Critical Care Neurology"
  },
  {
    "question_number": "Q212",
    "question_text": "A pregnant lady came with confusion and had a history of increased vomiting; she has no ophthalmology findings. What will you give?",
    "options": "{\"A\": \"Thiamine\", \"B\": \"Intravenous glucose\", \"C\": \"Antiemetics\", \"D\": \"Corticosteroids\"}",
    "correct_answer": "A",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Describes a scenario highly suggestive of impending or early Wernicke's encephalopathy requiring urgent treatment (Thiamine), fitting within Critical Care Neurology.",
    "subspecialty": "Critical Care Neurology"
  },
  {
    "question_number": "Q21",
    "question_text": "A patient was on warfarin and developed intracerebral hemorrhage (ICH). Which of the following has the best efficacy to manage this condition?",
    "options": "{\"A\": \"Fresh Frozen Plasma (FFP)\", \"B\": \"Vitamin K\", \"C\": \"Prothrombin Complex Concentrate (PCC)\", \"D\": \"FFP + Vitamin K\"}",
    "correct_answer": "C",
    "source_file": "Part II 2018_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2018,
    "explanation": "Classification Reason: Focuses on the acute management (reversal of anticoagulation using PCC) of a neurological emergency (ICH) in a critical care setting.",
    "subspecialty": "Critical Care Neurology"
  },
  {
    "question_number": "Q75",
    "question_text": "An alcoholic patient came with post-traumatic seizure and delirium. He was on Keppra and Depakin, then the seizure improved; after 2 days, the patient had worsening of his delirium. What will you do?",
    "options": "{\"A\": \"Alcohol level\", \"B\": \"Toxicology screening\", \"C\": \"Ammonia\", \"D\": \"Electrolyte panel\"}",
    "correct_answer": "C",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Deals with the management of a complex critically ill patient with multiple potential causes for altered mental status (post-traumatic, post-ictal, withdrawal, metabolic like hepatic encephalopathy suggested by checking ammonia) requiring investigation in an acute care/ICU setting.",
    "subspecialty": "Critical Care Neurology"
  },
  {
    "question_number": "Q12",
    "question_text": "A 6-year-old female has recurrent episodes of headache, nausea, and vomiting that occur shortly after dialysis sessions. What is the possible mechanism to explain these symptoms?",
    "options": "{\"A\": \"Water influx into brain parenchyma\", \"B\": \"PTH levels\", \"C\": \"Toxic effect of urea in blood\", \"D\": \"Dialysis disequilibrium syndrome\"}",
    "correct_answer": "A",
    "source_file": "Part I 2022_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2022,
    "explanation": "Classification Reason: Addresses a neurological complication (Dialysis Disequilibrium Syndrome) arising directly from a critical care procedure (dialysis).",
    "subspecialty": "Critical Care Neurology"
  },
  {
    "question_number": "Q19",
    "question_text": "What is the management of hyponatremia due to cerebral salt wasting syndrome?",
    "options": "{\"A\": \"Hypertonic saline\", \"B\": \"IV fluid (isotonic)\", \"C\": \"Fludrocortisone\", \"D\": \"Fluid restriction\"}",
    "correct_answer": "A",
    "source_file": "Part II 2018_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2018,
    "explanation": "Classification Reason: Focuses on managing a specific electrolyte disturbance (hyponatremia due to CSW) that commonly occurs after acute brain injury (like SAH, TBI), often managed in a neurocritical care setting.",
    "subspecialty": "Critical Care Neurology"
  },
  {
    "question_number": "Q26",
    "question_text": "A 60-year-old male presented to the ER with a 2-day history of unilateral weakness and dysarthria. On examination, his blood pressure is 70/90 mmHg [Likely typo, assume 170/90 or similar elevated BP]. What is the next step in the management?",
    "options": "{\"A\": \"IV labetalol\", \"B\": \"IV nitroprusside\", \"C\": \"Observation\", \"D\": \"Resume home medications\"}",
    "correct_answer": "A",
    "source_file": "Part II 2018_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2018,
    "explanation": "Classification Reason: Addresses the acute management of blood pressure in the setting of a likely acute stroke, a common decision point in emergency/critical care neurology. [Assuming BP was meant to be high requiring intervention like Labetalol]. If BP truly 70/90, the question changes but still involves acute physiological management in a neurological emergency.",
    "subspecialty": "Critical Care Neurology"
  },
  {
    "question_number": "Q90",
    "question_text": "What is the best imaging modality for diffuse axonal injury?",
    "options": "{\"A\": \"CT with contrast\", \"B\": \"MRI with diffusion-weighted imaging (DWI)\", \"C\": \"Non-contrast CT\", \"D\": \"PET scan\"}",
    "correct_answer": "B",
    "source_file": "Promotion 2018_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2018,
    "explanation": "Classification Reason: Tests knowledge of the optimal neuroimaging technique (MRI, specifically sequences like DWI/SWI) for detecting diffuse axonal injury, commonly seen in traumatic brain injury managed in critical care settings.",
    "subspecialty": "Critical Care Neurology"
  },
  {
    "question_number": "Q79",
    "question_text": "A patient presents with inattentiveness, and laboratory tests including liver function tests (LFT), electrolyte levels, and a CT scan of the brain are normal. What could explain this condition?",
    "options": "{\"A\": \"Brain infection\", \"B\": \"Systemic infection\", \"C\": \"Medication side effect\", \"D\": \"Psychiatric disorder\"}",
    "correct_answer": "B",
    "source_file": "Part 1 2021_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2021,
    "explanation": "Classification Reason: Addresses the differential diagnosis of altered mental status (inattentiveness/encephalopathy) when initial brain imaging and basic labs are normal, pointing towards systemic causes (like sepsis) affecting brain function.",
    "subspecialty": "Critical Care Neurology"
  },
  {
    "question_number": "Q13",
    "question_text": "A patient came after head trauma and was fine initially. After one hour, he started to have a decrease in level of consciousness (LOC). What type of hematoma is most likely?",
    "options": "{\"A\": \"Subarachnoid hemorrhage (SAH)\", \"B\": \"Epidural hematoma (EDH)\", \"C\": \"Subdural hematoma (SDH)\", \"D\": \"Intracerebral hemorrhage (ICH)\"}",
    "correct_answer": "B",
    "source_file": "PART I - 2024 - KSMC Revision_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2024,
    "explanation": "Classification Reason: Describes an acute neurological emergency (post-traumatic hematoma with rapid decline) typically managed in a critical care or neurosurgical setting.",
    "subspecialty": "Critical Care Neurology"
  },
  {
    "question_number": "Q154",
    "question_text": "A patient presented to the emergency room with meningitis and no papilledema, what is the appropriate management?",
    "options": "{\"A\": \"Wait for CT then perform lumbar puncture (LP)\", \"B\": \"Give antibiotics directly\", \"C\": \"Perform LP without CT\", \"D\": \"Administer corticosteroids before antibiotics\"}",
    "correct_answer": "C",
    "source_file": "Promotion 2019_mcqs.txt; Originally Critical_Care_Neurology",
    "exam_type": "Promotion",
    "exam_year": 2019,
    "explanation": "Classification Reason: Focuses on the immediate decision-making process and procedural sequencing (LP vs CT vs antibiotics) in the acute management of suspected bacterial meningitis in the emergency setting.",
    "subspecialty": "Critical Care Neurology"
  },
  {
    "question_number": "Q72",
    "question_text": "A patient known to have congenital heart disease presents with headache, fever, and hemiparesis. What will you do next?",
    "options": "{\"A\": \"Blood culture\", \"B\": \"CT without contrast\", \"C\": \"CT with contrast\", \"D\": \"LP\"}",
    "correct_answer": "B",
    "source_file": "Part I 2018_mcqs.txt; Originally Critical_Care_Neurology",
    "exam_type": "Part I",
    "exam_year": 2018,
    "explanation": "Classification Reason: Concerns the immediate next diagnostic step (neuroimaging choice) in the acute workup of a patient with risk factors (CHD) presenting with symptoms suggestive of a focal CNS infection like a brain abscess.",
    "subspecialty": "Critical Care Neurology"
  },
  {
    "question_number": "Q255",
    "question_text": "In the assessment of brain death, which of the following is a critical step?",
    "options": "{\"A\": \"Stop sedation\", \"B\": \"Stop muscle relaxants\", \"C\": \"Confirm absence of brainstem reflexes\", \"D\": \"Perform apnea test\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2023_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2023,
    "explanation": "Classification Reason: Focuses on the procedural requirements (eliminating confounders like medication effects) for brain death determination, a core critical care concept.",
    "subspecialty": "Critical Care Neurology"
  },
  {
    "question_number": "Q267",
    "question_text": "A patient on sedation has EEG findings suggestive of bilateral generalized slowing. What is the next best step in management?",
    "options": "{\"A\": \"Stop sedation\", \"B\": \"Load phenytoin 15-20 mg/kg\", \"C\": \"Perform a brain death assessment\", \"D\": \"Increase sedation\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2023_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2023,
    "explanation": "Classification Reason: Addresses the interpretation and management of EEG findings in a sedated patient, often seen in the ICU setting, considering medication effects versus underlying pathology.",
    "subspecialty": "Critical Care Neurology"
  },
  {
    "question_number": "Q289",
    "question_text": "An elderly patient is intubated with intact level of consciousness but is only able to move his extraocular muscles. What is the next step in workup? [Suggests Locked-in Syndrome or severe neuromuscular weakness]",
    "options": "{\"A\": \"NCS with RNS\", \"B\": \"EEG\", \"C\": \"MRI Brain\", \"D\": \"Urine toxicology\"}",
    "correct_answer": "A",
    "source_file": "part 2 2024_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Focuses on the diagnostic approach in a critically ill, non-communicative patient where distinguishing central (Locked-in) from peripheral (severe weakness/neuropathy/NMJ) causes is key, involving critical care diagnostics.",
    "subspecialty": "Critical Care Neurology"
  },
  {
    "question_number": "Q260",
    "question_text": "Which of the following is a mechanism by which hypertonic saline reduces intracranial pressure?",
    "options": "{\"A\": \"It increases the osmotic gradient across the blood-brain barrier.\", \"B\": \"It directly causes vasodilation.\", \"C\": \"It decreases blood volume.\", \"D\": \"It enhances cerebral perfusion pressure.\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2023_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2023,
    "explanation": "Classification Reason: Tests knowledge of the mechanism of action of therapies (hyperosmolar therapy) used to manage intracranial pressure in critically ill neurological patients.",
    "subspecialty": "Critical Care Neurology"
  },
  {
    "question_number": "Q257",
    "question_text": "A male elderly patient with liver disease and hypertension presents with decreased and fluctuating level of consciousness. Laboratory tests show high liver function tests, high renal function tests, and high ammonia levels. What is the most likely diagnosis?",
    "options": "{\"A\": \"Hepatic encephalopathy\", \"B\": \"Wernicke's encephalopathy\", \"C\": \"Herpes Simplex Virus encephalitis\", \"D\": \"Stroke\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2023_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2023,
    "explanation": "Classification Reason: Focuses on diagnosing the cause of altered mental status in a critically ill patient with multi-organ dysfunction, pointing towards a metabolic encephalopathy (hepatic).",
    "subspecialty": "Critical Care Neurology"
  },
  {
    "question_number": "Q75",
    "question_text": "A pregnant lady had a headache, and her CT showed an intracranial hemorrhage (ICH). What is the treatment?",
    "options": "{\"A\": \"Start Heparin\", \"B\": \"Warfarin\", \"C\": \"Supportive care and blood pressure control\", \"D\": \"Surgical evacuation of hematoma\"}",
    "correct_answer": "C",
    "source_file": "Part 2 2021_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: While involving ICH (Vascular), the core challenge is managing anticoagulation (or deciding against it) in a pregnant patient with ICH, leaning towards critical care considerations in a special population. Anticoagulation (Heparin, Warfarin) is contraindicated in acute ICH as it may worsen bleeding. The best treatment involves supportive care, blood pressure control, and possibly surgical intervention depending on hematoma size and clinical status.",
    "subspecialty": "Critical Care Neurology"
  },
  {
    "question_number": "Q192",
    "question_text": "What is the primary benefit of administering anticonvulsants during the first week after traumatic brain injury (TBI)?",
    "options": "{\"A\": \"Decrease early and late seizures\", \"B\": \"Decrease early seizures\", \"C\": \"Decrease late seizures\", \"D\": \"Don't decrease frequency but decrease severity of seizures\"}",
    "correct_answer": "B",
    "source_file": "Promotion 2018_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2018,
    "explanation": "Classification Reason: Concerns the acute management of TBI, specifically the role of seizure prophylaxis in the immediate post-injury period, a common issue in neurocritical care.",
    "subspecialty": "Critical Care Neurology"
  },
  {
    "question_number": "Q2",
    "question_text": "A brain CT shows a coup contrecoup injury with left frontal and right temporal bleed. What is the most likely mechanism of injury?",
    "options": "{\"A\": \"Trauma\", \"B\": \"Cardioembolic\", \"C\": \"Artery to artery\", \"D\": \"Obstruction of venous flow\"}",
    "correct_answer": "A",
    "source_file": "PART I - 2024 - KSMC Revision_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2024,
    "explanation": "Classification Reason: Identifies the mechanism of injury based on the specific pattern of brain hemorrhage (coup-contrecoup), which is pathognomonic for traumatic brain injury (TBI). While involving bleeding, the core concept is recognizing the TBI pattern, management of which often falls under neurocritical care or neurosurgery.",
    "subspecialty": "Critical Care Neurology"
  },
  {
    "question_number": "Q25",
    "question_text": "In a similar scenario to the previous one, what is the most likely diagnosis?",
    "options": "{\"A\": \"Acute confusional state\", \"B\": \"Stroke\", \"C\": \"Hypoglycaemia\", \"D\": \"Meningitis\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2020 copy_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2020,
    "explanation": "Classification Reason: Assuming the previous scenario involved an acutely unwell patient (common in critical care settings), identifying an acute confusional state (delirium) is a key diagnostic step in critical care neurology.",
    "subspecialty": "Critical Care Neurology"
  },
  {
    "question_number": "Q16",
    "question_text": "Pseudorossettes are characteristic of which of the following tumors?",
    "options": "{\"A\": \"Medulloblastoma\", \"B\": \"Ependymoma\", \"C\": \"Glioblastoma\", \"D\": \"Meningioma\"}",
    "correct_answer": "B",
    "source_file": "Part 2 2020 copy_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2020,
    "explanation": "Classification Reason: Tests knowledge of specific brain tumor histopathology.",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q136",
    "question_text": "What is the characteristic of diffuse astrocytoma grade 2?",
    "options": "{\"A\": \"Pilocytic astrocytoma\", \"B\": \"Has good response to resection\", \"C\": \"Typically shows high mitotic activity\", \"D\": \"Commonly presents with necrosis and microvascular proliferation\"}",
    "correct_answer": "B",
    "source_file": "Promotion 2019_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2019,
    "explanation": "Classification Reason: Asks about characteristics and prognosis of a specific glioma grade.",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q141",
    "question_text": "Patient with intracranial mass crossing the corpus callosum; what is the histology you will see?",
    "options": "{\"A\": \"Pseudopalisading necrosis\", \"B\": \"Rosenthal fibers\", \"C\": \"Perivascular lymphocytic cuffing\", \"D\": \"Homer Wright rosettes\"}",
    "correct_answer": "A",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Links characteristic imaging (\"butterfly glioma\") to its typical histology (pseudopalisading -> GBM).",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q40",
    "question_text": "A patient presents with headache and bilateral 6th nerve palsy with papilledema, and a red mass is seen from the nostril with MRI showing a cystic lesion arising from the clivus. What is the diagnosis?",
    "options": "{\"A\": \"Chordoma\", \"B\": \"Osteohistosis\", \"C\": \"Nasopharyngeal carcinoma\", \"D\": \"Meningioma\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2021_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Asks for diagnosis based on clinical presentation and imaging location typical for Chordoma.",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q127",
    "question_text": "Dexamethasone is best indicated for which type of edema?",
    "options": "{\"A\": \"Vasogenic edema\", \"B\": \"Cytotoxic edema\", \"C\": \"Hypertension\", \"D\": \"Liver encephalopathy\"}",
    "correct_answer": "A",
    "source_file": "Part II 2019_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2019,
    "explanation": "Classification Reason: Tests knowledge of treatment (steroids) for tumor-associated vasogenic edema.",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q18",
    "question_text": "Dexamethasone is helpful in which of the following clinical scenarios?",
    "options": "{\"A\": \"Traumatic brain injury (TBI)\", \"B\": \"Brain tumor with surrounding vasogenic edema\", \"C\": \"Bacterial meningitis\", \"D\": \"Acute ischemic stroke\"}",
    "correct_answer": "B",
    "source_file": "Part 2 2020 copy_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2020,
    "explanation": "Classification Reason: Asks about the indication for dexamethasone, specifically contrasting tumor edema with TBI.",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q341",
    "question_text": "A 30-year-old female smoker presents with sensory neuropathy and motor symptoms. A chest X-ray shows a mass at the lung apex. What is the most likely diagnosis?",
    "options": "{\"A\": \"Paraneoplastic syndrome\", \"B\": \"Pneumonia\", \"C\": \"Lung cancer\", \"D\": \"Tuberculosis\"}",
    "correct_answer": "C",
    "source_file": "Promotion 2023_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2023,
    "explanation": "Classification Reason: Links neurological symptoms (plexopathy/paraneoplastic) to an underlying malignancy (Pancoast tumor/lung cancer).",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q179",
    "question_text": "Which brain tumor is characterized by histopathological pseudorosettes?",
    "options": "{\"A\": \"Ependymoma\", \"B\": \"Astrocytoma\", \"C\": \"Schwannoma\", \"D\": \"Metastasis\"}",
    "correct_answer": "A",
    "source_file": "Part I 2022_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2022,
    "explanation": "Classification Reason: Tests knowledge of specific brain tumor histopathology.",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q128",
    "question_text": "Histopathology for the attached MRI shows which of the following features indicative of Glioblastoma?",
    "options": "{\"A\": \"Pseudopalisading necrosis\", \"B\": \"Pseudorosette\", \"C\": \"Fried egg appearance\", \"D\": \"Psammoma bodies\"}",
    "correct_answer": "A",
    "source_file": "Part II 2019_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2019,
    "explanation": "Classification Reason: Asks for the characteristic histopathology of Glioblastoma.",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q14",
    "question_text": "A brain tumor with histology of pseudorosette is most likely:",
    "options": "{\"A\": \"Ependymoma\", \"B\": \"Meningioma\", \"C\": \"Astrocytoma\", \"D\": \"Medulloblastoma\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2020 copy_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2020,
    "explanation": "Classification Reason: Links a specific histology (pseudorosette) to the most likely tumor type (Ependymoma).",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q126",
    "question_text": "A patient with a tumor in the lateral ventricle is most likely to have which type of tumor?",
    "options": "{\"A\": \"Choroid plexus papilloma\", \"B\": \"Ependymoma\", \"C\": \"Glioblastoma\", \"D\": \"Medulloblastoma\"}",
    "correct_answer": "A",
    "source_file": "Part II 2018_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2018,
    "explanation": "Classification Reason: Asks about common tumor types based on intraventricular location.",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q4",
    "question_text": "A brain lesion with a pathologic description of central necrosis is most likely which type of tumor?",
    "options": "{\"A\": \"Glioblastoma Multiforme (GBM)\", \"B\": \"Oligodendroglioma\", \"C\": \"Meningioma\", \"D\": \"Pilocytic Astrocytoma\"}",
    "correct_answer": "A",
    "source_file": "Part 1 2020_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2020,
    "explanation": "Classification Reason: Links a specific pathological feature (central necrosis) to the most likely tumor (GBM).",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q98",
    "question_text": "A case scenario involves a patient with a brain tumor. The MRI brain report shows a focal lesion with peripheral enhancement and a hypointense central core. The pathology report indicates highly vascular proliferation with atypia and central necrosis. Which of the following is the most likely diagnosis?",
    "options": "{\"A\": \"Glioblastoma multiforme\", \"B\": \"Meningioma\", \"C\": \"Astrocytoma\", \"D\": \"Oligodendroglioma\"}",
    "correct_answer": "A",
    "source_file": "Part I 2023_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2023,
    "explanation": "Classification Reason: Integrates imaging and pathology findings to diagnose Glioblastoma.",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q6",
    "question_text": "A coronal brain MRI shows a frontal extra-axial homogeneous mass. What is the likely histopathology?",
    "options": "{\"A\": \"Psammoma bodies (Meningioma)\", \"B\": \"Pseudopalisading\", \"C\": \"Neovascularization\", \"D\": \"Pseudopalisading tumor cells (Glioblastoma)\"}",
    "correct_answer": "A",
    "source_file": "Part 1 2020_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2020,
    "explanation": "Classification Reason: Links typical imaging features of Meningioma to its characteristic histology.",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q27",
    "question_text": "Anaplastic astrocytoma is characterized by which of the following features?",
    "options": "{\"A\": \"Psammoma bodies\", \"B\": \"Naked cells, GFAP positive\", \"C\": \"Pseudorosettes\", \"D\": \"Homer Wright rosettes\"}",
    "correct_answer": "B",
    "source_file": "Part 2 2020 copy_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2020,
    "explanation": "Classification Reason: Asks about specific characteristics/histology of Anaplastic Astrocytoma.",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q29",
    "question_text": "A patient presented with lethargy and unilateral weakness. MRI of the brain showed a tumor crossing the midline with necrotic features and mass effect. What is the diagnosis?",
    "options": "{\"A\": \"Grade 2 glioma\", \"B\": \"Grade 4 glioma\", \"C\": \"Meningioma\", \"D\": \"Benign tumor\"}",
    "correct_answer": "B",
    "source_file": "Part 2 Adult Neurology residency 2024 V9_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Asks for diagnosis/grading based on imaging features typical of high-grade glioma (GBM).",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q19",
    "question_text": "Homer Wright rosettes are associated with which type of tumor?",
    "options": "{\"A\": \"Ependymoma\", \"B\": \"Medulloblastoma\", \"C\": \"Oligodendroglioma\", \"D\": \"Anaplastic astrocytoma\"}",
    "correct_answer": "B",
    "source_file": "Part 2 2020 copy_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2020,
    "explanation": "Classification Reason: Tests knowledge of specific brain tumor histopathology (Medulloblastoma).",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q52",
    "question_text": "A butterfly mass with necrosis in the center is observed. What is the most likely grade of this glioma?",
    "options": "{\"A\": \"Grade 4 glioma\", \"B\": \"Grade 2 glioma\", \"C\": \"Grade 3 glioma\", \"D\": \"Grade 1 glioma\"}",
    "correct_answer": "A",
    "source_file": "Part 2 - 2023_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2023,
    "explanation": "Classification Reason: Asks for glioma grading based on characteristic imaging findings (butterfly mass + necrosis = Grade 4/GBM).",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q37",
    "question_text": "A child has a 3-week history of lower limb weakness. MRI of the spine shows T4 and T8 intramedullary irregular non-enhanced lesions. What is the likely diagnosis?",
    "options": "{\"A\": \"Astrocytoma\", \"B\": \"Ependymoma\", \"C\": \"Glioblastoma multiforme (GBM)\", \"D\": \"Hemangioblastoma\"}",
    "correct_answer": "A",
    "source_file": "Part I 2018_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2018,
    "explanation": "Classification Reason: Asks for diagnosis of a pediatric spinal cord tumor based on imaging characteristics (intramedullary, non-enhancing favors low-grade astrocytoma).",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q60",
    "question_text": "A brain MRI shows a mass originating from the fourth ventricle with histology showing pseudorosettes. What is the diagnosis?",
    "options": "{\"A\": \"Ependymoma\", \"B\": \"Medulloblastoma\", \"C\": \"Choroid plexus papilloma\", \"D\": \"Astrocytoma\"}",
    "correct_answer": "A",
    "source_file": "Part I 2019_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2019,
    "explanation": "Classification Reason: Combines location (4th ventricle) and histology (pseudorosettes) to diagnose Ependymoma.",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q130",
    "question_text": "A scenario describes a lady with a cerebellopontine angle mass. Pathology showed psammoma bodies. What is the likely diagnosis?",
    "options": "{\"A\": \"Meningioma\", \"B\": \"Ependymoma\", \"C\": \"Schwannoma\", \"D\": \"Epidermoid cyst\"}",
    "correct_answer": "A",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Combines location (CPA) and histology (psammoma bodies) to diagnose Meningioma.",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q23",
    "question_text": "In a patient with Neurofibromatosis type 1 who presented with syncopal attacks and a lateral ventricular mass, what is the most likely tumor?",
    "options": "{\"A\": \"Subependymal Giant Cell Astrocytoma (SEGA)\", \"B\": \"Central Neurocytoma\", \"C\": \"Choroid Plexus Papilloma\", \"D\": \"Ependymoma\"}",
    "correct_answer": "B",
    "source_file": "Part 2 2020 copy_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2020,
    "explanation": "Classification Reason: Asks for likely tumor type within the context of a specific genetic syndrome (NF1) and location.",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q2",
    "question_text": "In which case would steroids have an effect?",
    "options": "{\"A\": \"Brain cancer with vasogenic edema\", \"B\": \"Multiple sclerosis during remission\", \"C\": \"Parkinson\\u2019s disease with tremor\", \"D\": \"Alzheimer\\u2019s disease with memory loss\"}",
    "correct_answer": "A",
    "source_file": "Part 1 2020_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2020,
    "explanation": "Classification Reason: Tests knowledge of steroid effectiveness for tumor-related edema.",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q22",
    "question_text": "Which of the following tumors is characterized by the presence of Rosenthal fibers?",
    "options": "{\"A\": \"Pilocytic Astrocytoma\", \"B\": \"Meningioma\", \"C\": \"Medulloblastoma\", \"D\": \"Glioblastoma\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2020 copy_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2020,
    "explanation": "Classification Reason: Tests knowledge of specific brain tumor histopathology (Rosenthal fibers -> Pilocytic Astrocytoma).",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q142",
    "question_text": "A patient with CNS tumor pathology shows a Fried egg appearance. What is the appropriate treatment?",
    "options": "{\"A\": \"Chemotherapy\", \"B\": \"Radiotherapy\", \"C\": \"Gamma knife surgery\", \"D\": \"Debulking surgery\"}",
    "correct_answer": "D",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Links histology (Fried egg -> Oligodendroglioma) to potential treatment options.",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q133",
    "question_text": "A right brain lesion with pathology showing a fried egg appearance is noted. What is the next step? There is no mass effect on imaging.",
    "options": "{\"A\": \"Debulking surgery\", \"B\": \"Gamma knife\", \"C\": \"Radiotherapy\", \"D\": \"Chemotherapy\"}",
    "correct_answer": "A",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Asks about management considerations for Oligodendroglioma based on histology and imaging.",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q138",
    "question_text": "What are the most common posterior fossa tumors in children?",
    "options": "{\"A\": \"Medulloblastoma\", \"B\": \"Pilocytic astrocytoma\", \"C\": \"Ependymoma\", \"D\": \"Brainstem glioma\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2022_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2022,
    "explanation": "Classification Reason: Asks about the epidemiology of pediatric brain tumors by location.",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q144",
    "question_text": "A patient presents with headache and bilateral 6th nerve palsy with papilledema. A red mass is seen from the nostril, and MRI shows a cystic lesion arising from the clivus. What is the diagnosis?",
    "options": "{\"A\": \"Chordoma\", \"B\": \"Osteohestosis\", \"C\": \"Nasopharyngeal carcinoma\", \"D\": \"Meningioma\"}",
    "correct_answer": "A",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Repeat of Q40 (Part 2 2021). Asks for diagnosis based on clinical presentation and imaging location typical for Chordoma.",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q72",
    "question_text": "A 5-year-old male with renal cell carcinoma was brought to the ED with confusion and seizures. Brain MRI shows a single mass with vasogenic edema. What is the best treatment?",
    "options": "{\"A\": \"Chemotherapy\", \"B\": \"Radiotherapy\", \"C\": \"Surgical removal\", \"D\": \"Ablation\"}",
    "correct_answer": "C",
    "source_file": "Part I 2022_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2022,
    "explanation": "Classification Reason: Addresses the management (surgical removal) of a presumed solitary brain metastasis in a pediatric patient (context of RCC, likely VHL).",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q21",
    "question_text": "A patient with only skull and dural metastases, what is the next step?",
    "options": "{\"A\": \"Chest CT\", \"B\": \"MRI abdomen\", \"C\": \"Prostate ultrasound\", \"D\": \"Bone scan\"}",
    "correct_answer": "C",
    "source_file": "Part 2 2020 copy_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2020,
    "explanation": "Classification Reason: Asks about the diagnostic workup to find the primary source of specific types of metastases.",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q13",
    "question_text": "A 57-year-old male patient with renal cell carcinoma is brought to the emergency department with confusion and seizure. Brain MRI shows a single mass with vasogenic edema. Which of the following is the most appropriate treatment?",
    "options": "{\"A\": \"Surgical removal\", \"B\": \"Whole brain radiation\", \"C\": \"Stereotactic radiosurgery\", \"D\": \"Chemotherapy\"}",
    "correct_answer": "A",
    "source_file": "PART I - 2024 - KSMC Revision_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2024,
    "explanation": "Classification Reason: Addresses the management (surgical removal) of a solitary brain metastasis in an adult with known RCC.",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q139",
    "question_text": "What is the most common benign intracranial tumor?",
    "options": "{\"A\": \"Meningiomas\", \"B\": \"Glioma\", \"C\": \"Ependymoma\", \"D\": \"Medulloblastoma\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2022_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2022,
    "explanation": "Classification Reason: Asks about the epidemiology of benign brain tumors.",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q8",
    "question_text": "In which of the following scenarios does dexamethasone help?",
    "options": "{\"A\": \"Tumor with vasogenic edema\", \"B\": \"Bacterial meningitis without increased intracranial pressure\", \"C\": \"Viral encephalitis\", \"D\": \"Ischemic stroke\"}",
    "correct_answer": "A",
    "source_file": "Part 1 2020_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2020,
    "explanation": "Classification Reason: Tests knowledge of steroid effectiveness for tumor-related edema.",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q283",
    "question_text": "What is the treatment plan for a patient with a schwannoma?",
    "options": "{\"A\": \"Radiotherapy\", \"B\": \"Chemotherapy\", \"C\": \"De-bulking\", \"D\": \"Observation\"}",
    "correct_answer": "C",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Asks about treatment options for schwannoma.",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q46",
    "question_text": "A female patient has papilledema, signs of increased intracranial pressure, and MRI showed a frontal mass; what is the next step?",
    "options": "{\"A\": \"Debulking surgery\", \"B\": \"Stereotactic biopsy\", \"C\": \"Corticosteroid therapy\", \"D\": \"Observation with serial imaging\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2021_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Addresses the initial management decision (surgery vs. biopsy) for a symptomatic brain tumor.",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q222",
    "question_text": "A 40-year-old female presents with chronic headache. An MRI shows a frontal parasagittal enhancing lesion. What do you expect to find in the brain biopsy?",
    "options": "{\"A\": \"Pseudopalisading\", \"B\": \"Pseudorosette\", \"C\": \"Fried egg appearance\", \"D\": \"Psammoma bodies\"}",
    "correct_answer": "D",
    "source_file": "Part II 2019_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2019,
    "explanation": "Classification Reason: Links typical imaging of Meningioma to its characteristic histology.",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q11",
    "question_text": "What is the pathology of Ependymoma?",
    "options": "{\"A\": \"Rosette formation\", \"B\": \"Pseudorosette formation\", \"C\": \"Homer-Wright rosettes\", \"D\": \"Flexner-Wintersteiner rosettes\"}",
    "correct_answer": "A",
    "source_file": "PART I - 2024 - KSMC Revision_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2024,
    "explanation": "Classification Reason: Asks for the characteristic histopathology of Ependymoma.",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q10",
    "question_text": "In a case scenario of a patient with findings suggestive of Neurofibromatosis type 1 (NF1), what associated conditions should be considered?",
    "options": "{\"A\": \"Bilateral Vestibular Tumor\", \"B\": \"Bilateral Optic Glioma\", \"C\": \"Meningioma\", \"D\": \"Schwannoma\"}",
    "correct_answer": "B",
    "source_file": "Part 1 2021_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2021,
    "explanation": "Classification Reason: Tests knowledge of tumors specifically associated with NF1 (Optic Glioma).",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q149",
    "question_text": "A patient presented with tinnitus, hearing loss, and was found to have a tumor in the pons near the fourth ventricle. What is the most likely origin of the tumor?",
    "options": "{\"A\": \"Schwannoma\", \"B\": \"Ependymoma\", \"C\": \"Medulloblastoma\", \"D\": \"Astrocytoma\"}",
    "correct_answer": "A",
    "source_file": "part 2 2024_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Asks for likely tumor type based on location (CPA/brainstem) and symptoms.",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q12",
    "question_text": "A pathology report indicates atypia and necrosis. What is the most likely diagnosis?",
    "options": "{\"A\": \"Glioblastoma multiforme (GBM)\", \"B\": \"Astrocytoma\", \"C\": \"Oligodendroglioma\", \"D\": \"Meningioma\"}",
    "correct_answer": "A",
    "source_file": "Part 1 2021_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2021,
    "explanation": "Classification Reason: Links key high-grade pathological features (atypia, necrosis) to the most likely tumor (GBM).",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q36",
    "question_text": "A patient presents with bitemporal hemianopia and headache, along with a drop in hemoglobin. What is the most likely diagnosis?",
    "options": "{\"A\": \"Carotid cavernous fistula\", \"B\": \"Craniopharyngioma with a ruptured cyst\", \"C\": \"Pituitary apoplexy\", \"D\": \"Subarachnoid hemorrhage\"}",
    "correct_answer": "C",
    "source_file": "Part I 2018_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2018,
    "explanation": "Classification Reason: Asks for diagnosis of a pituitary tumor complication (apoplexy) based on clinical signs.",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q137",
    "question_text": "In the case of a 59-year-old male patient with a history of prostate cancer, what is the most likely diagnosis if the imaging shows no hemorrhagic lesions?",
    "options": "{\"A\": \"Hemorrhagic metastases\", \"B\": \"Amyloid angiopathy\", \"C\": \"Ischemic stroke\", \"D\": \"Tumor recurrence\"}",
    "correct_answer": "C",
    "source_file": "Promotion 2021_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2021,
    "explanation": "Classification Reason: Considers CNS complications (metastasis, stroke) in a patient with systemic cancer known for specific metastatic patterns.",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q3",
    "question_text": "Which of the following cancers can cause metastasis only to the dura and skull?",
    "options": "{\"A\": \"Prostate cancer\", \"B\": \"Breast cancer\", \"C\": \"Lung cancer\", \"D\": \"Head and neck cancer\"}",
    "correct_answer": "A",
    "source_file": "Part 1 2020_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2020,
    "explanation": "Classification Reason: Tests knowledge of primary cancers that typically metastasize to dura/skull.",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q71",
    "question_text": "A clival mass is visible from the nostril. What is the most likely diagnosis?",
    "options": "{\"A\": \"Chordoma\", \"B\": \"Histiocytosis\", \"C\": \"Nasopharyngeal carcinoma\", \"D\": \"Meningioma\"}",
    "correct_answer": "A",
    "source_file": "Part 2 - 2023_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2023,
    "explanation": "Classification Reason: Asks for diagnosis based on location (clivus) and presentation (mass visible from nostril).",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q15",
    "question_text": "A boy who presented with early morning headache and a suprasellar mass found on imaging with hormonal changes, what is the most likely tumor?",
    "options": "{\"A\": \"Germinoma\", \"B\": \"Medulloblastoma\", \"C\": \"DNET\", \"D\": \"Craniopharyngioma\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2020 copy_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2020,
    "explanation": "Classification Reason: Asks for likely pediatric tumor type based on location (suprasellar) and associated endocrine symptoms.",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q134",
    "question_text": "What is the most common posterior fossa tumor in children?",
    "options": "{\"A\": \"Ependymoma\", \"B\": \"Astrocytoma\", \"C\": \"Medulloblastoma\", \"D\": \"Brainstem glioma\"}",
    "correct_answer": "C",
    "source_file": "Promotion 2018_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2018,
    "explanation": "Classification Reason: Asks about the epidemiology of pediatric brain tumors by location.",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q9",
    "question_text": "A patient with non-Hodgkin lymphoma presents with a headache and urinary symptoms, and imaging shows findings in the brain and spine. What is the most likely route of spreading?",
    "options": "{\"A\": \"Artery\", \"B\": \"Vein\", \"C\": \"Direct invasion\", \"D\": \"Broken Blood-Brain Barrier (BBB)\"}",
    "correct_answer": "B",
    "source_file": "Part 1 2021_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2021,
    "explanation": "Classification Reason: Asks about the mechanism of CNS involvement in systemic lymphoma.",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q147",
    "question_text": "A tumor of the clivus is most likely to be which type of tumor?",
    "options": "{\"A\": \"Chordoma\", \"B\": \"Meningioma\", \"C\": \"Schwannoma\", \"D\": \"Ependymoma\"}",
    "correct_answer": "A",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Asks for the most common tumor type in a specific location (clivus).",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q34",
    "question_text": "A child with neurofibromatosis presents with headache and syncope and is found to have a tumor in the lateral ventricle. What is the most likely diagnosis?",
    "options": "{\"A\": \"Subependymoma\", \"B\": \"Central neurocytoma\", \"C\": \"Choroid plexus papilloma\", \"D\": \"Ependymoma\"}",
    "correct_answer": "B",
    "source_file": "Part 2 Adult Neurology residency 2024 V9_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Repeat of",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q33",
    "question_text": "In a male patient with metastatic cancer exclusive to the skull (or dura) and unknown origin of cancer, what should be done?",
    "options": "{\"A\": \"CT chest\", \"B\": \"Pelvic MRI\", \"C\": \"Abdomen MRI\", \"D\": \"Bone scan\"}",
    "correct_answer": "A",
    "source_file": "Part 2 Adult Neurology residency 2024 V9_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Repeat of",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q240",
    "question_text": "A patient with glioblastoma multiforme (GBM) has an MRI showing increased edema and mass effect. What is the next step in management?",
    "options": "{\"A\": \"Keppra\", \"B\": \"Steroid\", \"C\": \"Chemotherapy\", \"D\": \"Radiotherapy\"}",
    "correct_answer": "B",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Addresses the immediate management of symptomatic edema/mass effect in GBM.",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q38",
    "question_text": "Which condition is associated with Subependymal Giant Cell Astrocytoma (SEGA)?",
    "options": "{\"A\": \"Tuberous sclerosis\", \"B\": \"Neurofibromatosis\", \"C\": \"Sturge-Weber syndrome\", \"D\": \"Von Hippel-Lindau disease\"}",
    "correct_answer": "A",
    "source_file": "Part I 2018_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2018,
    "explanation": "Classification Reason: Tests knowledge of the specific genetic syndrome (Tuberous Sclerosis) associated with SEGA.",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q140",
    "question_text": "Which tumor is associated with opsoclonus myoclonus syndrome?",
    "options": "{\"A\": \"Breast cancer\", \"B\": \"Medulloblastoma\", \"C\": \"Ependymoma\", \"D\": \"Pilocytic astrocytoma\"}",
    "correct_answer": "B",
    "source_file": "Promotion 2022_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2022,
    "explanation": "Classification Reason: Asks which tumor type can cause a specific paraneoplastic syndrome (OMA).",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q7",
    "question_text": "A brain MRI shows a mass originating from the fourth ventricle with histology showing pseudorosettes. What is the diagnosis?",
    "options": "{\"A\": \"Ependymoma\", \"B\": \"Medulloblastoma\", \"C\": \"Choroid plexus papilloma\", \"D\": \"Astrocytoma\"}",
    "correct_answer": "A",
    "source_file": "Part 1 2020_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2020,
    "explanation": "Classification Reason: Repeat of",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q26",
    "question_text": "Blue cells can be found in which of the following tumors?",
    "options": "{\"A\": \"Oligodendroglioma\", \"B\": \"Medulloblastoma or atypical teratoid or rhabdoid tumors\", \"C\": \"Ependymoma\", \"D\": \"Meningioma\"}",
    "correct_answer": "B",
    "source_file": "Part 2 2020 copy_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2020,
    "explanation": "Classification Reason: Tests knowledge of \"small round blue cell\" tumors in neuro-oncology.",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q13",
    "question_text": "Which of the following histopathological features is associated with oligodendroglioma?",
    "options": "{\"A\": \"Pseudorossettes\", \"B\": \"Fried egg\", \"C\": \"Homer Wright rosettes\", \"D\": \"Psammoma bodies\"}",
    "correct_answer": "B",
    "source_file": "Part 2 2020 copy_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2020,
    "explanation": "Classification Reason: Tests knowledge of specific brain tumor histopathology (Oligodendroglioma).",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q11",
    "question_text": "A patient with hypopituitarism, a pituitary mass, and meningeal enhancement is being evaluated. What is the next appropriate imaging study?",
    "options": "{\"A\": \"MRA\", \"B\": \"MRV\", \"C\": \"MRI orbit\", \"D\": \"CT chest\"}",
    "correct_answer": "D",
    "source_file": "Part 1 2021_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2021,
    "explanation": "Classification Reason: Addresses the workup of a pituitary mass with concerning features (meningeal enhancement), potentially looking for primary malignancy.",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q143",
    "question_text": "A female patient has papilledema, signs of increased intracranial pressure, and MRI showed a frontal mass; what is the next step?",
    "options": "{\"A\": \"Debulking surgery\", \"B\": \"Stereotactic biopsy\", \"C\": \"Start corticosteroid therapy\", \"D\": \"Perform lumbar puncture\"}",
    "correct_answer": "B",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Repeat of",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q35",
    "question_text": "A patient with active but untreated renal cell carcinoma presents with a headache. Brain imaging reveals a single mass with surrounding edema. What is the most appropriate treatment?",
    "options": "{\"A\": \"Surgical removal\", \"B\": \"Intrathecal chemotherapy\", \"C\": \"Total brain radiation\", \"D\": \"Biological treatments\"}",
    "correct_answer": "A",
    "source_file": "Part 1 2021_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2021,
    "explanation": "Classification Reason: Repeat of Q13/",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q33",
    "question_text": "Patient with an intracranial mass crossing the corpus callosum; what is the histology you will see?",
    "options": "{\"A\": \"Pseudopalisading necrosis\", \"B\": \"Oligodendroglioma\", \"C\": \"Meningioma\", \"D\": \"Ependymoma\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2021_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Repeat of",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q1",
    "question_text": "Question of metastases only to the dura and skull will happen with what of the following?",
    "options": "{\"A\": \"Prostate cancer\", \"B\": \"Breast cancer\", \"C\": \"Lung cancer\", \"D\": \"Melanoma\"}",
    "correct_answer": "A",
    "source_file": "Part 1 2020_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2020,
    "explanation": "Classification Reason: Repeat of",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q135",
    "question_text": "What is the most common pediatric posterior fossa tumor?",
    "options": "{\"A\": \"Ependymoma\", \"B\": \"Pilocytic astrocytoma\", \"C\": \"Medulloblastoma\", \"D\": \"Meningioma\"}",
    "correct_answer": "B",
    "source_file": "Promotion 2019_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2019,
    "explanation": "Classification Reason: Repeat of Q134/",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q403",
    "question_text": "A patient came with a history of confusion and difficulty to arouse. MRI shows a glioblastoma multiforme (GBM) with large diffuse vasogenic edema. What is your next step in management?",
    "options": "{\"A\": \"Radiotherapy\", \"B\": \"Steroid\", \"C\": \"Chemotherapy\", \"D\": \"Debulking\"}",
    "correct_answer": "B",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Repeat of Q240/",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q71",
    "question_text": "A 4-year-old boy diagnosed with an intramedullary spinal cord tumor, non-enhancing on MRI, presents with no other details. What is the most likely diagnosis?",
    "options": "{\"A\": \"Ependymoma\", \"B\": \"Astrocytoma\", \"C\": \"Schwannoma\", \"D\": \"Metastasis\"}",
    "correct_answer": "B",
    "source_file": "Part I 2022_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2022,
    "explanation": "Classification Reason: Repeat of",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q24",
    "question_text": "Psammoma bodies are typically found in which of the following tumors?",
    "options": "{\"A\": \"Oligodendroglioma\", \"B\": \"Meningioma\", \"C\": \"Anaplastic astrocytoma\", \"D\": \"Ependymoma\"}",
    "correct_answer": "B",
    "source_file": "Part 2 2020 copy_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2020,
    "explanation": "Classification Reason: Tests knowledge of specific brain tumor histopathology (Meningioma).",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q122",
    "question_text": "A 57-year-old male patient with renal cell carcinoma is brought to the emergency department with confusion and seizures. The brain MRI shows a single mass with vasogenic edema. Which of the following is the most appropriate treatment?",
    "options": "{\"A\": \"Surgical removal\", \"B\": \"Intrathecal chemotherapy\", \"C\": \"Whole brain radiation\", \"D\": \"Biological treatments\"}",
    "correct_answer": "A",
    "source_file": "Part I 2023_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2023,
    "explanation": "Classification Reason: Repeat of Q13/Q35/",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q32",
    "question_text": "An elderly patient diagnosed with glioblastoma multiforme (GBM) and treated 5 years ago presented with decreased level of consciousness. MRI of the brain showed a tumor with vasogenic edema. What is the next step?",
    "options": "{\"A\": \"Steroid\", \"B\": \"Temozolomide\", \"C\": \"Radiation\", \"D\": \"Surgical resection\"}",
    "correct_answer": "A",
    "source_file": "Part 2 Adult Neurology residency 2024 V9_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Addresses management of recurrent GBM with symptomatic edema.",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q147",
    "question_text": "Regarding diffuse astrocytoma grade 2, which statement is true?",
    "options": "{\"A\": \"Most common type is polyastrocytoma\", \"B\": \"Surgical removal has a good outcome.\", \"C\": \"It typically shows rapid progression within weeks\", \"D\": \"It is highly responsive to chemotherapy alone\"}",
    "correct_answer": "B",
    "source_file": "Promotion 2018_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2018,
    "explanation": "Classification Reason: Repeat of",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q28",
    "question_text": "A patient with glioblastoma multiforme (GBM) has an MRI showing increased edema and mass effect. What is the next step in management?",
    "options": "{\"A\": \"Keppra\", \"B\": \"Steroid\", \"C\": \"Chemotherapy\", \"D\": \"Radiotherapy\"}",
    "correct_answer": "B",
    "source_file": "Part 2 2021_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Repeat of Q240/",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q189",
    "question_text": "A child presents with a cerebellopontine angle tumor and hearing loss for more than 5 months. What should be done?",
    "options": "{\"A\": \"Schedule him for elective surgery\", \"B\": \"Urgent spine MRI and send for genetic test\", \"C\": \"Start high-dose corticosteroids immediately\", \"D\": \"Observe with serial imaging and audiometry\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2018_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2018,
    "explanation": "Classification Reason: Addresses management considerations (workup vs. surgery) for a pediatric CPA tumor.",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q69",
    "question_text": "In which of the following conditions does dexamethasone provide benefit?",
    "options": "{\"A\": \"Tumor with vasogenic edema\", \"B\": \"Bacterial meningitis\", \"C\": \"Viral encephalitis\", \"D\": \"Acute ischemic stroke\"}",
    "correct_answer": "A",
    "source_file": "Part I 2019_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2019,
    "explanation": "Classification Reason: Repeat of Q2/Q8/",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q12",
    "question_text": "An MRI showed an intramedullary, ill-defined, non-enhancing lesion. What is the most likely diagnosis?",
    "options": "{\"A\": \"Astrocytoma\", \"B\": \"Ependymoma\", \"C\": \"Meningioma\", \"D\": \"Hemangioblastoma\"}",
    "correct_answer": "A",
    "source_file": "PART I - 2024 - KSMC Revision_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2024,
    "explanation": "Classification Reason: Repeat of Q37/",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q132",
    "question_text": "A patient has a left temporal lobe glioblastoma multiforme (GBM) with clear mass effect on imaging. What is the next step in management? The patient has right-sided weakness and confusion.",
    "options": "{\"A\": \"Steroid\", \"B\": \"Immediate surgical resection\", \"C\": \"Initiate chemotherapy with temozolomide\", \"D\": \"Observation with repeat imaging in 2 weeks\"}",
    "correct_answer": "A",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Repeat concept. Addresses immediate management of symptomatic edema in GBM.",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q16",
    "question_text": "A patient presents with a left-sided chronic headache and develops upper extremity weakness. Imaging reveals a mass with a dural tail. What is the most likely location of the mass?",
    "options": "{\"A\": \"Olfactory groove meningioma\", \"B\": \"Parasagittal meningioma\", \"C\": \"Convexity meningioma\", \"D\": \"Sphenoid wing meningioma\"}",
    "correct_answer": "B",
    "source_file": "Part 2 - 2023_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2023,
    "explanation": "Classification Reason: Links symptoms and imaging (\"dural tail\" -> meningioma) to likely location based on neurological deficit.",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q283",
    "question_text": "Most common benign intracranial neoplasm:",
    "options": "{\"A\": \"Meningioma\", \"B\": \"GBM\", \"C\": \"Pituitary adenoma\", \"D\": \"Schwannoma\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2018_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2018,
    "explanation": "Classification Reason: Repeat of",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q30",
    "question_text": "A young patient presented with new onset seizure. MRI of the brain showed a focal small hyperintensity on the cortical surface of the frontoparietal lobe. A biopsy was done, and histology reported a fried egg appearance. What is the management?",
    "options": "{\"A\": \"Debulking surgery\", \"B\": \"Radiotherapy\", \"C\": \"Chemotherapy\", \"D\": \"Observation and follow-up imaging\"}",
    "correct_answer": "A",
    "source_file": "Part 2 Adult Neurology residency 2024 V9_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Links seizure presentation, imaging, and histology (Oligodendroglioma) to management (surgery).",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q42",
    "question_text": "A patient with CNS tumor pathology showed a Fried egg appearance on imaging. What is the appropriate treatment?",
    "options": "{\"A\": \"Chemotherapy\", \"B\": \"Radiotherapy\", \"C\": \"Gamma knife surgery\", \"D\": \"Debulking surgery\"}",
    "correct_answer": "D",
    "source_file": "Part 2 2021_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Repeat of",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q146",
    "question_text": "A patient with renal cell carcinoma presents with retinal hemangioblastoma and cerebellar hemangioblastoma. What is the diagnosis?",
    "options": "{\"A\": \"Von Hippel-Lindau syndrome.\", \"B\": \"Tuberous sclerosis complex\", \"C\": \"Neurofibromatosis type 2\", \"D\": \"Sturge-Weber syndrome\"}",
    "correct_answer": "A",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Links specific tumor types (hemangioblastomas) and systemic cancer (RCC) to the underlying genetic syndrome (VHL).",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q31",
    "question_text": "A 50-year-old lady with dizziness, sensorineural hearing loss, and nystagmus was found to have a brain tumor on MRI originating from the pons near the 4th ventricle. What is the likely diagnosis?",
    "options": "{\"A\": \"Schwannoma\", \"B\": \"Ependymoma\", \"C\": \"Meningioma\", \"D\": \"Medulloblastoma\"}",
    "correct_answer": "B",
    "source_file": "Part 2 Adult Neurology residency 2024 V9_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Repeat of",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q35",
    "question_text": "Tumor pathology showing pseudorosette is indicative of which diagnosis?",
    "options": "{\"A\": \"Ependymoma\", \"B\": \"Meningioma\", \"C\": \"Astrocytoma\", \"D\": \"Oligodendroglioma\"}",
    "correct_answer": "A",
    "source_file": "Part I 2018_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2018,
    "explanation": "Classification Reason: Repeat of Q14/",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q25",
    "question_text": "What histopathological feature is associated with glioblastoma?",
    "options": "{\"A\": \"Naked cells\", \"B\": \"Pseudopalisading\", \"C\": \"Blue cells\", \"D\": \"Fried egg\"}",
    "correct_answer": "B",
    "source_file": "Part 2 2020 copy_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2020,
    "explanation": "Classification Reason: Asks for characteristic histology of Glioblastoma.",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q139",
    "question_text": "A 6-year-old girl has a headache and diplopia. On examination, she has impaired upward gaze, lid retraction, and convergence retraction nystagmus. What is the diagnosis?",
    "options": "{\"A\": \"Pinealoma\", \"B\": \"Medulloblastoma\", \"C\": \"Oligodendroglioma\", \"D\": \"Vestibular schwannoma\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2018_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2018,
    "explanation": "Classification Reason: Links specific neurological signs (Parinaud's syndrome) to a likely tumor location/type (Pineal region tumor).",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q54",
    "question_text": "A male patient over the age of 50 presents with subcortical/cortical metastases. What is the most likely primary origin of his brain metastases?",
    "options": "{\"A\": \"Prostate cancer\", \"B\": \"Lung cancer\", \"C\": \"Breast cancer\", \"D\": \"Melanoma\"}",
    "correct_answer": "B",
    "source_file": "Part 1 2021_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2021,
    "explanation": "Classification Reason: Asks about the most common primary source for brain metastases in a specific demographic.",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q148",
    "question_text": "A tumor located in the lateral ventricle is most likely a:",
    "options": "{\"A\": \"Choroid plexus papilloma\", \"B\": \"Ependymoma\", \"C\": \"Astrocytoma\", \"D\": \"Medulloblastoma\"}",
    "correct_answer": "A",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Repeat of",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q5",
    "question_text": "In a case of cranial metastases, what is the most appropriate initial imaging study to perform?",
    "options": "{\"A\": \"Chest CT\", \"B\": \"Brain MRI with contrast\", \"C\": \"Skull X-ray\", \"D\": \"PET scan\"}",
    "correct_answer": "B",
    "source_file": "Part 1 2020_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2020,
    "explanation": "Classification Reason: Repeat concept Q21/",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q417",
    "question_text": "Pathology features of meningioma include psammoma bodies. What is the diagnosis?",
    "options": "{\"A\": \"Meningioma\", \"B\": \"Schwannoma\", \"C\": \"Glioblastoma\", \"D\": \"Oligodendroglioma\"}",
    "correct_answer": "A",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Links specific histology (psammoma bodies) to the tumor type (Meningioma).",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q51",
    "question_text": "A coronal brain MRI shows a frontal extra-axial homogeneous mass. What is the likely histopathology finding?",
    "options": "{\"A\": \"Psammoma bodies\", \"B\": \"Pseudopalisading\", \"C\": \"Neovascularization\", \"D\": \"Antoni A and B areas\"}",
    "correct_answer": "A",
    "source_file": "Part I 2019_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2019,
    "explanation": "Classification Reason: Repeat of",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q17",
    "question_text": "A brain tumor with characteristic cells encircling each other called psammoma bodies is:",
    "options": "{\"A\": \"Meningioma\", \"B\": \"Ependymoma\", \"C\": \"Astrocytoma\", \"D\": \"Oligodendroglioma\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2020 copy_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2020,
    "explanation": "Classification Reason: Repeat concept. Tests knowledge of Meningioma histology.",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q145",
    "question_text": "A brain MRI shows a butterfly mass. What is the most likely diagnosis?",
    "options": "{\"A\": \"Glioblastoma multiforme (GBM)\", \"B\": \"Metastatic brain tumor\", \"C\": \"Primary CNS lymphoma\", \"D\": \"Astrocytoma\"}",
    "correct_answer": "A",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Links characteristic imaging (\"butterfly mass\") to the most likely diagnosis (GBM).",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q129",
    "question_text": "Histopathology for the attached MRI shows which of the following features indicative of Ependymoma grade II WHO?",
    "options": "{\"A\": \"Pseudopalisading\", \"B\": \"Pseudorosette\", \"C\": \"Fried egg appearance\", \"D\": \"Psammoma bodies\"}",
    "correct_answer": "B",
    "source_file": "Part II 2019_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2019,
    "explanation": "Classification Reason: Asks for the characteristic histopathology of Ependymoma.",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q20",
    "question_text": "A pediatric patient presented with expansile spinal cord signal changes with partial enhancement. What is the most likely diagnosis?",
    "options": "{\"A\": \"Astrocytoma\", \"B\": \"Ependymoma\", \"C\": \"Hemangioma\", \"D\": \"Medulloblastoma\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2020 copy_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2020,
    "explanation": "Classification Reason: Asks for diagnosis of pediatric spinal cord tumor based on imaging (expansile, partial enhancement -> Astrocytoma).",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q25",
    "question_text": "A spine MRI shows an intermediary non-enhancing mass. What is the most likely diagnosis?",
    "options": "{\"A\": \"Astrocytoma\", \"B\": \"Ependymoma\", \"C\": \"Schwannoma\", \"D\": \"Meningioma\"}",
    "correct_answer": "B",
    "source_file": "Part 2 - 2023_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2023,
    "explanation": "Classification Reason: Repeat concept Q12/Q37/",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q131",
    "question_text": "A pseudorosette is observed. What is the diagnosis?",
    "options": "{\"A\": \"Ependymoma\", \"B\": \"Medulloblastoma\", \"C\": \"Oligodendroglioma\", \"D\": \"Astrocytoma\"}",
    "correct_answer": "A",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Repeat of Q14/Q179/",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q89",
    "question_text": "In HIV/AIDS patients, what are the most common subtypes of AIDS-associated lymphoma?",
    "options": "{\"A\": \"EBV-related lymphoma\", \"B\": \"Burkitt\\u2019s lymphoma (BL)\", \"C\": \"Large B-cell lymphoma (DLBCL)\", \"D\": \"Primary central nervous system lymphoma (PCNSL)\"}",
    "correct_answer": "C",
    "source_file": "Part 2 - 2023_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2023,
    "explanation": "Classification Reason: Tests knowledge of specific types of primary CNS lymphoma commonly associated with immunocompromised states like HIV/AIDS.",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q101",
    "question_text": "A patient with breast cancer post-treatment presented with horizontal nystagmus without fast components, clumsiness, and falling. What is the likely diagnosis?",
    "options": "{\"A\": \"Paraneoplastic cerebellar degeneration\", \"B\": \"Chemotherapy-induced peripheral neuropathy\", \"C\": \"Brainstem metastasis\", \"D\": \"Vestibular neuritis\"}",
    "correct_answer": "A",
    "source_file": "Part 2 - 2023_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2023,
    "explanation": "Classification Reason: Focuses on neurological symptoms (ataxia, specific nystagmus type - possibly pendular) likely representing a paraneoplastic syndrome (e.g., cerebellar degeneration) or treatment side effect in a patient with a history of breast cancer.",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q477",
    "question_text": "A patient who is a smoker has an X-ray showing a lung tumor and presents with peripheral neuropathy. What is the most likely cause?",
    "options": "{\"A\": \"Paraneoplastic syndrome\", \"B\": \"Cervical radiculopathy due to epidural metastasis\", \"C\": \"Neoplastic plexopathy\", \"D\": \"Radiation plexopathy\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2021_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2021,
    "explanation": "Classification Reason: Links neurological symptoms (peripheral neuropathy) to an underlying malignancy (lung tumor), suggesting a paraneoplastic etiology.",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q517",
    "question_text": "A gynecological ultrasound shows an ovarian tumor. What is the recommended treatment?",
    "options": "{\"A\": \"Oophorectomy\", \"B\": \"Chemotherapy\", \"C\": \"Radiation therapy\", \"D\": \"Observation\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2023_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2023,
    "explanation": "Classification Reason: While about cancer treatment, if presented in a neurology context, it likely precedes a question about paraneoplastic syndromes associated with ovarian tumors (e.g., anti-Yo cerebellar degeneration).* Context is limited, but placed here assuming a paraneoplastic link.",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q39",
    "question_text": "A smoker presenting with polyneuropathy may have antibodies against which of the following?",
    "options": "{\"A\": \"P/Q Calcium Channel (Lambert-Eaton Myasthenic Syndrome - LEMS)\", \"B\": \"N-type Calcium Channel\", \"C\": \"L-type Calcium Channel\", \"D\": \"R-type Calcium Channel\"}",
    "correct_answer": "A",
    "source_file": "Part 2 - 2023_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2023,
    "explanation": "Classification Reason: Links smoking (risk factor for Small Cell Lung Cancer) and polyneuropathy to a paraneoplastic syndrome (LEMS is associated with anti-P/Q antibodies, though typically presents with weakness/autonomic features more than pure polyneuropathy. Anti-Hu is more classic for sensory neuronopathy).* Assuming LEMS context or a related paraneoplastic channelopathy.",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q489",
    "question_text": "A 31-year-old female smoker with sensory neuropathy and motor symptoms has a chest X-ray showing a mass at the lung apex. What is the appropriate antibiotic treatment?",
    "options": "{\"A\": \"Anti-Hu\", \"B\": \"Azithromycin\", \"C\": \"Ciprofloxacin\", \"D\": \"Doxycycline\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2023_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2023,
    "explanation": "Classification Reason: Presents a scenario suggesting paraneoplastic sensory neuronopathy (likely Anti-Hu associated with SCLC) or potentially Pancoast tumor effects. Option A is an antibody, not an antibiotic, suggesting confusion in the question/options. If the question intended to ask for the associated antibody, it's Neuro-oncology.",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q217",
    "question_text": "An elderly patient came with sensory motor neuropathy with distal weakness (he has dorsiflexion weakness), weight loss, and malaise; what is the next step?",
    "options": "{\"A\": \"CT chest\", \"B\": \"Send for Anti-Hu\", \"C\": \"Electrophoresis\", \"D\": \"Nerve biopsy\"}",
    "correct_answer": "A",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Describes symptoms suggestive of a paraneoplastic syndrome (neuropathy, constitutional symptoms) and asks for appropriate investigations (Anti-Hu antibodies, imaging for underlying malignancy).",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q486",
    "question_text": "Upon workup of the same patient, you find an ovarian teratoma. What is the best management option?",
    "options": "{\"A\": \"Observation\", \"B\": \"Chemotherapy\", \"C\": \"Removal of the tumor\", \"D\": \"Radiation therapy\"}",
    "correct_answer": "C",
    "source_file": "Promotion 2023_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2023,
    "explanation": "Classification Reason: Directly addresses the management (tumor removal) of an underlying malignancy (ovarian teratoma) causing a paraneoplastic neurological syndrome (likely anti-NMDA receptor encephalitis given the tumor type).",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q76",
    "question_text": "An elderly patient came with sensory motor neuropathy with distal weakness (he has dorsiflexion weakness), weight loss, and malaise; what is the next step?",
    "options": "{\"A\": \"CT chest\", \"B\": \"Send for Anti-Hu\", \"C\": \"Electrophoresis\", \"D\": \"Nerve biopsy\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2021_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Duplicate of",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q498",
    "question_text": "A patient with a history of breast cancer presents post-resection and chemoradiation therapy with arm pain. Nerve conduction studies show evidence of lower plexopathy. What is the most likely cause?",
    "options": "{\"A\": \"Compression\", \"B\": \"Radiation\", \"C\": \"Infiltrating plexopathy\", \"D\": \"Chemotherapy-induced neuropathy\"}",
    "correct_answer": "B",
    "source_file": "Promotion 2023_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2023,
    "explanation": "Classification Reason: Focuses on differentiating causes of plexopathy (radiation-induced vs. tumor infiltration vs. compression) in a patient with a history of cancer and treatment.",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q114",
    "question_text": "A 44-year-old woman is evaluated for severe and progressive left shoulder pain radiating down to the left arm and forearm that started 5 weeks ago. Since then, she has developed left hand weakness and numbness in the fourth and fifth fingers. She has a history of localized left breast adenocarcinoma that was diagnosed 5 years ago and treated with lumpectomy and axillary node dissection followed by radiation therapy and chemotherapy, including paclitaxel. Examination shows anisocoria with the left pupil smaller than the right, mild left eyelid ptosis, weakness in intrinsic left hand muscles, and sensory loss in the left medial arm, forearm, and fourth and fifth fingers. Reflexes are normal. The rest of her neurologic examination is normal. Which of the following is the most likely diagnosis?",
    "options": "{\"A\": \"Carcinomatous meningitis\", \"B\": \"Cervical radiculopathy due to epidural metastasis\", \"C\": \"Neoplastic plexopathy\", \"D\": \"Radiation plexopathy\"}",
    "correct_answer": "C",
    "source_file": "Part II 2018_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2018,
    "explanation": "Classification Reason: Focuses on the differential diagnosis of plexopathy (neoplastic vs. radiation-induced) occurring as a delayed complication of cancer and its treatment.",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q55",
    "question_text": "A patient with renal cell carcinoma presents with retinal hemangioblastoma and cerebellar hemangioblastoma. What is the diagnosis?",
    "options": "{\"A\": \"Von Hippel-Lindau syndrome.\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2021_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Centers on diagnosing a syndrome (VHL) characterized by specific CNS and systemic tumors.*",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q183",
    "question_text": "A male patient exhibits behavior changes and has an MRI showing a frontal lesion with heterogeneous enhancement. What is the recommended next step?",
    "options": "{\"A\": \"Referral to neurosurgery\", \"B\": \"Start valproic acid 1000 mg\", \"C\": \"Initiate corticosteroid therapy\", \"D\": \"Schedule repeat MRI in 6 weeks\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2023_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2023,
    "explanation": "Classification Reason: Scenario describes symptoms localizing to the frontal lobe with MRI findings suggestive of a brain tumor, asking for the appropriate next step (neurosurgical consultation).",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q14",
    "question_text": "A 25-year-old patient complains of inability to walk down the stairs. Upon examination, he has impaired vertical gaze, normal horizontal gaze, and normal visual acuity. Where is the lesion likely located?",
    "options": "{\"A\": \"Bilateral frontal stroke\", \"B\": \"Medullary stroke\", \"C\": \"Pineal tumor compressing the midbrain\", \"D\": \"Glioma\"}",
    "correct_answer": "C",
    "source_file": "Part I 2018_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2018,
    "explanation": "Classification Reason: While describing neurological signs (Parinaud's syndrome), the question asks for the most likely *cause* among the options, pointing towards a tumor (pineal region) compressing the dorsal midbrain.",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q34",
    "question_text": "A female patient with a history of breast cancer underwent radical mastectomy followed by radiation therapy. She now presents with left upper limb weakness and paresthesia involving the last two and a half digits, along with decreased sensation in the medial forearm. EMG showed myokymic discharges. Which of the following is the diagnosis?",
    "options": "{\"A\": \"Radiation induced plexopathy\", \"B\": \"Neoplastic plexopathy\", \"C\": \"Thoracic outlet syndrome\", \"D\": \"Cervical radiculopathy\"}",
    "correct_answer": "A",
    "source_file": "Part I 2023_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2023,
    "explanation": "Classification Reason: Focuses on diagnosing a complication of cancer treatment (radiation plexopathy) based on history, clinical signs, and specific EMG findings (myokymia).",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q44",
    "question_text": "Which of the following tumors is most commonly associated with opsoclonus-myoclonus?",
    "options": "{\"A\": \"Breast cancer\", \"B\": \"Ovarian cancer\", \"C\": \"Bronchogenic cancer\", \"D\": \"Neuroblastoma\"}",
    "correct_answer": "C",
    "source_file": "Part I 2023_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2023,
    "explanation": "Classification Reason: Tests knowledge of paraneoplastic syndromes, specifically the association between opsoclonus-myoclonus and certain types of cancer.",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q11",
    "question_text": "A young boy presents with 4th nerve palsy. Where is the tumor likely located?",
    "options": "{\"A\": \"Midbrain\", \"B\": \"Pons\", \"C\": \"Medulla\", \"D\": \"Cerebellum\"}",
    "correct_answer": "A",
    "source_file": "Part I 2018_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2018,
    "explanation": "Classification Reason: Asks to localize a potential tumor based on a specific cranial nerve deficit (CN IV palsy originates in the midbrain).",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q299",
    "question_text": "A 4-year-old child presents with nausea, vomiting, diplopia, and ataxia. What is the most likely diagnosis?",
    "options": "{\"A\": \"Craniopharyngioma\", \"B\": \"Medulloblastoma\", \"C\": \"Pilocytic astrocytoma\", \"D\": \"Ependymoma\"}",
    "correct_answer": "B",
    "source_file": "Promotion 2018_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2018,
    "explanation": "Classification Reason: Requires diagnosing the most likely posterior fossa tumor (Medulloblastoma) in a child based on typical presenting symptoms.",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q261",
    "question_text": "A patient with a history of breast cancer presents with opsoclonus-myoclonus syndrome. Which antibody is most likely associated with this condition?",
    "options": "{\"A\": \"Anti-Yo\", \"B\": \"Anti-Ri\", \"C\": \"Anti-amphiphysin\", \"D\": \"Anti-Ma2\"}",
    "correct_answer": "B",
    "source_file": "Part II 2019_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2019,
    "explanation": "Classification Reason: Tests knowledge of paraneoplastic syndromes and their associated antibodies and underlying malignancies (OMS with Anti-Ri often linked to breast cancer).",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q14",
    "question_text": "In a case scenario of small cell lung cancer (SCLC) with peripheral neuropathy, which antibody is commonly associated?",
    "options": "{\"A\": \"Anti-Hu\", \"B\": \"Anti-Yo\", \"C\": \"Anti-Ri\", \"D\": \"Anti-Ma2\"}",
    "correct_answer": "A",
    "source_file": "Part 1 2020_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2020,
    "explanation": "Classification Reason: Focuses on the association between a specific paraneoplastic antibody (Anti-Hu) and a specific cancer type (SCLC) presenting with neurological symptoms.",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q25",
    "question_text": "Case scenario of a patient with breast cancer presenting with spontaneous nystagmus suggestive of opsoclonus myoclonus. Which antibody is associated with this condition?",
    "options": "{\"A\": \"Anti Ri\", \"B\": \"Anti Yo\", \"C\": \"Anti Hu\", \"D\": \"Anti Ma2\"}",
    "correct_answer": "A",
    "source_file": "Part 1 2021_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2021,
    "explanation": "Classification Reason: Tests knowledge of the paraneoplastic antibody (Anti-Ri) associated with opsoclonus-myoclonus syndrome in the context of breast cancer.",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q15",
    "question_text": "In a case scenario of opsoclonus myoclonus associated with breast cancer, which antibody is typically found?",
    "options": "{\"A\": \"Anti-RI\", \"B\": \"Anti-Hu\", \"C\": \"Anti-Yo\", \"D\": \"Anti-Ma2\"}",
    "correct_answer": "A",
    "source_file": "Part 1 2020_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2020,
    "explanation": "Classification Reason: Tests knowledge of the paraneoplastic antibody (Anti-Ri) associated with opsoclonus-myoclonus syndrome, specifically linked to breast cancer.",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q307",
    "question_text": "A patient presents with opsoclonus myoclonus. What is the associated malignancy?",
    "options": "{\"A\": \"Breast\", \"B\": \"Colon\", \"C\": \"Thyroid\", \"D\": \"Ovary\"}",
    "correct_answer": "D",
    "source_file": "Promotion 2019_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2019,
    "explanation": "Classification Reason: Focuses on identifying the common malignancies associated with a specific paraneoplastic syndrome (opsoclonus myoclonus).",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q102",
    "question_text": "A patient with ADHD presents with light brown lesions. What is the most likely diagnosis?",
    "options": "{\"A\": \"Neurofibromatosis Type 1\", \"B\": \"Tuberous Sclerosis Complex\", \"C\": \"Sturge-Weber Syndrome\", \"D\": \"Von Hippel-Lindau Disease\"}",
    "correct_answer": "A",
    "source_file": "Part II 2018_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2018,
    "explanation": "Classification Reason: Connects characteristic skin findings (cafe-au-lait spots implied by \"light brown lesions\") and a common association (ADHD) to diagnose Neurofibromatosis Type 1, a phakomatosis with tumor predisposition.",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q112",
    "question_text": "A child with proptosis has a mother who also has proptosis and light brown dots in the neck. What is the most likely diagnosis?",
    "options": "{\"A\": \"Retinoblastoma\", \"B\": \"Benign optic glioma\", \"C\": \"Neurofibromatosis Type 1\", \"D\": \"Optic nerve glioma\"}",
    "correct_answer": "C",
    "source_file": "Part II 2018_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2018,
    "explanation": "Classification Reason: Links familial proptosis (suggesting optic pathway glioma) and skin findings (cafe-au-lait spots/neurofibromas implied) to diagnose Neurofibromatosis Type 1.",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q120",
    "question_text": "A patient has 7 flat brown lesions on the skin. What is the most likely diagnosis?",
    "options": "{\"A\": \"Neurofibromatosis Type 1\", \"B\": \"Tuberous Sclerosis Complex\", \"C\": \"Melanoma\", \"D\": \"Basal Cell Carcinoma\"}",
    "correct_answer": "A",
    "source_file": "Part II 2018_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2018,
    "explanation": "Classification Reason: Tests knowledge of diagnostic criteria for Neurofibromatosis Type 1 based on the number of cafe-au-lait macules.",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q162",
    "question_text": "In a case with spinal cord and posterior fossa tumors, the most likely diagnosis is:",
    "options": "{\"A\": \"Neurofibromatosis type 2 (NF2)\", \"B\": \"Von Hippel-Lindau (VHL)\", \"C\": \"Neurofibromatosis type 1 (NF1)\", \"D\": \"Tuberous sclerosis complex (TSC)\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2022_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2022,
    "explanation": "Classification Reason: Associates a pattern of tumor locations (spinal cord, posterior fossa - likely schwannomas/meningiomas/ependymomas) with the most characteristic underlying genetic syndrome (NF2 or VHL vs NF1).",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q172",
    "question_text": "A patient with ADHD has a mother with brown pigmentations in her neck. What is the diagnosis?",
    "options": "{\"A\": \"Neurofibromatosis type 1 (NF1).\", \"B\": \"Tuberous sclerosis complex\", \"C\": \"Sturge-Weber syndrome\", \"D\": \"McCune-Albright syndrome\"}",
    "correct_answer": "A",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Connects ADHD and familial skin pigmentation (suggesting cafe-au-lait spots or freckling) to diagnose NF1.",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q180",
    "question_text": "A child with proptosis has a mother with similar symptoms and light brown dots on the neck. What is the most likely diagnosis?",
    "options": "{\"A\": \"Retinoblastoma\", \"B\": \"Benign optic glioma\", \"C\": \"Neurofibromatosis type 1\", \"D\": \"Optic nerve glioma\"}",
    "correct_answer": "C",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Links familial proptosis (suggesting optic pathway glioma) and characteristic skin findings to NF1.",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q182",
    "question_text": "In a scenario of neurofibromatosis (NF), what is the most likely diagnosis?",
    "options": "{\"A\": \"Neurofibromatosis type 1\", \"B\": \"Neurofibromatosis type 2\", \"C\": \"Schwannomatosis\", \"D\": \"Tuberous sclerosis\"}",
    "correct_answer": "A",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Although vague (\"a scenario of NF\"), it requires differentiating between the types of NF and related disorders, which falls under the scope of neuro-oncology/phakomatoses.",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q37",
    "question_text": "A child who presented with ADHD and multiple light brown macula on skin, what is the diagnosis?",
    "options": "{\"A\": \"Neurofibromatosis type 1 (NF1)\", \"B\": \"Tuberous sclerosis (TS)\", \"C\": \"Sturge-Weber syndrome\", \"D\": \"Von Hippel-Lindau disease\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2020 copy_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2020,
    "explanation": "Classification Reason: Links characteristic skin findings (cafe-au-lait macules) and ADHD to NF1.",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q1",
    "question_text": "SEGA is associated with which disease?",
    "options": "{\"A\": \"Something not related\", \"B\": \"Tuberous Sclerosis\", \"C\": \"Neurofibromatosis type 1\", \"D\": \"Von Hippel-Lindau disease\"}",
    "correct_answer": "B",
    "source_file": "PART I - 2024 - KSMC Revision_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2024,
    "explanation": "Classification Reason: Links a specific type of brain tumor (SEGA - Subependymal Giant Cell Astrocytoma) to its associated genetic syndrome (Tuberous Sclerosis).",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q3",
    "question_text": "A patient presents with a cyst, and his brother has a hemangioblastoma. There is a family history of similar conditions in his brother and sister. What syndrome is this indicative of?",
    "options": "{\"A\": \"von Hippel-Lindau syndrome\", \"B\": \"Neurofibromatosis type 1\", \"C\": \"Tuberous sclerosis complex\", \"D\": \"Sturge-Weber syndrome\"}",
    "correct_answer": "A",
    "source_file": "PART I - 2024 - KSMC Revision_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2024,
    "explanation": "Classification Reason: Identifies von Hippel-Lindau syndrome, a genetic condition predisposing to tumors, based on characteristic lesions (hemangioblastoma, cysts) and family history.",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q32",
    "question_text": "A patient presents with retinal lesions and a family history of cerebellar hemangioblastoma. What is the most likely diagnosis?",
    "options": "{\"A\": \"Von Hippel-Lindau syndrome\", \"B\": \"Sturge-Weber syndrome\", \"C\": \"Tuberous sclerosis\", \"D\": \"Neurofibromatosis type 1\"}",
    "correct_answer": "A",
    "source_file": "Part 1 2021_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2021,
    "explanation": "Classification Reason: Tests recognition of Von Hippel-Lindau syndrome, a phakomatosis characterized by specific tumors (hemangioblastomas) and retinal findings, falling under Neuro-oncology.",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q141",
    "question_text": "What are the criteria for Tuberous Sclerosis (TS)?",
    "options": "{\"A\": \"Cardiac rhabdomyoma\", \"B\": \"Renal angiomyolipoma\", \"C\": \"Facial angiofibromas\", \"D\": \"Cortical tubers\"}",
    "correct_answer": "A",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Asks about diagnostic criteria for Tuberous Sclerosis, focusing on associated benign tumors (cardiac rhabdomyoma, renal angiomyolipoma), placing it within the Neuro-oncology domain due to its tumor predisposition nature.",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q158",
    "question_text": "A child is suspected to have ADHD and presents with caf\u00e9 au lait spots and flickering movements. What is the most likely diagnosis?",
    "options": "{\"A\": \"Neurofibromatosis type 1 (NF1)\", \"B\": \"Neurofibromatosis type 2 (NF2)\", \"C\": \"Tuberous sclerosis complex\", \"D\": \"Sturge-Weber syndrome\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2021_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2021,
    "explanation": "Classification Reason: Tests recognition of Neurofibromatosis type 1 (a phakomatosis/tumor predisposition syndrome) based on characteristic skin findings (caf\u00e9 au lait spots) and associated features (possible Lisch nodules, ADHD link), fitting within Neuro-oncology.",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q6",
    "question_text": "A patient known to have breast cancer presents with ataxia and nystagmus. Which antibodies might be relevant in this case?",
    "options": "{\"A\": \"Anti-RI\", \"B\": \"Anti-Yo\", \"C\": \"Anti-Hu\", \"D\": \"Anti-Ma\"}",
    "correct_answer": "B",
    "source_file": "PART I - 2024 - KSMC Revision_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2024,
    "explanation": "Classification Reason: Deals with a paraneoplastic neurological syndrome (cerebellar degeneration) associated with breast cancer, asking for the characteristic antibody (Anti-Yo).",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q30",
    "question_text": "A patient with a history of breast cancer presents with weight loss and loss of sensation in the medial forearm. Which trunk is likely affected?",
    "options": "{\"A\": \"Lower trunk\", \"B\": \"Upper trunk\", \"C\": \"Middle trunk\", \"D\": \"Posterior trunk\"}",
    "correct_answer": "A",
    "source_file": "PART I - 2024 - KSMC Revision_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2024,
    "explanation": "Classification Reason: Focuses on localizing a neurological deficit (lower trunk brachial plexopathy) in the context of metastatic cancer (likely Pancoast tumor or direct metastasis).",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q43",
    "question_text": "A male known case of testicular cancer presented with encephalitis. Which antibodies might be involved?",
    "options": "{\"A\": \"Anti-Ma2\", \"B\": \"Anti-Hu\", \"C\": \"Anti-LGI1\", \"D\": \"Anti-NMDA receptor\"}",
    "correct_answer": "A",
    "source_file": "PART I - 2024 - KSMC Revision_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2024,
    "explanation": "Classification Reason: Deals with a paraneoplastic neurological syndrome (limbic encephalitis) associated with testicular cancer, asking for the characteristic antibody (Anti-Ma2).",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q208",
    "question_text": "A patient came with a brain tumor, and his first-degree relative had a history of spine tumor and persisting high blood pressure. What is the diagnosis?",
    "options": "{\"A\": \"Neurofibromatosis type 1 (NF1)\", \"B\": \"Familial schwannoma\", \"C\": \"Von-Hippel Lindau\", \"D\": \"Tuberous sclerosis complex\"}",
    "correct_answer": "C",
    "source_file": "Promotion 2018_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2018,
    "explanation": "Classification Reason: Asks for the diagnosis of a neurocutaneous syndrome (VHL) based on a constellation of findings (brain tumor - likely hemangioblastoma, relative with spine tumor, hypertension - possibly pheochromocytoma).",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q41",
    "question_text": "A patient presents with proptosis and decreased eye movements, and he has brown pigmentations. What is the diagnosis of his eye condition? (Pigmentations likely suggest NF1)",
    "options": "{\"A\": \"Benign optic glioma\", \"B\": \"Malignant optic glioblastoma\", \"C\": \"Orbital neurofibroma\", \"D\": \"Orbital cellulitis\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2021_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: The combination of proptosis, eye movement limitation, and pigmentation (suggesting neurofibromatosis) points towards an optic pathway glioma, a type of brain tumor often associated with NF1. The question asks for the tumor diagnosis.",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q32",
    "question_text": "Brun's nystagmus localizes to the cerebellopontine angle (CPA) and is most commonly indicative of what?",
    "options": "{\"A\": \"Schwannoma\", \"B\": \"Aneurysm\", \"C\": \"Arachnoid cyst\", \"D\": \"Meningioma\"}",
    "correct_answer": "A",
    "source_file": "Part I 2022_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2022,
    "explanation": "Classification Reason: While Brun's nystagmus is a neuro-ophthalmic sign, the question's core concept is identifying the most common *pathology* (Schwannoma, a tumor) at the CPA associated with this sign.",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q25",
    "question_text": "An elderly patient with a history of pituitary adenoma found on multiple brain MRIs had decreased vision in the right eye and visual field deficits in the left eye. Where is the lesion?",
    "options": "{\"A\": \"Anterior chiasm\", \"B\": \"Optic chiasm\", \"C\": \"Optic tract\", \"D\": \"Optic nerve\"}",
    "correct_answer": "A",
    "source_file": "Part 2 Adult Neurology residency 2024 V9_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Although it involves visual field deficits related to a pituitary adenoma (tumor), the question specifically asks for localization of the visual pathway compression (anterior chiasm/junctional scotoma), making it primarily neuro-ophthalmology focused on localization.*",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q380",
    "question_text": "In Foster Kennedy syndrome with right optic atrophy, where is the lesion located?",
    "options": "{\"A\": \"Right frontal mass\", \"B\": \"Left frontal mass\", \"C\": \"Right temporal lobe mass\", \"D\": \"Left occipital lobe mass\"}",
    "correct_answer": "A",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Tests knowledge of Foster Kennedy syndrome, which is defined by ipsilateral optic atrophy and contralateral papilledema due to a compressive mass (tumor), requiring localization of the causative tumor.",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q50",
    "question_text": "A patient presents with proptosis and decreased eye movements, and he has brown pigmentations. What is the diagnosis of his eye condition? (Pigmentations likely suggest NF1)",
    "options": "{\"A\": \"Benign optic glioma\", \"B\": \"Malignant optic glioblastoma\", \"C\": \"Orbital plexiform neurofibroma\", \"D\": \"Optic nerve meningioma\"}",
    "correct_answer": "A",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Duplicate of",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q40",
    "question_text": "An 8-year-old girl with a pineal gland tumor and obstructive hydrocephalus is being examined. What is expected to be found in her neuro-ophthalmological exam?",
    "options": "{\"A\": \"Convergence-retraction nystagmus\", \"B\": \"Oculogyric crisis\", \"C\": \"Internuclear ophthalmoplegia\", \"D\": \"Optic neuritis\"}",
    "correct_answer": "A",
    "source_file": "Part II 2019_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2019,
    "explanation": "Classification Reason: Links a specific tumor location (pineal gland) to its characteristic neuro-ophthalmological syndrome (Parinaud's syndrome, featuring convergence-retraction nystagmus).",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q46",
    "question_text": "A young female presented with a severe headache; CT imaging shows pituitary apoplexy. What is the likely diagnosis?",
    "options": "{\"A\": \"Pituitary apoplexy\", \"B\": \"Migraine\", \"C\": \"Tension headache\", \"D\": \"Cluster headache\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2021_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2021,
    "explanation": "Classification Reason: Focuses on identifying pituitary apoplexy, an acute event often occurring within a pre-existing pituitary adenoma, based on presentation (headache) and imaging findings.* (Reclassified from Headache/Critical Care).",
    "subspecialty": "Neuro oncology"
  },
  {
    "question_number": "Q70",
    "question_text": "The disruption within the Guillain-Mollaret triangle is associated with which type of palatal myoclonus?",
    "options": "{\"A\": \"Essential palatal myoclonus\", \"B\": \"Symptomatic palatal myoclonus\", \"C\": \"Both types of palatal myoclonus\", \"D\": \"Neither type of palatal myoclonus\"}",
    "correct_answer": "B",
    "source_file": "Part I 2019_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2019,
    "explanation": "Classification Reason: Focuses on the specific etiology (Guillain-Mollaret triangle disruption) of symptomatic palatal myoclonus, a movement disorder.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q72",
    "question_text": "A patient with Parkinson's disease presented with peak dose dyskinesia. Which medication is most commonly used to manage this condition?",
    "options": "{\"A\": \"Amantadine\", \"B\": \"Levodopa\", \"C\": \"Pramipexole\", \"D\": \"Ropinirole\"}",
    "correct_answer": "A",
    "source_file": "Part I 2019_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2019,
    "explanation": "Classification Reason: Addresses the management of dyskinesia, a common motor complication of Parkinson's disease treatment.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q44",
    "question_text": "A patient with progressive supranuclear palsy (PSP) presents with impaired vertical gaze and axial rigidity. What is the diagnosis?",
    "options": "{\"A\": \"Progressive supranuclear palsy (PSP)\", \"B\": \"Parkinson\\u2019s disease\", \"C\": \"Multiple system atrophy\", \"D\": \"Corticobasal degeneration\"}",
    "correct_answer": "A",
    "source_file": "Part I 2019_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2019,
    "explanation": "Classification Reason: Tests the ability to diagnose PSP based on its core clinical features (parkinsonism plus vertical gaze palsy).",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q46",
    "question_text": "Essential palatal myoclonus is frequently associated with which of the following characteristics?",
    "options": "{\"A\": \"Muscle agonist is the tensor veli palatini\", \"B\": \"More persistent than symptomatic palatal myoclonus\", \"C\": \"Caused by a structural lesion\", \"D\": \"Associated with other neurological symptoms\"}",
    "correct_answer": "A",
    "source_file": "Part I 2019_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2019,
    "explanation": "Classification Reason: Asks about the clinical characteristics distinguishing essential palatal myoclonus, a specific movement disorder.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q47",
    "question_text": "A young patient presents with dystonia and myoclonus. Which of the following is a characteristic feature of myoclonic-dystonia DYT11?",
    "options": "{\"A\": \"Diurnal variation\", \"B\": \"Typical onset in adulthood\", \"C\": \"Caused by KCTD17 mutation\", \"D\": \"Predominantly affects males\"}",
    "correct_answer": "A",
    "source_file": "Part I 2019_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2019,
    "explanation": "Classification Reason: Focuses on the clinical features of a specific genetic movement disorder syndrome (Myoclonus-Dystonia, DYT11/SGCE).",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q48",
    "question_text": "A patient with frequent falls and vertical gaze palsy shows tectal atrophy on Brain MRI. What condition is most likely indicated?",
    "options": "{\"A\": \"Progressive Supranuclear Palsy (PSP)\", \"B\": \"Multiple System Atrophy (MSA)\", \"C\": \"Alzheimer's Disease\", \"D\": \"Parkinson's Disease\"}",
    "correct_answer": "A",
    "source_file": "Part I 2019_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2019,
    "explanation": "Classification Reason: Requires diagnosis of an atypical parkinsonian syndrome (PSP) based on clinical signs and associated imaging findings.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q18",
    "question_text": "Which type of palatal myoclonus is characterized by palatal movements due to contractions of the levator veli palatini and is often associated with other symptoms related to a causative lesion?",
    "options": "{\"A\": \"Essential palatal myoclonus\", \"B\": \"Symptomatic palatal myoclonus\", \"C\": \"Idiopathic palatal myoclonus\", \"D\": \"Familial palatal myoclonus\"}",
    "correct_answer": "B",
    "source_file": "Part I 2019_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2019,
    "explanation": "Classification Reason: Tests knowledge of the definition and characteristics of symptomatic palatal myoclonus.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q19",
    "question_text": "A 30-year-old male presents with a history of symmetrical action tremor that improves with alcohol. What is the most likely diagnosis?",
    "options": "{\"A\": \"Essential tremor\", \"B\": \"Enhanced physiological tremor\", \"C\": \"Parkinson\\u2019s disease\", \"D\": \"Cerebellar tremor\"}",
    "correct_answer": "A",
    "source_file": "Part I 2019_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2019,
    "explanation": "Classification Reason: Focuses on diagnosing essential tremor based on its classic clinical presentation.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q120",
    "question_text": "An elderly male patient with a history suggestive of Parkinson's disease (tremors, rigidity, and bradykinesia) presents for evaluation. What is the next step in management?",
    "options": "{\"A\": \"Levodopa/carbidopa trial\", \"B\": \"PET scan\", \"C\": \"MRI brain\", \"D\": \"Physical therapy\"}",
    "correct_answer": "A",
    "source_file": "Part I 2023_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2023,
    "explanation": "Classification Reason: Addresses the initial diagnostic and management strategy (levodopa trial) for suspected Parkinson's disease.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q4",
    "question_text": "Axial brain CT shows bilateral caudate atrophy. What is the most likely diagnosis?",
    "options": "{\"A\": \"Huntington disease\", \"B\": \"Chorea-acanthocytosis\", \"C\": \"Huntington disease-like 2\", \"D\": \"FTLD-FUS\"}",
    "correct_answer": "A",
    "source_file": "Part 1 2020_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2020,
    "explanation": "Classification Reason: Connects a characteristic imaging finding (caudate atrophy) to its most common associated movement disorder (Huntington's disease).",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q221",
    "question_text": "A female patient has a tremor and her father has a tremor; the father reported that his tremor is improved with wine. What is the diagnosis?",
    "options": "{\"A\": \"Essential tremor\", \"B\": \"Parkinson\\u2019s disease\", \"C\": \"Cerebellar tremor\", \"D\": \"Dystonic tremor\"}",
    "correct_answer": "A",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Diagnosis of essential tremor based on classic features including family history and alcohol responsiveness.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q361",
    "question_text": "A scenario describes a woman who has suffered from falls and unsteady gait for 3 years, accompanied by urinary urgency and then incontinence. MRI shows atrophy of the midbrain. What is the most likely diagnosis?",
    "options": "{\"A\": \"Multiple System Atrophy (MSA)\", \"B\": \"Progressive Supranuclear Palsy (PSP)\", \"C\": \"Normal Pressure Hydrocephalus (NPH)\", \"D\": \"Corticobasal Degeneration (CBD)\"}",
    "correct_answer": "B",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Requires diagnosis of an atypical parkinsonian syndrome (PSP) based on clinical features (falls, gait issues, urinary symptoms) and imaging (midbrain atrophy).",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q82",
    "question_text": "A Parkinson's patient on medication develops wearing-off phenomena. What is the mechanism?",
    "options": "{\"A\": \"Failure of medication\", \"B\": \"Disease progression\", \"C\": \"Medication intolerance\", \"D\": \"Altered pharmacokinetics of levodopa\"}",
    "correct_answer": "B",
    "source_file": "Part 2 2021_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Asks about the underlying reason for wearing-off, a common motor fluctuation in treated Parkinson's disease.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q411",
    "question_text": "In a case of multiple system atrophy (MSA), what radiological finding is commonly associated?",
    "options": "{\"A\": \"Hot cross bun sign\", \"B\": \"Dawson\\u2019s fingers\", \"C\": \"Butterfly glioma\", \"D\": \"Ring-enhancing lesion\"}",
    "correct_answer": "A",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Tests knowledge of a characteristic imaging finding (hot cross bun sign) associated with MSA.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q111",
    "question_text": "A 60-year-old male presented with a history of falls, dyskinesia, and depression. His sister died at age 50 from the same condition. What is the diagnosis?",
    "options": "{\"A\": \"Dystonia\", \"B\": \"Huntington's Disease\", \"C\": \"Depression\", \"D\": \"Parkinson's Disease\"}",
    "correct_answer": "B",
    "source_file": "Part I 2022_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2022,
    "explanation": "Classification Reason: Diagnosis of Huntington's disease based on the characteristic triad of motor (dyskinesia), cognitive/psychiatric symptoms, and positive family history.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q112",
    "question_text": "What is dyskinesia related to essential physiological conditions?",
    "options": "{\"A\": \"Shambolic\", \"B\": \"Amnesia related to alcohol\", \"C\": \"Y- Be\", \"D\": \"Bandhand neck\"}",
    "correct_answer": "C",
    "source_file": "Part I 2022_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2022,
    "explanation": "Classification Reason: Appears to inquire about features or types related to tremor or dyskinesia, although the question and options are unclear. Classified based on the likely intended topic.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q136",
    "question_text": "If a patient with orthostatic tremor does not respond to clonazepam, what is the next step in management?",
    "options": "{\"A\": \"L-Dopa\", \"B\": \"Gabapentin\", \"C\": \"Primidone\", \"D\": \"Levetiracetam\"}",
    "correct_answer": "B",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Addresses second-line treatment options for orthostatic tremor, a specific movement disorder.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q85",
    "question_text": "A young man who is a law student in the last year of college has a long-standing intentional tremor that has worsened over the past few months. He has bronchial asthma and is on inhalers. What is the most appropriate treatment?",
    "options": "{\"A\": \"Primidone\", \"B\": \"Propranolol\", \"C\": \"Topiramate\", \"D\": \"Gabapentin\"}",
    "correct_answer": "A",
    "source_file": "Part 2 Adult Neurology residency 2024 V9_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Focuses on selecting the appropriate treatment for tremor (likely essential tremor, despite being described as intentional) considering a common comorbidity (asthma) that contraindicates beta-blockers.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q65",
    "question_text": "In a patient on risperidone, how can you differentiate tardive dyskinesia from Huntington\u2019s disease?",
    "options": "{\"A\": \"Family history\", \"B\": \"Lack of eye movement\", \"C\": \"Presence of chorea\", \"D\": \"Age of onset\"}",
    "correct_answer": "A",
    "source_file": "Part 2 - 2023_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2023,
    "explanation": "Classification Reason: Addresses the clinical differentiation between two conditions presenting with choreiform movements (drug-induced tardive dyskinesia vs. inherited Huntington's disease).",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q27",
    "question_text": "In a scenario about a patient with parkinsonism, urinary symptoms, and falls, what would you find on MRI?",
    "options": "{\"A\": \"Hummingbird sign\", \"B\": \"Hot cross bun sign\", \"C\": \"Panda face\", \"D\": \"Tiger eyes\"}",
    "correct_answer": "B",
    "source_file": "Part 2 2020 copy_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2020,
    "explanation": "Classification Reason: Links clinical features suggestive of atypical parkinsonism (MSA or PSP) to their characteristic MRI signs.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q107",
    "question_text": "What medication is commonly used to treat essential tremor in a patient with asthma?",
    "options": "{\"A\": \"Primidone\", \"B\": \"Propranolol\", \"C\": \"Diazepam\", \"D\": \"Gabapentin\"}",
    "correct_answer": "A",
    "source_file": "Part II 2018_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2018,
    "explanation": "Classification Reason: Focuses on treatment selection for essential tremor, specifically choosing an agent suitable for a patient with asthma (avoiding beta-blockers).",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q157",
    "question_text": "A patient with parkinsonism, ataxia, falls, and orthostatic hypotension has an MRI showing a \"hot cross bun\" sign. What is the likely diagnosis?",
    "options": "{\"A\": \"Multiple System Atrophy (MSA)\", \"B\": \"Corticobasal Degeneration (CBD)\", \"C\": \"Dementia with Lewy Bodies (DLB)\", \"D\": \"Parkinson's Disease\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2021_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2021,
    "explanation": "Classification Reason: Diagnosis of MSA based on the combination of clinical features (parkinsonism, cerebellar signs, autonomic failure) and a characteristic MRI sign.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q222",
    "question_text": "In a scenario of progressive supranuclear palsy (PSP), what is the most likely diagnosis?",
    "options": "{\"A\": \"Parkinson's disease\", \"B\": \"Multiple sclerosis\", \"C\": \"Progressive supranuclear palsy\", \"D\": \"Essential tremor\"}",
    "correct_answer": "C",
    "source_file": "Part II 2018_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2018,
    "explanation": "Classification Reason: Direct diagnosis of PSP based on an (unstated) clinical scenario.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q104",
    "question_text": "Regarding essential palatal myoclonus, which of the following statements is true?",
    "options": "{\"A\": \"Disappears with sleep\", \"B\": \"Hypertrophy of the ipsilateral olivary nucleus\", \"C\": \"Pathology involving the triangle of Mollaret\", \"D\": \"Responds well to anticonvulsant therapy\"}",
    "correct_answer": "A",
    "source_file": "Part I 2018_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2018,
    "explanation": "Classification Reason: Tests knowledge of the clinical and pathological features of essential palatal myoclonus.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q3",
    "question_text": "Case scenario of a patient with a 5-month history of unilateral rigidity, bradykinesia, tremor, and postural instability. What is the next step in management?",
    "options": "{\"A\": \"Levodopa\", \"B\": \"DOPA-PET scan\", \"C\": \"Physical therapy\", \"D\": \"Anticholinergic medication\"}",
    "correct_answer": "A",
    "source_file": "Part 1 2020_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2020,
    "explanation": "Classification Reason: Addresses the initial management (likely a levodopa trial) for a patient presenting with cardinal features of Parkinson's disease.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q161",
    "question_text": "A patient presents with bilateral tremors, and her father has a similar tremor. What is the recommended treatment?",
    "options": "{\"A\": \"Propranolol\", \"B\": \"Levodopa\", \"C\": \"Carbamazepine\", \"D\": \"Phenytoin\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2021_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2021,
    "explanation": "Classification Reason: Implies diagnosis of essential tremor based on presentation and family history, and asks about its treatment (options missing).",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q194",
    "question_text": "In the same scenario, what is the next step in management?",
    "options": "{\"A\": \"Start levodopa\", \"B\": \"Initiate dopamine agonist therapy\", \"C\": \"Begin physical therapy and exercise\", \"D\": \"Order brain MRI to rule out other causes\"}",
    "correct_answer": "A",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Assumes the preceding scenario described Parkinson's disease symptoms, and asks about initiating treatment.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q203",
    "question_text": "What is the first-line treatment for Sydenham chorea?",
    "options": "{\"A\": \"Haloperidol\", \"B\": \"Valproic acid\", \"C\": \"Carbamazepine\", \"D\": \"Prednisone\"}",
    "correct_answer": "A",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Focuses on the specific pharmacological treatment for Sydenham chorea.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q15",
    "question_text": "A patient presents with frequent falls and vertical gaze palsy. Brain MRI shows tectal atrophy. What is the likely diagnosis?",
    "options": "{\"A\": \"Progressive supranuclear palsy (PSP)\", \"B\": \"Parkinson\\u2019s disease\", \"C\": \"Multiple system atrophy\", \"D\": \"Corticobasal degeneration\"}",
    "correct_answer": "A",
    "source_file": "Part 1 2020_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2020,
    "explanation": "Classification Reason: Diagnosis of PSP based on cardinal clinical features and associated imaging findings.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q231",
    "question_text": "A patient with Parkinson's disease has developed dystonia that is not improving with treatment. What is the next step?",
    "options": "{\"A\": \"Propranolol\", \"B\": \"Levodopa\", \"C\": \"Pramipexol\", \"D\": \"Trihexyphenidyl\"}",
    "correct_answer": "D",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Addresses the management of dystonia, a motor complication that can occur in Parkinson's disease.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q5",
    "question_text": "A scenario of a patient with parkinsonian features and vertical gaze palsy is most likely indicative of which condition?",
    "options": "{\"A\": \"Progressive Supranuclear Palsy (PSP)\", \"B\": \"Parkinson\\u2019s Disease\", \"C\": \"Multiple System Atrophy\", \"D\": \"Corticobasal Degeneration\"}",
    "correct_answer": "A",
    "source_file": "Part 1 2020_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2020,
    "explanation": "Classification Reason: Diagnosis of PSP based on the combination of parkinsonism and the characteristic vertical gaze palsy.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q188",
    "question_text": "An approximately 70-year-old male patient has had recurrent falls and gait imbalance over the last 6 months. On examination, he has a masked face, vertical gaze palsy, retrocollis, and bradykinesia. MRI showed a hummingbird sign. What is the diagnosis?",
    "options": "{\"A\": \"Progressive Supranuclear Palsy (PSP)\", \"B\": \"Multiple System Atrophy (MSA)\", \"C\": \"Lewy Body Dementia (LBD)\", \"D\": \"Corticobasal Degeneration (CBD)\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2023_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2023,
    "explanation": "Classification Reason: Diagnosis of PSP based on classic clinical features (falls, gaze palsy, axial rigidity/retrocollis, parkinsonism) and the characteristic hummingbird sign on MRI.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q133",
    "question_text": "In patients with progressive supranuclear palsy (PSP), what symptom does L-dopa primarily treat?",
    "options": "{\"A\": \"Bradykinesia\", \"B\": \"Rigidity\", \"C\": \"Gait instability\", \"D\": \"Vertical gaze palsy\"}",
    "correct_answer": "A",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Discusses the limited symptomatic benefit of levodopa in PSP, typically affecting bradykinesia and rigidity more than other features.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q91",
    "question_text": "A patient presented with recurrent unilateral facial twitching, mostly triggered by anxiety, what is the treatment of choice?",
    "options": "{\"A\": \"Botox\", \"B\": \"Carbamazepine\", \"C\": \"Phenytoin\", \"D\": \"Surgical decompression\"}",
    "correct_answer": "A",
    "source_file": "Part 2 Adult Neurology residency 2024 V9_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Describes symptoms consistent with hemifacial spasm and asks for the primary treatment (Botulinum toxin).",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q53",
    "question_text": "A patient with Parkinson's disease presents with increased dyskinesia and parkinsonism. He is on Levodopa 100/25 mg every 6 hours. What should be done next?",
    "options": "{\"A\": \"Decrease Levodopa and increase dopamine agonist\", \"B\": \"Increase Levodopa and add amantadine\", \"C\": \"Add a COMT inhibitor\", \"D\": \"Start MAO-B inhibitor\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2021_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Addresses the complex management decisions involved in balancing anti-parkinsonian effects and treatment-induced dyskinesia in Parkinson's disease.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q1",
    "question_text": "Which condition is characterized by chorea, cognitive decline, and behavioral changes?",
    "options": "{\"A\": \"Huntington's disease\", \"B\": \"Parkinson's disease\", \"C\": \"Wilson's disease\", \"D\": \"Multiple sclerosis\"}",
    "correct_answer": "A",
    "source_file": "PART I - 2024 - KSMC Revision_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2024,
    "explanation": "Classification Reason: Tests recognition of the classic triad of symptoms characteristic of Huntington's disease.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q181",
    "question_text": "A 61-year-old male with a 2-year history of limb tremors and bradykinesia has postural instability and vertical jaw limitation on exam. What is the likely diagnosis?",
    "options": "{\"A\": \"Corticobasal degeneration (CBD)\", \"B\": \"Multiple system atrophy (MSA)\", \"C\": \"Alzheimer\\u2019s disease (AD)\", \"D\": \"Parkinson's disease (PD)\"}",
    "correct_answer": "A",
    "source_file": "Part I 2022_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2022,
    "explanation": "Classification Reason: Differential diagnosis of parkinsonian syndromes based on clinical features, including potential \"plus\" signs suggesting atypical parkinsonism like CBD.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q39",
    "question_text": "An elderly patient with a history of coronary artery bypass grafting (CABG) two years ago presents with a six-month history of frequent falls and restricted upward gaze. What is the most likely diagnosis?",
    "options": "{\"A\": \"Vascular Parkinsonism\", \"B\": \"Progressive Supranuclear Palsy (PSP)\", \"C\": \"Parkinson\\u2019s Disease\", \"D\": \"Normal Pressure Hydrocephalus\"}",
    "correct_answer": "B",
    "source_file": "Part 1 2021_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2021,
    "explanation": "Classification Reason: Differentiating PSP (suggested by falls and gaze palsy) from vascular parkinsonism (suggested by vascular history) based on predominant clinical signs.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q134",
    "question_text": "Oculopalatal myoclonus is caused by a lesion involving which pathway?",
    "options": "{\"A\": \"Dentate-rubro-olivary pathway\", \"B\": \"Corticospinal tract\", \"C\": \"Spinothalamic tract\", \"D\": \"Medial lemniscus\"}",
    "correct_answer": "A",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Asks about the neuroanatomical basis (Guillain-Mollaret triangle / dentato-rubro-olivary pathway) underlying oculopalatal myoclonus.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q96",
    "question_text": "In a case of corticobasal degeneration, where is the involvement seen on MRI?",
    "options": "{\"A\": \"Association cortex of parietal and temporal lobe\", \"B\": \"Association cortex of unilateral parietal lobe with asymmetrical finding\", \"C\": \"Basal ganglia with symmetrical involvement\", \"D\": \"Frontal lobe with diffuse atrophy\"}",
    "correct_answer": "B",
    "source_file": "Part 2 Adult Neurology residency 2024 V9_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Tests knowledge of the characteristic, often asymmetric, pattern of cortical atrophy seen on imaging in Corticobasal Degeneration (CBD).",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q136",
    "question_text": "A patient with Parkinson's Disease (PD) experiences excessive sleep and motor fluctuations. What medication should be considered?",
    "options": "{\"A\": \"Selegiline\", \"B\": \"Levodopa\", \"C\": \"Amantadine\", \"D\": \"Pramipexole\"}",
    "correct_answer": "A",
    "source_file": "Part II 2018_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2018,
    "explanation": "Classification Reason: Addresses the management of motor fluctuations and non-motor symptoms (sleep issues) in Parkinson's disease.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q36",
    "question_text": "What is the most common cause of hereditary chorea?",
    "options": "{\"A\": \"Huntington disease\", \"B\": \"Sydenham chorea\", \"C\": \"Benign hereditary chorea\", \"D\": \"Wilson disease\"}",
    "correct_answer": "A",
    "source_file": "Part I 2023_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2023,
    "explanation": "Classification Reason: Asks about the most frequent etiology among inherited choreas (Huntington's disease).",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q38",
    "question_text": "A patient with essential tremor and asthma, what is the treatment?",
    "options": "{\"A\": \"Primidone\", \"B\": \"Propranolol\", \"C\": \"Topiramate\", \"D\": \"Gabapentin\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2021_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Focuses on treatment selection for essential tremor considering a comorbidity (asthma) that affects medication choice.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q10",
    "question_text": "Regarding enhanced physiological tremor, which statement is correct?",
    "options": "{\"A\": \"Tremor attenuation with alcohol\", \"B\": \"Tremor worsens with beta-blockers\", \"C\": \"It is a resting tremor\", \"D\": \"It is typically asymmetric\"}",
    "correct_answer": "A",
    "source_file": "Part I 2018_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2018,
    "explanation": "Classification Reason: Tests knowledge of the characteristics of enhanced physiological tremor, distinguishing it from essential tremor (lack of alcohol response).",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q87",
    "question_text": "A patient with recurrent unilateral eye twitching and sometimes mouth twitching, with no history of facial (Bell's) palsy, what is the treatment?",
    "options": "{\"A\": \"Botox injections\", \"B\": \"Carbamazepine\", \"C\": \"Phenytoin\", \"D\": \"Surgical microvascular decompression\"}",
    "correct_answer": "A",
    "source_file": "Part 2 Adult Neurology residency 2024 V9_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Describes hemifacial spasm and asks for its primary treatment (Botulinum toxin).",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q106",
    "question_text": "An elderly patient has a history of frequent falls, limited vertical gaze, and parkinsonian features. What is the diagnosis?",
    "options": "{\"A\": \"Progressive supranuclear palsy (PSP)\", \"B\": \"Multiple system atrophy (MSA)\", \"C\": \"Parkinson\\u2019s disease\", \"D\": \"Corticobasal degeneration\"}",
    "correct_answer": "A",
    "source_file": "Part I 2018_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2018,
    "explanation": "Classification Reason: Diagnosis of PSP based on the classic combination of parkinsonism, falls, and vertical gaze limitation.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q195",
    "question_text": "In a patient with Parkinson's disease experiencing motor function issues and dyskinesia, what is the recommended adjustment to treatment?",
    "options": "{\"A\": \"Decrease Sinemet and add a dopamine agonist\", \"B\": \"Increase Sinemet dosage\", \"C\": \"Start amantadine\", \"D\": \"Discontinue all medications\"}",
    "correct_answer": "A",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Addresses strategies for managing motor complications (fluctuations and dyskinesia) in Parkinson's disease.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q334",
    "question_text": "A scenario suggests a diagnosis of dyt11. What type of myoclonus is associated with this condition, especially since her father has a similar condition that improves with alcohol?",
    "options": "{\"A\": \"Essential myoclonus\", \"B\": \"Cortical myoclonus\", \"C\": \"Subcortical myoclonus\", \"D\": \"Reticular reflex myoclonus\"}",
    "correct_answer": "A",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Characterizes the specific type of myoclonus (often essential-like, alcohol-responsive) seen in Myoclonus-Dystonia (DYT11/SGCE).",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q29",
    "question_text": "A female patient reports throat discomfort and a \u201cclicking tinnitus\u201d that subsides during her sleep. On exam, there is an objective clicking sound, and otherwise, her exam is normal. What is the diagnosis?",
    "options": "{\"A\": \"Palatal tremor\", \"B\": \"Temporomandibular joint dysfunction\", \"C\": \"Glossopharyngeal neuralgia\", \"D\": \"Middle ear myoclonus\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2020 copy_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2020,
    "explanation": "Classification Reason: Directly asks for the diagnosis of a specific movement disorder (palatal tremor/myoclonus) based on characteristic symptoms.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q335",
    "question_text": "A patient with Parkinson's disease for 7 years presents with severe disabling dyskinesia on medical therapy and mild cognitive impairment. What is the recommended treatment?",
    "options": "{\"A\": \"DBS to GPI\", \"B\": \"Medication reduction > STN\", \"C\": \"DBS to STN\", \"D\": \"DBS to VIM\"}",
    "correct_answer": "A",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Deals with advanced surgical management decisions (DBS target selection) for motor complications (dyskinesia) in Parkinson's disease.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q81",
    "question_text": "In Progressive Supranuclear Palsy (PSP), which symptom will improve with treatment?",
    "options": "{\"A\": \"Rigidity\", \"B\": \"Bradykinesia\", \"C\": \"Postural instability\", \"D\": \"Vertical gaze palsy\"}",
    "correct_answer": "B",
    "source_file": "Part 2 2021_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Inquires about the specific treatment response of motor symptoms within an atypical parkinsonian disorder (PSP).",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q14",
    "question_text": "A patient with Parkinson's disease presents with peak dose dyskinesia. What medication is commonly used to manage this condition?",
    "options": "{\"A\": \"Amantadine\", \"B\": \"Levodopa\", \"C\": \"Pramipexole\", \"D\": \"Entacapone\"}",
    "correct_answer": "A",
    "source_file": "Part 1 2020_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2020,
    "explanation": "Classification Reason: Asks for the standard pharmacological treatment (Amantadine) for a specific motor complication (peak dose dyskinesia) of Parkinson's disease.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q18",
    "question_text": "A patient with diabetes mellitus presents with tremor at rest, during action, and with kinetic movements. What type of tremor is most likely?",
    "options": "{\"A\": \"Neuropathy Tremor\", \"B\": \"Rubral Tremor\", \"C\": \"Essential Tremor\", \"D\": \"Parkinsonian Tremor\"}",
    "correct_answer": "B",
    "source_file": "Part 2 - 2023_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2023,
    "explanation": "Classification Reason: Focuses on classifying a specific type of tremor (rubral tremor) based on its phenomenological characteristics, even within a broader medical context (diabetes).",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q123",
    "question_text": "A female patient presents with bilateral upper limb dystonia that improves with alcohol. Which of the following treatments is most appropriate?",
    "options": "{\"A\": \"Clonazepam\", \"B\": \"DYT11\", \"C\": \"Depakine\", \"D\": \"Trihexyphenidyl\"}",
    "correct_answer": "A",
    "source_file": "Part II 2019_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2019,
    "explanation": "Classification Reason: Focuses on the diagnosis (implied Myoclonus-Dystonia/DYT11 due to alcohol response) and treatment of a specific type of dystonia.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q116",
    "question_text": "For a patient with orthostatic tremor who is not tolerating clonazepam, what is the second-line treatment option?",
    "options": "{\"A\": \"Propranolol\", \"B\": \"Levodopa\", \"C\": \"Pramipexole\", \"D\": \"Trihexyphenidyl\"}",
    "correct_answer": "C",
    "source_file": "Part II 2018_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2018,
    "explanation": "Classification Reason: Concerns the pharmacological management sequence (second-line options) for orthostatic tremor.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q117",
    "question_text": "A patient with Parkinson's disease is experiencing motor function issues and dyskinesia. What is the most appropriate adjustment to their medication?",
    "options": "{\"A\": \"Decrease Sinemet and add a dopamine agonist\", \"B\": \"Increase Sinemet dosage\", \"C\": \"Start amantadine\", \"D\": \"Stop all medications\"}",
    "correct_answer": "A",
    "source_file": "Part II 2018_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2018,
    "explanation": "Classification Reason: Deals with specific medication adjustments to manage motor fluctuations and dyskinesia in Parkinson's disease.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q177",
    "question_text": "A 34-year-old female was brought by her family due to a history of abnormal movements of her hands and legs, and difficulty in eating due to sustained contraction of her mouth. Her father had the same history and died early. On examination, she was found to have orolingual dystonia. What should be done next to reach a diagnosis?",
    "options": "{\"A\": \"Blood film (check for acanthocytes)\", \"B\": \"Huntington's repeat\", \"C\": \"MRI brain with basal ganglia focus\", \"D\": \"Serum ceruloplasmin level\"}",
    "correct_answer": "B",
    "source_file": "Promotion 2023_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2023,
    "explanation": "Classification Reason: Focuses on the diagnostic workup (checking for acanthocytes for Neuroacanthocytosis vs Huntington's) for a specific presentation involving movement disorders (dystonia/chorea).",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q18",
    "question_text": "A 14-year-old girl, medically free, has episodes of jerky movements of the right upper limb followed by dystonia with posturing, which occurs suddenly when she turns while running. There is also a family history of migraine. What is the most likely diagnosis?",
    "options": "{\"A\": \"Paroxysmal kinesigenic dyskinesia\", \"B\": \"Dystonia\", \"C\": \"Epilepsy\", \"D\": \"Tourette syndrome\"}",
    "correct_answer": "A",
    "source_file": "Part 1 2021_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2021,
    "explanation": "Classification Reason: Describes classic features of Paroxysmal Kinesigenic Dyskinesia (a specific movement disorder) and asks for the diagnosis.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q118",
    "question_text": "A 62-year-old male has two episodes of asymmetric tremors in the left arm. What investigation should be done to determine the diagnosis?",
    "options": "{\"A\": \"Dopaminergic imaging\", \"B\": \"Dopamine transporter scan\", \"C\": \"MRI of the brain\", \"D\": \"Electromyography\"}",
    "correct_answer": "B",
    "source_file": "Part I 2022_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2022,
    "explanation": "Classification Reason: Focuses on the appropriate diagnostic imaging (DAT scan) used to investigate suspected parkinsonism presenting with asymmetric tremor.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q110",
    "question_text": "Which of the following statements is true regarding symptomatic palatal myoclonus?",
    "options": "{\"A\": \"It often disappears with sleep.\", \"B\": \"It is idiopathic with or without a family history.\", \"C\": \"It is most often due to a structural lesion such as a stroke.\", \"D\": \"It is characterized by an ear-clicking sound.\"}",
    "correct_answer": "C",
    "source_file": "Part I 2019_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2019,
    "explanation": "Classification Reason: Tests knowledge about the etiology and characteristics of symptomatic palatal myoclonus, a specific movement disorder subtype.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q126",
    "question_text": "What is the best treatment for peak dose dyskinesia in patients with Parkinson's disease?",
    "options": "{\"A\": \"Increase levodopa\\u2019s dose\", \"B\": \"Amantadine\", \"C\": \"Surgical intervention\", \"D\": \"Reduce Carbidopa/Levodopa\"}",
    "correct_answer": "B",
    "source_file": "Part II 2019_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2019,
    "explanation": "Classification Reason: Asks for the standard pharmacological treatment (Amantadine) for peak dose dyskinesia, a common motor complication in Parkinson's disease.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q84",
    "question_text": "A Parkinson's patient takes Levodopa/Carbidopa 250/25mg QID and is complaining of wearing off in terms of pain and bradykinesia 30 minutes before the next dose. What is the management of his symptoms?",
    "options": "{\"A\": \"Increase frequency to 5 times per day\", \"B\": \"Start Amantadine\", \"C\": \"Start selegiline\", \"D\": \"Switch to pramipexole\"}",
    "correct_answer": "A",
    "source_file": "Part 2 Adult Neurology residency 2024 V9_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Concerns the management strategies for \"wearing off\" motor fluctuations in Parkinson's disease.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q155",
    "question_text": "What is the benefit of deep brain stimulation of the subthalamic nucleus?",
    "options": "{\"A\": \"Dyskinesia\", \"B\": \"Tremor\", \"C\": \"Dystonia\", \"D\": \"Reduction of dopaminergic medication\"}",
    "correct_answer": "D",
    "source_file": "Promotion 2019_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2019,
    "explanation": "Classification Reason: Inquires about the primary benefits and effects of a specific surgical intervention (STN DBS) used in Parkinson's disease management.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q200",
    "question_text": "A patient with Parkinson's disease presents with increased dyskinesia and parkinsonism. He is on Levodopa 100/25 mg every 6 hours. What should be done next?",
    "options": "{\"A\": \"Decrease Levodopa and increase dopamine agonist\", \"B\": \"Increase Levodopa and add amantadine\", \"C\": \"Add a monoamine oxidase B (MAO-B) inhibitor\", \"D\": \"Switch to a controlled-release Levodopa formulation\"}",
    "correct_answer": "A",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Addresses the complex medication adjustments required to balance worsening parkinsonism and dyskinesia in Parkinson's disease.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q88",
    "question_text": "A patient with idiopathic Parkinson disease, complaining of hallucinations, has mild rigidity, bradykinesia, and minimal dyskinesia. What medication should be discontinued?",
    "options": "{\"A\": \"Pramipexole\", \"B\": \"Amantadine\", \"C\": \"Trihexyphenidyl\", \"D\": \"Selegiline\"}",
    "correct_answer": "A",
    "source_file": "Part 2 Adult Neurology residency 2024 V9_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Deals with managing medication-induced side effects (hallucinations) by adjusting Parkinson's disease therapy, specifically which drug class to target first.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q189",
    "question_text": "A typical case of orthostatic tremor is presented. What is the recommended treatment?",
    "options": "{\"A\": \"Clonazepam\", \"B\": \"Primidone\", \"C\": \"Propranolol\", \"D\": \"Gabapentin\"}",
    "correct_answer": "A",
    "source_file": "part 2 2024_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Asks for the standard first-line pharmacological treatment for orthostatic tremor.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q107",
    "question_text": "A patient who works as a chef has been complaining of a months-long history of upper limb resting tremor and rigidity. During the examination, he was found to have unilateral bradykinesia and resting tremor. The patient also mentioned he has a gambling problem. What will you do?",
    "options": "{\"A\": \"Carbidopa/levodopa\", \"B\": \"Carbidopa/levodopa/entacapone\", \"C\": \"Dopamine antagonist\", \"D\": \"Initiate non-pharmacological therapy and monitor symptoms\"}",
    "correct_answer": "A",
    "source_file": "Part I 2018_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2018,
    "explanation": "Classification Reason: Involves initiating treatment for newly diagnosed Parkinson's disease while considering the risk/presence of a common treatment-related complication (impulse control disorder - gambling).",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q138",
    "question_text": "What is the next investigation for a patient with orthostatic tremor?",
    "options": "{\"A\": \"NCS/EMG\", \"B\": \"MRI brain\", \"C\": \"Dopamine transporter (DAT) scan\", \"D\": \"Blood glucose levels\"}",
    "correct_answer": "A",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Asks for the key diagnostic investigation (EMG showing characteristic high-frequency tremor) for orthostatic tremor.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q233",
    "question_text": "Deep brain stimulation (DBS) of the globus pallidus interna (GPi) may be more effective than DBS of the subthalamic nucleus (STN) in treating which of the following features of Parkinson's disease?",
    "options": "{\"A\": \"Bradykinesia\", \"B\": \"Dementia\", \"C\": \"Dyskinesias\", \"D\": \"On-off fluctuations\"}",
    "correct_answer": "C",
    "source_file": "Promotion 2019_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2019,
    "explanation": "Classification Reason: Compares the relative efficacy of different DBS targets (GPi vs STN) for specific Parkinson's disease symptoms, particularly dyskinesias.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q169",
    "question_text": "What is the recommended treatment for a patient with Parkinson's Disease (PD) who has features of Restless Legs Syndrome (RLS)?",
    "options": "{\"A\": \"Dopamine agonist\", \"B\": \"Antidepressants\", \"C\": \"Benzodiazepines\", \"D\": \"Opioids\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2022_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2022,
    "explanation": "Classification Reason: Addresses the treatment of RLS symptoms specifically occurring in a patient with Parkinson's disease, where dopaminergic treatments often overlap.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q112",
    "question_text": "Which of the following Parkinsonian disorders commonly presents with asymmetrical features?",
    "options": "{\"A\": \"MSA\", \"B\": \"PSP\", \"C\": \"CBD\", \"D\": \"Parkinson\\u2019s disease\"}",
    "correct_answer": "C",
    "source_file": "Part I 2023_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2023,
    "explanation": "Classification Reason: Tests knowledge of the typical clinical presentation patterns (symmetry vs asymmetry) differentiating atypical parkinsonian syndromes like CBD, PSP, and MSA.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q325",
    "question_text": "A male patient, 85 years old, presents with gait freezing, cognitive changes, bradykinesia, and urinary incontinence. MRI shows moderate ventriculomegaly and mild brain atrophy. What is the most appropriate management?",
    "options": "{\"A\": \"Start levodopa\", \"B\": \"Start donepezil\", \"C\": \"Refer for surgery\", \"D\": \"Initiate physical therapy\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2021_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2021,
    "explanation": "Classification Reason: Presents a scenario with overlapping features of NPH and parkinsonism (gait freezing, bradykinesia), asking about initial management steps including a diagnostic/therapeutic trial of Levodopa.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q17",
    "question_text": "A 50-year-old male came with a history suggestive of Parkinson's disease (rigidity, tremors, bradykinesia). What is the next step in management?",
    "options": "{\"A\": \"Levodopa/Carbidopa\", \"B\": \"Levodopa/Carbidopa/Entacapone\", \"C\": \"PET Scan\", \"D\": \"Dopamine agonists\"}",
    "correct_answer": "A",
    "source_file": "Part 1 2021_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2021,
    "explanation": "Classification Reason: Concerns the standard initial management step (initiating Levodopa therapy) after diagnosing classic Parkinson's disease symptoms.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q7",
    "question_text": "Which of the following describes orthostatic tremor?",
    "options": "{\"A\": \"It improves with walking.\", \"B\": \"It is characterized by unsteadiness on standing and a high frequency tremor in the legs.\", \"C\": \"The typical onset is in the sixth decade of life.\", \"D\": \"It is associated with resting tremor and bradykinesia\"}",
    "correct_answer": "B",
    "source_file": "Part 1 2020_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2020,
    "explanation": "Classification Reason: Tests knowledge of the defining clinical characteristics and epidemiology of orthostatic tremor.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q456",
    "question_text": "A female presents with action and intention tremor, dropping things, and a slightly asymmetric family history. What is the most likely diagnosis?",
    "options": "{\"A\": \"Physiological tremor\", \"B\": \"Essential tremor\", \"C\": \"Parkinsonian tremor\", \"D\": \"Cerebellar tremor\"}",
    "correct_answer": "B",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Asks for the diagnosis based on classic clinical features strongly suggestive of Essential Tremor.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q170",
    "question_text": "A 70-year-old male presents with a history of left arm dystonia, bradykinesia, and myoclonus. He moves his head to look to the sides. What is the diagnosis?",
    "options": "{\"A\": \"Frontotemporal dementia (FTD)\", \"B\": \"Alzheimer's disease (AD)\", \"C\": \"Dementia with Lewy bodies (DLB)\", \"D\": \"Corticobasal degeneration (CBD)\"}",
    "correct_answer": "D",
    "source_file": "Promotion 2022_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2022,
    "explanation": "Classification Reason: Asks for the diagnosis of an atypical parkinsonian syndrome (likely Corticobasal Degeneration) based on a characteristic constellation of motor signs (unilateral dystonia, bradykinesia, myoclonus).",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q202",
    "question_text": "What is the treatment for hemifacial spasm?",
    "options": "{\"A\": \"Botox\", \"B\": \"Carbamazepine\", \"C\": \"Physical therapy\", \"D\": \"Surgical decompression\"}",
    "correct_answer": "A",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Asks for the standard first-line treatment (Botulinum toxin) for hemifacial spasm.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q151",
    "question_text": "A 60-year-old male presents with recent onset of progressive difficulty using the right hand. Clinically, he is found to have right hand myoclonus, rigidity, and cortical sensory loss, with no history of falls. What is the most likely diagnosis?",
    "options": "{\"A\": \"Corticobasal degeneration\", \"B\": \"Basal ganglia stroke\", \"C\": \"Progressive Supranuclear Palsy (PSP)\", \"D\": \"Multiple System Atrophy (MSA)\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2018_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2018,
    "explanation": "Classification Reason: Asks for the diagnosis based on a classic clinical presentation (unilateral limb rigidity, myoclonus, cortical sensory loss/apraxia) highly suggestive of Corticobasal Degeneration (CBD).",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q28",
    "question_text": "In a scenario of orthostatic tremor not responding to clonazepam, which of the following is a second-line treatment?",
    "options": "{\"A\": \"Levodopa\", \"B\": \"Propranolol\", \"C\": \"Gabapentin\", \"D\": \"Primidone\"}",
    "correct_answer": "C",
    "source_file": "Part 2 2020 copy_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2020,
    "explanation": "Classification Reason: Asks for second-line pharmacological treatment options (e.g., Gabapentin) for orthostatic tremor after first-line failure.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q227",
    "question_text": "Which of the following is most likely to be associated with essential palatal myoclonus?",
    "options": "{\"A\": \"Most likely due to stroke\", \"B\": \"Symptomatic palatal myoclonus\", \"C\": \"Essential palatal myoclonus\", \"D\": \"Family history (FHX)\"}",
    "correct_answer": "C",
    "source_file": "Part II 2019_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2019,
    "explanation": "Classification Reason: Tests understanding of the definition of essential (idiopathic) palatal myoclonus versus symptomatic forms.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q86",
    "question_text": "A patient with idiopathic Parkinson disease, complaining of hallucinations, has mild rigidity and bradykinesia with minimal dyskinesia. What medication should be discontinued?",
    "options": "{\"A\": \"Pramipexole\", \"B\": \"Amantadine\", \"C\": \"Trihexyphenidyl\", \"D\": \"Levodopa\"}",
    "correct_answer": "A",
    "source_file": "Part 2 Adult Neurology residency 2024 V9_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Deals with managing medication-induced side effects (hallucinations) by prioritizing which Parkinson's medications (e.g., dopamine agonists, anticholinergics) to discontinue first.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q100",
    "question_text": "What type of focal dystonia improves when touching the face?",
    "options": "{\"A\": \"Torticollis\", \"B\": \"Writer's cramp\", \"C\": \"Blepharospasm\", \"D\": \"Dystonic tremor\"}",
    "correct_answer": "A",
    "source_file": "Part 2 - 2023_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2023,
    "explanation": "Classification Reason: Tests knowledge of sensory tricks (geste antagoniste) as a characteristic feature often seen in focal dystonias, particularly cervical dystonia (torticollis).",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q351",
    "question_text": "A patient with tremor-predominant Parkinson's disease on levodopa/carbidopa (LDCD) 250/25 mg every 4 hours is experiencing off symptoms 2.5 hours before the next dose with peak dyskinesia. What is the next best step in management?",
    "options": "{\"A\": \"Decrease individual dose with increasing frequency\", \"B\": \"Consider referral for subthalamic nucleus deep brain stimulation (DBS)\", \"C\": \"Increase the dose of levodopa\", \"D\": \"Switch to a different medication\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2023_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2023,
    "explanation": "Classification Reason: Addresses the management of complex motor fluctuations (wearing off) combined with peak-dose dyskinesia in advanced Parkinson's disease, requiring medication adjustment.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q10",
    "question_text": "A 30-year-old male with a history of action tremor presents with symmetrical tremors that improve with alcohol and have a frequency of 12 Hz. What is the likely diagnosis?",
    "options": "{\"A\": \"Essential tremor\", \"B\": \"Enhanced physiological tremor\", \"C\": \"Parkinsonian tremor\", \"D\": \"Cerebellar intention tremor\"}",
    "correct_answer": "A",
    "source_file": "Part 1 2020_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2020,
    "explanation": "Classification Reason: Asks to differentiate between types of tremor (Essential vs Enhanced Physiological) based on specific clinical characteristics like frequency, symmetry, and response to alcohol.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q210",
    "question_text": "Which of the following symptoms is the most common side effect of botulinum toxin injection for cervical dystonia?",
    "options": "{\"A\": \"Muscle weakness\", \"B\": \"Dysphagia\", \"C\": \"Dry mouth\", \"D\": \"Localized pain at the injection site\"}",
    "correct_answer": "B",
    "source_file": "Promotion 2018_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2018,
    "explanation": "Classification Reason: Inquires about common adverse effects (like dysphagia) associated with a standard treatment (Botulinum toxin) for a specific movement disorder (cervical dystonia).",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q244",
    "question_text": "What is the treatment for Sydenham chorea?",
    "options": "{\"A\": \"Haloperidol\", \"B\": \"Valproic acid\", \"C\": \"Carbamazepine\", \"D\": \"Prednisone\"}",
    "correct_answer": "A",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Asks for the pharmacological treatment options for the motor manifestation (chorea) of Sydenham chorea.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q93",
    "question_text": "An elderly patient presents with imbalance that improves with walking. On examination, you find gait hesitancy that improves with walking. What should be the next step? (case of Orthostatic tremor)",
    "options": "{\"A\": \"NCS/EMG\", \"B\": \"Brain MRI\", \"C\": \"Dopamine transporter (DAT) scan\", \"D\": \"Trial of levodopa\"}",
    "correct_answer": "A",
    "source_file": "Part 2 Adult Neurology residency 2024 V9_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Identifies orthostatic tremor based on the characteristic clinical description (imbalance/hesitancy improving with walking) and asks for the key diagnostic test (EMG).",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q2",
    "question_text": "A 14-year-old girl, medically free, has episodes of jerky movements of the right upper limb followed by dystonia with posturing, which occurs suddenly when she turns while running. There is also a family history of migraine. What is the most likely diagnosis?",
    "options": "{\"A\": \"Paroxysmal kinesigenic dyskinesia\", \"B\": \"Paroxysmal exercise-induced dyskinesia\", \"C\": \"DYT1\", \"D\": \"Juvenile myoclonic epilepsy\"}",
    "correct_answer": "A",
    "source_file": "Part 1 2020_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2020,
    "explanation": "Classification Reason: Tests the ability to differentiate between types of paroxysmal dyskinesias based on triggers (kinesigenic vs. exercise-induced) and clinical presentation.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q167",
    "question_text": "A 70-year-old female with a known case of Parkinson's disease has stable symptoms for the last 6 years. She now reports a \"wear-off\" effect of her medication after 1.5 hours and peak onset dyskinesia. She is taking Sinemet 250/25 every 4 hours and selegiline. What is the next step in management?",
    "options": "{\"A\": \"Add Artane\", \"B\": \"Decrease levodopa and increase interval\", \"C\": \"Deep brain stimulation (DBS)\", \"D\": \"Rescue injection\"}",
    "correct_answer": "C",
    "source_file": "Promotion 2022_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2022,
    "explanation": "Classification Reason: Focuses on managing motor complications (wearing-off, dyskinesia) in a patient with established Parkinson's disease.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q26",
    "question_text": "A 16-year-old female patient presented with jerking movements that improved with wine. Her father has the same symptoms. What is the diagnosis?",
    "options": "{\"A\": \"Myoclonus dystonia DYT11\", \"B\": \"Orthostatic tremor\", \"C\": \"Lewy body dementia\", \"D\": \"Familial insomnia\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2021_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Assesses knowledge of specific inherited movement disorders (Myoclonus dystonia, DYT11) characterized by myoclonus, dystonia, and alcohol responsiveness.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q115",
    "question_text": "A 42-year-old female has gait difficulty and feels very dizzy, but when she wakes, she no longer has dizziness. An EMG shows subtle abnormalities. What is the best treatment for her?",
    "options": "{\"A\": \"Propranolol\", \"B\": \"Clonazepam\", \"C\": \"Lamotrigine\", \"D\": \"Deep brain stimulation (DBS)\"}",
    "correct_answer": "B",
    "source_file": "Part I 2022_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2022,
    "explanation": "Classification Reason: Describes symptoms suggestive of orthostatic tremor (dizziness/gait difficulty improving upon waking/sitting) and asks for its treatment, a specific movement disorder.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q108",
    "question_text": "A patient presents with lower limb tremor that starts when she stands up and does not improve when she starts walking. She mentions that she has a relative with hand tremor when he holds the newspaper. EMG shows orthostatic tremor. What will you give her?",
    "options": "{\"A\": \"Propranolol\", \"B\": \"Levodopa\", \"C\": \"Clonazepam\", \"D\": \"Gabapentin\"}",
    "correct_answer": "C",
    "source_file": "Part I 2018_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2018,
    "explanation": "Classification Reason: Tests knowledge of the first-line treatment for orthostatic tremor, a specific movement disorder identified by clinical features and EMG.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q24",
    "question_text": "A man who presented with abnormal movement (from a psychiatry hospital) and is unable to sit still. On exam, he is fidgeting and moving back and forth, constantly crossing and uncrossing his legs. What is the diagnosis?",
    "options": "{\"A\": \"Chorea\", \"B\": \"Dystonia\", \"C\": \"Akathisia\", \"D\": \"Restless legs syndrome\"}",
    "correct_answer": "C",
    "source_file": "Part 2 2020 copy_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2020,
    "explanation": "Classification Reason: Requires differentiating akathisia (a feeling of inner restlessness often medication-induced) from other movement disorders based on phenomenological description.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q24",
    "question_text": "Thalamotomy in Parkinson's Disease (PD) is expected to improve which of the following symptoms?",
    "options": "{\"A\": \"Tremor\", \"B\": \"Bradykinesia\", \"C\": \"Rigidity\", \"D\": \"Postural instability\"}",
    "correct_answer": "A",
    "source_file": "PART I - 2024 - KSMC Revision_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2024,
    "explanation": "Classification Reason: Assesses knowledge of the specific target symptom improved by thalamotomy, a surgical treatment for Parkinson's disease tremor.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q162",
    "question_text": "Levodopa",
    "options": "{\"A\": \"Is a dopamine precursor used to treat Parkinson's disease\", \"B\": \"Is an acetylcholinesterase inhibitor used in Alzheimer's disease\", \"C\": \"Is a GABA agonist used to treat epilepsy\", \"D\": \"Is a serotonin reuptake inhibitor used in depression\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2021_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2021,
    "explanation": "Classification Reason: This is just a term, likely part of an incomplete question about Parkinson's disease treatment or response.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q321",
    "question_text": "In a patient with Progressive Supranuclear Palsy (PSP), which symptom is most likely to improve with levodopa treatment?",
    "options": "{\"A\": \"Bradykinesia\", \"B\": \"Tremor\", \"C\": \"Gait instability\", \"D\": \"Urinary incontinence\"}",
    "correct_answer": "A",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Tests understanding of the limited and specific response of PSP symptoms (a parkinsonian syndrome) to levodopa therapy.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q116",
    "question_text": "A 35-year-old male presented to the clinic with complaints of atonic jerks at age 10. He has a history of dystonia, depression, chorea, and ataxia. There is no family history of a similar condition. What is the likely diagnosis?",
    "options": "{\"A\": \"Dystonia\", \"B\": \"Anderson Disease\", \"C\": \"Neuroacanthocytosis\", \"D\": \"Parkinson's Disease\"}",
    "correct_answer": "C",
    "source_file": "Part I 2022_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2022,
    "explanation": "Classification Reason: Asks for the diagnosis of a complex movement disorder syndrome (chorea, dystonia, ataxia) with specific associated features (atonic jerks, depression), pointing towards Neuroacanthocytosis.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q192",
    "question_text": "A patient with schizophrenia is unable to sit and is on antipsychotic medication. What is the likely diagnosis?",
    "options": "{\"A\": \"Chorea\", \"B\": \"Tics\", \"C\": \"Akathisia\", \"D\": \"Dystonia\"}",
    "correct_answer": "C",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Focuses on identifying akathisia as a medication-induced movement disorder (side effect of antipsychotics) based on clinical description.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q97",
    "question_text": "An elderly patient presents with imbalance that improves with walking. On examination, you find gait hesitancy that improves with walking. What is the treatment? (case of Orthostatic tremor)",
    "options": "{\"A\": \"Clonazepam\", \"B\": \"Gabapentin\", \"C\": \"Levodopa\", \"D\": \"Propranolol\"}",
    "correct_answer": "A",
    "source_file": "Part 2 Adult Neurology residency 2024 V9_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Although the presentation description is slightly atypical (\"improves with walking\" vs. typical OT description), the explicit mention \"(case of Orthostatic tremor)\" and asking for treatment classifies it as Movement Disorders.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q45",
    "question_text": "In Huntington's disease, how many gene repeats are typically present?",
    "options": "{\"A\": \"More than 48 repeats\", \"B\": \"Between 36 and 39 repeats\", \"C\": \"Less than 26 repeats\", \"D\": \"Between 27 and 35 repeats\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2021_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Tests knowledge of the specific genetic basis (repeat expansion number correlating with disease) of Huntington's disease, a classic movement disorder.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q35",
    "question_text": "In the scenario of orthostatic tremor, what diagnostic tests should be performed?",
    "options": "{\"A\": \"Nerve Conduction Study (NCS) and Electromyography (EMG)\", \"B\": \"MRI of the brain\", \"C\": \"Blood tests\", \"D\": \"Lumbar puncture\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2020 copy_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2020,
    "explanation": "Classification Reason: Assesses knowledge of the key diagnostic test (surface EMG during standing) used to confirm orthostatic tremor.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q32",
    "question_text": "In a scenario about essential myoclonus relieved by alcohol, which of the following is the most likely diagnosis?",
    "options": "{\"A\": \"Cortical myoclonus\", \"B\": \"Essential myoclonus\", \"C\": \"Physiological myoclonus\", \"D\": \"Epileptic myoclonus\"}",
    "correct_answer": "B",
    "source_file": "Part 2 2020 copy_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2020,
    "explanation": "Classification Reason: Focuses on diagnosing Essential Myoclonus (often associated with dystonia and alcohol responsiveness, i.e., Myoclonus-Dystonia syndrome) based on clinical features.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q92",
    "question_text": "A patient has dystonia of the lower limbs and a positive family history of similar symptoms. She was given Levodopa before and had a significant response. What is the treatment? (case of DYT5)",
    "options": "{\"A\": \"Levodopa/Carbidopa\", \"B\": \"Baclofen\", \"C\": \"Botulinum toxin injections\", \"D\": \"Deep brain stimulation\"}",
    "correct_answer": "A",
    "source_file": "Part 2 Adult Neurology residency 2024 V9_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Tests knowledge of the treatment for Dopa-Responsive Dystonia (DYT5/Segawa syndrome), identified by clinical features (limb dystonia, family history, L-dopa response).",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q121",
    "question_text": "A young lady presented to the outpatient clinic with a history of abnormal movement in the form of sudden abduction at the shoulder and tonic posturing of her hand noticed while writing. She has a family history of her father and brother with a similar condition. Which of the following is associated with this condition (Myoclonic dystonia)?",
    "options": "{\"A\": \"Diurnal variation\", \"B\": \"Improvement with ethanol\", \"C\": \"Response to levodopa\", \"D\": \"Early progression to dementia\"}",
    "correct_answer": "B",
    "source_file": "Part I 2023_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2023,
    "explanation": "Classification Reason: Asks about characteristic features (alcohol responsiveness) of Myoclonus-Dystonia syndrome, a specific inherited movement disorder.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q232",
    "question_text": "A Parkinson's patient on medication developed wearing off phenomena; what is the mechanism?",
    "options": "{\"A\": \"Failure of medication\", \"B\": \"Disease progression\", \"C\": \"Medication intolerance\", \"D\": \"Altered dopamine receptor sensitivity\"}",
    "correct_answer": "B",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Tests understanding of the underlying pathophysiology (disease progression leading to reduced dopamine storage) contributing to wearing-off phenomena in Parkinson's disease.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q20",
    "question_text": "A case scenario of a patient suggestive of Corticobasal Degeneration (CBD) is presented, with a hint of abnormal hand movements. What MRI finding is expected?",
    "options": "{\"A\": \"Asymmetrical parietal atrophy\", \"B\": \"Symmetrical basal ganglia hyperintensities\", \"C\": \"Diffuse cortical atrophy\", \"D\": \"Cerebellar atrophy\"}",
    "correct_answer": "A",
    "source_file": "Part 1 2021_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2021,
    "explanation": "Classification Reason: Focuses on the characteristic neuroimaging finding associated with Corticobasal Degeneration, a parkinsonian syndrome presenting with movement disorders.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q153",
    "question_text": "What is the site of deep brain stimulation (DBS) for tremor?",
    "options": "{\"A\": \"Thalamus\", \"B\": \"Globus Pallidus Interna (GPi)\", \"C\": \"Subthalamic Nucleus (STN)\", \"D\": \"Caudate Nucleus\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2019_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2019,
    "explanation": "Classification Reason: Assesses knowledge of the specific brain target (Thalamus, specifically Vim nucleus) used in DBS surgery to treat tremor (often essential tremor or Parkinson's tremor).",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q9",
    "question_text": "Which of the following is a common trigger for paroxysmal kinesigenic dyskinesia?",
    "options": "{\"A\": \"Cold exposure\", \"B\": \"Stress\", \"C\": \"Alcohol\", \"D\": \"Non-REM sleep\"}",
    "correct_answer": "B",
    "source_file": "Part 1 2020_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2020,
    "explanation": "Classification Reason: Tests knowledge of the specific triggers associated with Paroxysmal Kinesigenic Dyskinesia, helping differentiate it from other paroxysmal movement disorders.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q73",
    "question_text": "In refractory essential tremor, which structure is the target for deep brain stimulation (DBS)?",
    "options": "{\"A\": \"Thalamus\", \"B\": \"Hypothalamus\", \"C\": \"Globus pallidus (GP)\", \"D\": \"Subthalamic nucleus\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2023_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2023,
    "explanation": "Classification Reason: Asks for the specific DBS target (Thalamus/Vim) for treating Essential Tremor, a common movement disorder.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q8",
    "question_text": "In a patient with Parkinson's Disease (PD) on Sinemet, who has shown improvement in motor control and dyskinesia after adding pramipexole, but is experiencing cognitive impairment and mood changes, what is the best course of action?",
    "options": "{\"A\": \"Change the Sinemet to a combination with a COMT inhibitor\", \"B\": \"Increase the Sinemet dosage\", \"C\": \"Stop the pramipexole\", \"D\": \"Start quetiapine\"}",
    "correct_answer": "C",
    "source_file": "Part 2 - 2023_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2023,
    "explanation": "Classification Reason: Focuses on managing medication side effects (cognitive/mood changes from dopamine agonist) in the context of Parkinson's disease treatment.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q16",
    "question_text": "What is the male-to-female ratio in the inheritance of paroxysmal kinesigenic dyskinesia?",
    "options": "{\"A\": \"1:1\", \"B\": \"4:1\", \"C\": \"2:1\", \"D\": \"3:1\"}",
    "correct_answer": "A",
    "source_file": "Part 1 2020_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2020,
    "explanation": "Classification Reason: Tests knowledge of the epidemiological/genetic characteristics (sex ratio) of Paroxysmal Kinesigenic Dyskinesia.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q205",
    "question_text": "In a patient with progressive supranuclear palsy (PSP) receiving Sinemet, which symptom is likely to improve?",
    "options": "{\"A\": \"Rigidity\", \"B\": \"Bradykinesia\", \"C\": \"Both A and B\", \"D\": \"None of the above\"}",
    "correct_answer": "B",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Assesses understanding of the specific parkinsonian symptoms (rigidity, bradykinesia) that might show some, albeit limited, response to levodopa in PSP.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q12",
    "question_text": "A young patient presents with dystonia and myoclonus. What characteristic is likely associated with this condition?",
    "options": "{\"A\": \"Diurnal variation\", \"B\": \"Alcohol-responsive\", \"C\": \"Progressive cognitive decline\", \"D\": \"Sensory loss\"}",
    "correct_answer": "B",
    "source_file": "Part 1 2020_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2020,
    "explanation": "Classification Reason: Tests knowledge of a key characteristic (alcohol responsiveness) of Myoclonus-Dystonia syndrome.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q88",
    "question_text": "A patient with a known case of Parkinson's disease on levodopa/carbidopa describes having recurrent tremor and bradykinesia before the next dose. What is the description of this phenomenon?",
    "options": "{\"A\": \"Off dystonia\", \"B\": \"On and off phenomena\", \"C\": \"Wearing-off phenomenon\", \"D\": \"Peak-dose dyskinesia\"}",
    "correct_answer": "B",
    "source_file": "Part I 2023_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2023,
    "explanation": "Classification Reason: Asks for the correct terminology (\"wearing-off\", a component of on-off phenomena) used to describe predictable end-of-dose motor fluctuations in Parkinson's disease.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q54",
    "question_text": "A patient with typical orthostatic tremor is being treated. What is the recommended treatment?",
    "options": "{\"A\": \"Clonazepam\", \"B\": \"Gabapentin\", \"C\": \"Levodopa\", \"D\": \"Primidone\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2021_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Tests knowledge of the primary treatments (Clonazepam, Gabapentin) for orthostatic tremor.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q83",
    "question_text": "What is the treatment for Sydenham chorea?",
    "options": "{\"A\": \"Haloperidol\", \"B\": \"Valproic acid\", \"C\": \"Carbamazepine\", \"D\": \"Prednisone\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2021_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Asks for the treatment of Sydenham chorea, a specific type of chorea (movement disorder) associated with rheumatic fever.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q101",
    "question_text": "What is the diagnosis for a clear case of Parkinson's Disease (PD)?",
    "options": "{\"A\": \"Essential tremor\", \"B\": \"Parkinson's Disease\", \"C\": \"Multiple sclerosis\", \"D\": \"Alzheimer's disease\"}",
    "correct_answer": "B",
    "source_file": "Part I 2018_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2018,
    "explanation": "Classification Reason: Basic identification of Parkinson's Disease based on a (presumed) clear clinical description.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q163",
    "question_text": "Multiple System Atrophy (MSA)",
    "options": "{\"A\": \"A neurodegenerative disorder characterized by alpha-synuclein accumulation in oligodendrocytes\", \"B\": \"A demyelinating disease primarily affecting the peripheral nervous system\", \"C\": \"A hereditary ataxia caused by trinucleotide repeat expansions\", \"D\": \"An autoimmune disorder targeting the neuromuscular junction\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2021_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2021,
    "explanation": "Classification Reason: This is just a term, likely part of an incomplete question about diagnosing or differentiating atypical parkinsonian syndromes.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q196",
    "question_text": "A 16-year-old had dystonia that improved with wine, and her father has the same condition. What is the treatment?",
    "options": "{\"A\": \"Clonazepam\", \"B\": \"Levodopa\", \"C\": \"Botulinum toxin injection\", \"D\": \"Deep brain stimulation\"}",
    "correct_answer": "A",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Although Clonazepam can be used, the core concept is identifying Myoclonus-Dystonia (implied by alcohol response and family history) and its management. While Clonazepam is *a* treatment, the question tests recognition and management strategy for this specific movement disorder.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q98",
    "question_text": "A young patient with lip biting and face and limb dystonia has a blood smear showing abnormal RBCs with thorny projections. What is the diagnosis?",
    "options": "{\"A\": \"Neuroacanthocytosis\", \"B\": \"Huntington's disease\", \"C\": \"Wilson's disease\", \"D\": \"Pantothenate kinase-associated neurodegeneration\"}",
    "correct_answer": "A",
    "source_file": "Part 2 Adult Neurology residency 2024 V9_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Tests the ability to diagnose Neuroacanthocytosis based on the combination of specific movement disorders (dystonia, lip biting) and a characteristic laboratory finding (acanthocytes).",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q193",
    "question_text": "A patient with essential tremor and asthma, what is the treatment?",
    "options": "{\"A\": \"Primidone\", \"B\": \"Propranolol\", \"C\": \"Topiramate\", \"D\": \"Benzodiazepines\"}",
    "correct_answer": "A",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Tests knowledge of treatment selection for essential tremor, considering comorbidities (asthma precluding beta-blocker use, making primidone a suitable alternative).",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q2",
    "question_text": "A female patient presents with a hand tremor that improves with alcohol, and there is a family history of similar symptoms. What is the most likely diagnosis?",
    "options": "{\"A\": \"Essential tremor\", \"B\": \"Enhanced physiological tremor\", \"C\": \"Parkinson\\u2019s disease\", \"D\": \"Cerebellar tremor\"}",
    "correct_answer": "A",
    "source_file": "PART I - 2024 - KSMC Revision_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2024,
    "explanation": "Classification Reason: Focuses on diagnosing Essential Tremor based on classic clinical features (action tremor, alcohol responsiveness, family history).",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q448",
    "question_text": "A 32-year-old female with a history of Parkinson's disease presents with worsening symptoms, including resting tremor. She has had remarkable improvement with L-dopa. What is the next step in management?",
    "options": "{\"A\": \"Dopamine agonist\", \"B\": \"Increase L-dopa dose\", \"C\": \"Add MAO-B inhibitor\", \"D\": \"Deep brain stimulation\"}",
    "correct_answer": "A",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Addresses treatment strategy in Parkinson's disease, specifically considering options like optimizing L-dopa or adding a dopamine agonist based on L-dopa response and symptom profile. The \"history of PD\" might imply early onset given the age, but the core is PD management.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q108",
    "question_text": "A patient with Parkinson's disease on multiple agents has developed hallucinations. What is the first step in management?",
    "options": "{\"A\": \"Stop amantadine\", \"B\": \"Increase Sinemet dosage\", \"C\": \"Start quetiapine\", \"D\": \"Add rivastigmine\"}",
    "correct_answer": "A",
    "source_file": "Part II 2018_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2018,
    "explanation": "Classification Reason: Tests the approach to managing medication-induced psychosis/hallucinations in Parkinson's disease, involving medication review and potential adjustments (stopping offending agents like amantadine first).",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q23",
    "question_text": "A 30-year-old child with dopa-responsive dystonia started with foot dystonia and progressed to generalized symptoms with diurnal variation. What is the diagnosis?",
    "options": "{\"A\": \"DYT1\", \"B\": \"DYT5\", \"C\": \"DYT11\", \"D\": \"DYT12\"}",
    "correct_answer": "B",
    "source_file": "Part 2 - 2023_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2023,
    "explanation": "Classification Reason: Requires identification of the specific genetic type of dystonia (DYT5/Segawa syndrome) based on clinical features (dopa-responsiveness, diurnal variation, onset).",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q89",
    "question_text": "A 68-year-old male presented to the clinic due to a history of recurrent falls. He has a history of CABG 6 months ago. Physical examination showed limited vertical gaze, bradykinesia, and an unsteady gait. Brain MRI showed generalized atrophy with ex-vacuo and atrophy of the midbrain tectum. What is the most likely diagnosis?",
    "options": "{\"A\": \"Vascular parkinsonism (VP)\", \"B\": \"Progressive supranuclear palsy (PSP)\", \"C\": \"Normal pressure hydrocephalus (NPH)\", \"D\": \"Multisystem atrophy (MSA)\"}",
    "correct_answer": "B",
    "source_file": "Part I 2023_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2023,
    "explanation": "Classification Reason: Focuses on differentiating parkinsonian syndromes based on clinical signs (vertical gaze palsy, falls) and supportive MRI findings (midbrain atrophy/hummingbird sign - though not explicitly stated, implied by tectal atrophy) characteristic of PSP.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q100",
    "question_text": "An elderly patient with gait imbalance and urinary urgency that progressed to incontinence has bilateral mild rigidity with no tremor. What are the likely findings on MRI of the brain?",
    "options": "{\"A\": \"Hot cross bun sign\", \"B\": \"Hummingbird sign\", \"C\": \"Brain atrophy\", \"D\": \"Putaminal hypointensity\"}",
    "correct_answer": "A",
    "source_file": "Part 2 Adult Neurology residency 2024 V9_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Tests knowledge of the characteristic MRI finding (\"Hot cross bun sign\") associated with Multiple System Atrophy (MSA-C type), based on clinical features suggestive of MSA (parkinsonism + autonomic failure/cerebellar signs implied by gait imbalance).",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q80",
    "question_text": "A female patient has a tremor, and her father also has a tremor. The father reports that his tremor improves with wine. What is the diagnosis?",
    "options": "{\"A\": \"Essential tremor\", \"B\": \"Parkinson\\u2019s disease\", \"C\": \"Cerebellar tremor\", \"D\": \"Drug-induced tremor\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2021_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Basic diagnosis of Essential Tremor based on hallmark features (familial tremor, alcohol responsiveness).",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q160",
    "question_text": "A 70-year-old male patient with a history of Parkinson\u2019s disease for 10 years, who has been responding well to levodopa, presents with orthostatic hypotension and frequent falls. What is the most likely diagnosis?",
    "options": "{\"A\": \"Idiopathic Parkinson disease\", \"B\": \"Multiple System Atrophy (MSA)\", \"C\": \"Progressive Supranuclear Palsy\", \"D\": \"Lewy Body Dementia\"}",
    "correct_answer": "B",
    "source_file": "Promotion 2021_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2021,
    "explanation": "Classification Reason: Focuses on differentiating Idiopathic Parkinson's Disease from MSA based on the development of prominent autonomic failure (orthostatic hypotension) later in the disease course.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q171",
    "question_text": "A patient with Parkinson's disease on Sinemet every 4 hours and Selegiline complains of wearing off 2.5 hours before his next dose and peak dose dyskinesia. What is the best management option?",
    "options": "{\"A\": \"Deep Brain Stimulation (DBS) surgery\", \"B\": \"Add a Dopamine Agonist\", \"C\": \"Increase the frequency of Sinemet\", \"D\": \"Add a COMT inhibitor\"}",
    "correct_answer": "C",
    "source_file": "Promotion 2022_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2022,
    "explanation": "Classification Reason: Addresses the management of motor fluctuations (wearing off) and peak-dose dyskinesia, core challenges in treating Parkinson's disease.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q164",
    "question_text": "A male patient presents with parkinsonism and swallowing difficulty, and MRI shows atrophy of the midbrain. What is the most likely diagnosis?",
    "options": "{\"A\": \"Progressive Supranuclear Palsy (PSP)\", \"B\": \"Multiple System Atrophy (MSA)\", \"C\": \"Parkinson\\u2019s Disease\", \"D\": \"Corticobasal Degeneration\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2021_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2021,
    "explanation": "Classification Reason: Tests the ability to diagnose an atypical parkinsonian syndrome (Progressive Supranuclear Palsy) based on characteristic clinical features and neuroimaging findings.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q87",
    "question_text": "A 30-year-old female patient presents with parkinsonism and worsening dystonia. She had a similar presentation 10 years ago and improved with levodopa. What should you give her?",
    "options": "{\"A\": \"Levodopa\", \"B\": \"Dopaminergic agonist\", \"C\": \"Anticholinergic medication\", \"D\": \"Deep brain stimulation\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2021_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Describes a clinical scenario highly suggestive of Dopamine-Responsive Dystonia (Segawa syndrome), focusing on its characteristic levodopa response and treatment.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q33",
    "question_text": "A young female patient presents to the clinic with head tremor and neck pain. On exam, she has torticollis and reports improvement of her symptoms when she faces the wall. What is the most accurate statement?",
    "options": "{\"A\": \"She has a good response to sensory trick\", \"B\": \"Treatment with Botox is contraindicated\", \"C\": \"The symptoms are typical of essential tremor\", \"D\": \"Neck pain suggests a diagnosis of cervical spondylosis\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2020 copy_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2020,
    "explanation": "Classification Reason: Assesses understanding of dystonia symptoms (torticollis), characteristic features (sensory trick/'geste antagoniste'), and treatment implications.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q286",
    "question_text": "Palatal Myoclonus with continuous ear sound in a young male. What is the most likely explanation?",
    "options": "{\"A\": \"Caudate atrophy\", \"B\": \"It is myoclonic seizure\", \"C\": \"It is palatal myoclonus and it may continue in sleep\", \"D\": \"Not a movement disorder and will disappear in sleep\"}",
    "correct_answer": "C",
    "source_file": "Promotion 2018_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2018,
    "explanation": "Classification Reason: Tests knowledge about the characteristics of palatal myoclonus (symptomatic palatal tremor), a specific type of movement disorder, including associated symptoms (ear sound) and persistence during sleep.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q156",
    "question_text": "A case presents with axial rigidity and parkinsonism, and the patient has upgaze palsy. What is the likely diagnosis?",
    "options": "{\"A\": \"Progressive supranuclear palsy (PSP).\", \"B\": \"Parkinson\\u2019s disease\", \"C\": \"Multiple system atrophy\", \"D\": \"Corticobasal degeneration\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2019_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2019,
    "explanation": "Classification Reason: Asks for the diagnosis based on key clinical features (axial rigidity, parkinsonism, supranuclear gaze palsy) characteristic of Progressive Supranuclear Palsy (PSP).",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q158",
    "question_text": "Corticobasal Degeneration (CBD)",
    "options": "{\"A\": \"Characterized by early and prominent autonomic failure\", \"B\": \"Typically presents with asymmetric rigidity and apraxia\", \"C\": \"Responds well to levodopa therapy\", \"D\": \"Mainly affects the lower motor neurons\"}",
    "correct_answer": "B",
    "source_file": "Promotion 2021_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2021,
    "explanation": "Classification Reason: Refers to Corticobasal Degeneration, a distinct neurodegenerative atypical parkinsonian syndrome. (Assuming the implicit question relates to its features or diagnosis).",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q505",
    "question_text": "A Parkinson's disease patient on Sinemet every 4 hours and selegiline complains of wearing off 2.5 hours before his next dose and peak dose dyskinesia. What is the best course of action?",
    "options": "{\"A\": \"Deep brain stimulation (DBS) surgery\", \"B\": \"Add a dopamine agonist\", \"C\": \"Increase the frequency of Sinemet\", \"D\": \"Switch to a different medication\"}",
    "correct_answer": "C",
    "source_file": "Promotion 2023_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2023,
    "explanation": "Classification Reason: Focuses on the management strategies for common motor complications in Parkinson's disease, specifically wearing off and peak-dose dyskinesia.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q97",
    "question_text": "A patient with Parkinson's disease and dystonia is not improving with treatment. What is the most appropriate next step?",
    "options": "{\"A\": \"Increase Sinemet dosage\", \"B\": \"Add a dopamine agonist\", \"C\": \"DBS of the globus pallidus internus (GPi)\", \"D\": \"Start amantadine\"}",
    "correct_answer": "C",
    "source_file": "Part II 2018_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2018,
    "explanation": "Classification Reason: Asks about the next step in managing Parkinson's disease complicated by dystonia, including consideration of advanced therapies like Deep Brain Stimulation (DBS).",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q145",
    "question_text": "A Parkinson's patient on levodopa/carbidopa 25/250 Q4 and selegiline for 7 years has started to experience rigidity and wearing off symptoms for two and a half hours. What is the best management for peak dose dyskinesia?",
    "options": "{\"A\": \"Amantadine\", \"B\": \"Beta agonist pramipexole\", \"C\": \"Decrease levodopa dose and increase frequency\", \"D\": \"Add a COMT inhibitor\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2018_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2018,
    "explanation": "Classification Reason: Concerns the specific management of peak-dose dyskinesia and wearing-off phenomena in a patient with established Parkinson's disease.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q36",
    "question_text": "A 17-year-old boy has developed multiple verbal and motor tics since the age of 11. What is the diagnosis?",
    "options": "{\"A\": \"Tourette syndrome\", \"B\": \"Hemicrania continua\", \"C\": \"Medication overuse headache\", \"D\": \"Basilar migraine\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2020 copy_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2020,
    "explanation": "Classification Reason: Describes the typical age of onset and clinical features (motor and verbal tics) of Tourette syndrome and asks for the diagnosis.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q51",
    "question_text": "A patient with orthostatic tremor not tolerating clonazepam, what is the treatment?",
    "options": "{\"A\": \"Propranolol\", \"B\": \"Levodopa\", \"C\": \"Pramipexole\", \"D\": \"Trihexyphenidyl\"}",
    "correct_answer": "C",
    "source_file": "Part 2 2021_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Asks for alternative treatment options for orthostatic tremor, a specific tremor syndrome classified as a movement disorder.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q90",
    "question_text": "A young female has recurrent muscle (or neck) spasms triggered by sudden neck movement. What is the treatment?",
    "options": "{\"A\": \"Carbamazepine\", \"B\": \"Baclofen\", \"C\": \"Diazepam\", \"D\": \"Levodopa\"}",
    "correct_answer": "A",
    "source_file": "Part 2 Adult Neurology residency 2024 V9_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Describes symptoms consistent with paroxysmal kinesigenic dyskinesia (PKD), a type of movement disorder, and asks for the appropriate first-line treatment (Carbamazepine).",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q182",
    "question_text": "A patient with Parkinson's Disease for 6 years on Sinemet and experiencing depressed mood, changes in issues, and worsening dyskinesia also shows slowness and bradykinesia. What should be done?",
    "options": "{\"A\": \"Increase dose of Sinemet\", \"B\": \"Add Amantadine\", \"C\": \"Decrease dose of Sinemet\", \"D\": \"Add COMT inhibitor\"}",
    "correct_answer": "B",
    "source_file": "Part I 2022_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2022,
    "explanation": "Classification Reason: Focuses on adjusting dopaminergic therapy (managing bradykinesia vs. dyskinesia) in Parkinson's disease, a core aspect of movement disorder management.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q197",
    "question_text": "A patient with orthostatic tremor not tolerating clonazepam, what is the treatment?",
    "options": "{\"A\": \"Propranolol\", \"B\": \"Levodopa\", \"C\": \"Pramipexole\", \"D\": \"Trihexiphenidyl\"}",
    "correct_answer": "C",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Asks for alternative treatment options for orthostatic tremor, a specific tremor syndrome classified as a movement disorder.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q112",
    "question_text": "In a patient with Progressive Supranuclear Palsy (PSP) receiving Sinemet, which symptom is likely to improve?",
    "options": "{\"A\": \"Rigidity\", \"B\": \"Bradykinesia\", \"C\": \"Tremor\", \"D\": \"Postural instability\"}",
    "correct_answer": "A",
    "source_file": "Part II 2018_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2018,
    "explanation": "Classification Reason: Assesses understanding of the differential response to levodopa therapy in Progressive Supranuclear Palsy (an atypical parkinsonian syndrome) compared to idiopathic Parkinson's disease.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q22",
    "question_text": "What is the appropriate management for a Parkinson's disease patient on Sinemet 5 times daily who experiences wearing off 30 minutes before the next dose?",
    "options": "{\"A\": \"Add COMT inhibitors\", \"B\": \"Increase Sinemet dose\", \"C\": \"Add Selegiline\", \"D\": \"Switch to a different medication\"}",
    "correct_answer": "A",
    "source_file": "Part 2 - 2023_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2023,
    "explanation": "Classification Reason: Addresses the management of predictable \"wearing off\" motor fluctuations, a common issue in the treatment of Parkinson's disease.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q13",
    "question_text": "Which treatment is commonly used for paroxysmal exertion-induced dyskinesia?",
    "options": "{\"A\": \"L-Dopa\", \"B\": \"Clonazepam\", \"C\": \"Anticonvulsants\", \"D\": \"Acetazolamide\"}",
    "correct_answer": "D",
    "source_file": "Part 1 2020_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2020,
    "explanation": "Classification Reason: Asks about the specific treatment (often Acetazolamide) for Paroxysmal Exertion-Induced Dyskinesia, a distinct type of paroxysmal movement disorder.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q119",
    "question_text": "An elderly patient presented with abnormal limb movement. He described that his left upper limb seems to move involuntarily. He reported some memory issues. On examination, he exhibited involuntary left upper limb movement and visuospatial dissociation. What is the most likely diagnosis?",
    "options": "{\"A\": \"Multiple system atrophy\", \"B\": \"Corticobasal degeneration\", \"C\": \"Progressive supranuclear palsy\", \"D\": \"Lewy body dementia\"}",
    "correct_answer": "B",
    "source_file": "Part I 2023_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2023,
    "explanation": "Classification Reason: Describes key features (asymmetric involuntary movement, cognitive decline, alien limb phenomenon inferred, visuospatial issues) highly suggestive of Corticobasal Degeneration (CBD), an atypical parkinsonian syndrome.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q39",
    "question_text": "A 16-year-old had dystonia that improved with wine, and her father has the same symptoms. What is the treatment?",
    "options": "{\"A\": \"Clonazepam\", \"B\": \"Valproate\", \"C\": \"Trihexyphenidyl\", \"D\": \"Gabapentin\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2021_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Describes a scenario suggestive of Myoclonus-Dystonia syndrome (characterized by alcohol responsiveness) and asks about potential treatment options (Clonazepam is often used).",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q135",
    "question_text": "In a patient with hemifacial spasm, what is the most common treatment option?",
    "options": "{\"A\": \"Botox\", \"B\": \"Carbamazepine\", \"C\": \"Clonazepam\", \"D\": \"Gabapentin\"}",
    "correct_answer": "A",
    "source_file": "Part II 2018_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2018,
    "explanation": "Classification Reason: Asks for the most common treatment (Botulinum toxin/Botox) for hemifacial spasm, which is phenotypically classified and managed as a focal movement disorder.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q132",
    "question_text": "A patient presents with dystonia, tremor, and Parkinsonism. MRI shows bilateral basal ganglia and brainstem hyperintensity. What treatment would you consider for Wilson's disease?",
    "options": "{\"A\": \"Levodopa\", \"B\": \"D-penicillamine\", \"C\": \"Botulinum toxin\", \"D\": \"Deep brain stimulation\"}",
    "correct_answer": "B",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Asks for the treatment of Wilson's disease, focusing on its common movement disorder manifestations (dystonia, tremor, parkinsonism).",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q165",
    "question_text": "A 70-year-old male patient presents with recurrent falls and gait imbalance over the last 6 months. On examination, he has a masked face, vertical gaze palsy, retrocollis, and bradykinesia. MRI findings are pending. What is the most likely diagnosis?",
    "options": "{\"A\": \"Progressive Supranuclear Palsy (PSP)\", \"B\": \"Multiple System Atrophy (MSA)\", \"C\": \"Lewy Body Dementia (LBD)\", \"D\": \"Corticobasal Degeneration (CBD)\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2022_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2022,
    "explanation": "Classification Reason: Describes classic clinical features (vertical gaze palsy, falls, parkinsonism) pointing towards Progressive Supranuclear Palsy (PSP), an atypical parkinsonian syndrome.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q225",
    "question_text": "A patient with orthostatic tremor is not tolerating clonazepam. What is the second-line treatment?",
    "options": "{\"A\": \"Propranolol\", \"B\": \"Levodopa\", \"C\": \"Pramipexol\", \"D\": \"Trihexyphenidyl\"}",
    "correct_answer": "C",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Focuses on the pharmacological management (second-line treatment) of orthostatic tremor, a specific type of movement disorder.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q47",
    "question_text": "A Parkinson's disease patient on levodopa/Carbidopa every 4 hours experiences reoccurrence of rigidity and tremors half an hour before the next dose. What is this phenomenon called?",
    "options": "{\"A\": \"Peak dose dyskinesia\", \"B\": \"On & off phenomena\", \"C\": \"Wearing-off phenomenon\", \"D\": \"Drug-induced psychosis\"}",
    "correct_answer": "B",
    "source_file": "Part 1 2021_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2021,
    "explanation": "Classification Reason: Tests knowledge of motor fluctuations (specifically 'wearing-off') experienced by Parkinson's disease patients on levodopa therapy.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q223",
    "question_text": "In a patient with essential tremor and asthma, which medication is commonly used?",
    "options": "{\"A\": \"Primidone\", \"B\": \"Propranolol\", \"C\": \"Gabapentin\", \"D\": \"Topiramate\"}",
    "correct_answer": "A",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Addresses the treatment of essential tremor, considering a common comorbidity (asthma) that influences medication choice (avoiding non-selective beta-blockers).",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q11",
    "question_text": "What is the typical age of onset for paroxysmal nonkinesigenic dyskinesia?",
    "options": "{\"A\": \"Birth to early childhood\", \"B\": \"1-40 years\", \"C\": \"2-20 years\", \"D\": \"0-40 years\"}",
    "correct_answer": "B",
    "source_file": "Part 1 2020_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2020,
    "explanation": "Classification Reason: Asks about the epidemiology (age of onset) of a specific paroxysmal movement disorder (PNKD).",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q166",
    "question_text": "A 70-year-old male patient has a history of urinary retention, syncope, and memory impairment. He later developed laryngeal stridor. MRI findings are pending. What is the most likely diagnosis?",
    "options": "{\"A\": \"Progressive Supranuclear Palsy (PSP)\", \"B\": \"Multiple System Atrophy (MSA)\", \"C\": \"Lewy Body Dementia (LBD)\", \"D\": \"Corticobasal Degeneration (CBD)\"}",
    "correct_answer": "B",
    "source_file": "Promotion 2022_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2022,
    "explanation": "Classification Reason: Describes a combination of autonomic failure (urinary retention, syncope), possible cognitive impairment, parkinsonism (implied by options), and laryngeal stridor, highly suggestive of Multiple System Atrophy (MSA).",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q39",
    "question_text": "Pathology showed Lewy bodies. What is the diagnosis?",
    "options": "{\"A\": \"Lewy body dementia\", \"B\": \"Alzheimer's disease\", \"C\": \"Parkinson's disease\", \"D\": \"Multiple system atrophy\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2021_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Tests knowledge of the core pathology (Lewy bodies) underlying synucleinopathies, which include Parkinson's disease, Dementia with Lewy Bodies, and MSA, all frequently managed within movement disorders.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q8",
    "question_text": "A patient exhibits palatal abnormal movements that are fast, rhythmic, and persist during sleep. What is the likely diagnosis?",
    "options": "{\"A\": \"Symptomatic palatal myoclonus\", \"B\": \"Essential palatal myoclonus\", \"C\": \"Palatal tremor\", \"D\": \"Palatal dystonia\"}",
    "correct_answer": "A",
    "source_file": "Part 1 2020_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2020,
    "explanation": "Classification Reason: Focuses on diagnosing palatal myoclonus based on clinical characteristics (persistence during sleep suggesting symptomatic type).",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q37",
    "question_text": "What is the PET finding in CBDG?",
    "options": "{\"A\": \"Specific finding not provided\", \"B\": \"Generalized atrophy\", \"C\": \"Increased glucose metabolism\", \"D\": \"Decreased glucose metabolism\"}",
    "correct_answer": "D",
    "source_file": "Part 2 2020 copy_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2020,
    "explanation": "Classification Reason: Asks about characteristic neuroimaging (FDG-PET hypometabolism patterns) in Corticobasal Degeneration (CBD), an atypical parkinsonian syndrome.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q118",
    "question_text": "A 67-year-old man with a 3-year history of Parkinson disease has had increasingly distressing problems with visual and auditory hallucinations and very severe and disturbing delusions. Which of the following medications is US Food and Drug Administration (FDA) approved for treatment of these symptoms in Parkinson disease?",
    "options": "{\"A\": \"Clozapine\", \"B\": \"Lurasidone\", \"C\": \"Pimavanserin\", \"D\": \"Quetiapine\"}",
    "correct_answer": "C",
    "source_file": "Part II 2018_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2018,
    "explanation": "Classification Reason: Deals with the management of non-motor symptoms (psychosis) specifically occurring in the context of Parkinson's disease.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q224",
    "question_text": "A 30-year-old female patient presents with parkinsonism and worsening dystonia. She had a similar presentation 10 years ago and improved with levodopa. What should you prescribe for her today?",
    "options": "{\"A\": \"Levodopa\", \"B\": \"Dopamine agonist\", \"C\": \"Anticholinergic medication\", \"D\": \"Deep brain stimulation\"}",
    "correct_answer": "A",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Describes a clinical scenario highly suggestive of Dopa-Responsive Dystonia (Segawa syndrome) and asks about its primary treatment (Levodopa).",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q60",
    "question_text": "A patient with schizophrenia on antipsychotics presents with orolingual dystonia. What is the diagnosis?",
    "options": "{\"A\": \"Tardive Dyskinesia\", \"B\": \"Acute Dystonic Reaction\", \"C\": \"Neuroleptic Malignant Syndrome\", \"D\": \"Parkinsonism\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2021_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Focuses on identifying a drug-induced movement disorder (Tardive Dyskinesia) resulting from antipsychotic use.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q134",
    "question_text": "What is the first-line treatment for Sydenham chorea?",
    "options": "{\"A\": \"Haloperidol\", \"B\": \"Valproic acid\", \"C\": \"Carbamazepine (CMZ)\", \"D\": \"Prednisolone\"}",
    "correct_answer": "A",
    "source_file": "Part II 2018_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2018,
    "explanation": "Classification Reason: Asks about the pharmacological management of Sydenham chorea, a specific type of acquired chorea.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q189",
    "question_text": "Scenario of a girl with dystonia, no Parkinsonism features. What is the most likely diagnosis?",
    "options": "{\"A\": \"DYT 1\", \"B\": \"DYT 5 (GCH1)\", \"C\": \"Wilson\\u2019s disease\", \"D\": \"Dopa-responsive dystonia\"}",
    "correct_answer": "A",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Focuses on the differential diagnosis of isolated dystonia in a young person, likely pointing towards primary genetic dystonias (like DYT1).",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q118",
    "question_text": "In a girl with Sydenham chorea, what laboratory test is indicated?",
    "options": "{\"A\": \"ASO titer\", \"B\": \"Anti-DNase B antibody\", \"C\": \"Serum ceruloplasmin\", \"D\": \"Thyroid function tests\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2021_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Asks about the diagnostic workup (specifically testing for antecedent streptococcal infection) for Sydenham chorea, a movement disorder.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q9",
    "question_text": "What is the pathology associated with Multiple System Atrophy (MSA)?",
    "options": "{\"A\": \"Iron deposition\", \"B\": \"Glial cytoplasmic inclusions\", \"C\": \"Neurofibrillary tangles\", \"D\": \"Lewy bodies\"}",
    "correct_answer": "B",
    "source_file": "Part I 2018_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2018,
    "explanation": "Classification Reason: Tests knowledge of the specific neuropathological hallmark (glial cytoplasmic inclusions) of Multiple System Atrophy (MSA).",
    "subspecialty": "Movement Disorders"
  }
]